[{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/oNgFmgd6eO","expanded_url":"http://bit.ly/1mGZAuQ","display_url":"bit.ly/1mGZAuQ"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"489069407331971075","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T15:30:07.000Z","conversation_id":"489069407331971075","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Publication of the monthly bulletin from the Spanish medicines agency for the month of June 2014 http://t.co/oNgFmgd6eO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"annotations":[{"start":17,"end":28,"probability":0.4427,"type":"Organization","normalized_text":"FDA MedWatch"}],"hashtags":{}},"id":"489065182090760192","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T15:13:20.000Z","conversation_id":"489065182090760192","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAMedWatch: FDA MedWatch - June 2014 Safety Labeling Changes includes 52 products with revisions to Prescribing Information http://t.c…","referenced_tweets":[{"type":"retweeted","id":"489065069804650496"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":96,"end":111,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{},"hashtags":[{"start":71,"end":79,"tag":"measles"},{"start":86,"end":94,"tag":"rubella"}]},"id":"489057586877329409","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T14:43:09.000Z","conversation_id":"489057586877329409","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe: Are you interested in joining our mission to eliminate #measles &amp; #rubella? @WHO_Europe_VPI calls for consultants: http://t…","referenced_tweets":[{"type":"retweeted","id":"489052896194228224"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":69,"end":74,"probability":0.7532,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":80,"end":90,"tag":"influenza"}]},"id":"489057503792361473","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T14:42:49.000Z","conversation_id":"489057503792361473","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Presentations from this year's annual joint ECDC &amp; WHO/Europe #influenza surveillance meeting are now available: http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"489052840137347072"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/BEF5oMF3L0","expanded_url":"http://ow.ly/zaZS8","display_url":"ow.ly/zaZS8"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{},"hashtags":[{"start":53,"end":61,"tag":"generic"}]},"id":"489056709420539904","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T14:39:40.000Z","conversation_id":"489056709420539904","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Changes in color &amp; shape for a #generic medication may lead to some patients discontinuing use http://t.co/BEF5oMF3L0","referenced_tweets":[{"type":"retweeted","id":"489047479686803456"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/FVbMSJBKGN","expanded_url":"http://bit.ly/1wpVPee","display_url":"bit.ly/1wpVPee"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":90,"end":97,"tag":"Sunset"},{"start":98,"end":105,"tag":"Yellow"}]},"id":"489045130503274496","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T13:53:39.000Z","conversation_id":"489045130503274496","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: Reconsideration of the temporary ADI and refined exposure assessment for #Sunset #Yellow FCF (E110) http://t.co/FVbMSJBKGN","referenced_tweets":[{"type":"retweeted","id":"489040553758457856"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/631MrdDNPP","expanded_url":"http://bit.ly/1ksrZAz","display_url":"bit.ly/1ksrZAz"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":{}},"id":"489045022437040128","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T13:53:14.000Z","conversation_id":"489045022437040128","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: 26 September French medicines agency meeting: see the programme of talks and round tables http://t.co/631MrdDNPP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/4jIIdxezDr","expanded_url":"http://bit.ly/1mGACfl","display_url":"bit.ly/1mGACfl"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":{}},"id":"489044509536571392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T13:51:11.000Z","conversation_id":"489044509536571392","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: 1st French medicines agency meeting, Friday, 26 September 2014, at Maison de la Chimie http://t.co/4jIIdxezDr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{},"hashtags":{}},"id":"489043248443555840","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T13:46:11.000Z","conversation_id":"489043248443555840","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IlaeWeb: The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy-and more online Epilepsia articles http://t…","referenced_tweets":[{"type":"retweeted","id":"489036335383334913"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/BmJzHxNA05","expanded_url":"http://bit.ly/1ksqiTI","display_url":"bit.ly/1ksqiTI"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":20,"end":25,"tag":"PRAC"}]},"id":"489042518290747393","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T13:43:16.000Z","conversation_id":"489042518290747393","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: #PRAC recommends suspension and reformulation of oral methadone solutions containing povidone http://t.co/BmJzHxNA05","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/3MUWosBHqJ","expanded_url":"http://bit.ly/1tLJzIV","display_url":"bit.ly/1tLJzIV"}],"mentions":{},"annotations":{},"hashtags":[{"start":63,"end":73,"tag":"Myroxylon"},{"start":108,"end":115,"tag":"herbal"},{"start":116,"end":129,"tag":"consultation"}]},"id":"489001666809982977","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T11:00:57.000Z","conversation_id":"489001666809982977","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're calling for scientific data to use in assessment work on #Myroxylon balsamum: http://t.co/3MUWosBHqJ  #herbal #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/uFtC4tFzKn","expanded_url":"http://n.pr/1iQf5uT","display_url":"n.pr/1iQf5uT"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{},"hashtags":{}},"id":"488991787743449089","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T10:21:41.000Z","conversation_id":"488991787743449089","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: Hospitals Put Pharmacists In The ER To Cut Medication Errors http://t.co/uFtC4tFzKn","referenced_tweets":[{"type":"retweeted","id":"488991236229853184"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/pgQtvvbcaI","expanded_url":"http://www.LifeTrain.eu","display_url":"LifeTrain.eu"},{"start":71,"end":93,"url":"http://t.co/S01tyGd42Z","expanded_url":"https://twitter.com/Eu2P/status/488989373833412608/photo/1","display_url":"pic.twitter.com/S01tyGd42Z"}],"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"},{"start":18,"end":32,"username":"IMI_LifeTrain","id":"2200520319"}],"annotations":{},"hashtags":{}},"id":"488989648061218816","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T10:13:11.000Z","conversation_id":"488989648061218816","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Eu2P: The new @IMI_LifeTrain website is out http://t.co/pgQtvvbcaI http://t.co/S01tyGd42Z","referenced_tweets":[{"type":"retweeted","id":"488989373833412608"}],"attachments":{"media_keys":["3_488989371169656832"]}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/6ucX0LxJFW","expanded_url":"http://bit.ly/1nrwFX3","display_url":"bit.ly/1nrwFX3"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{},"hashtags":{}},"id":"488985984500260865","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T09:58:38.000Z","conversation_id":"488985984500260865","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Information on periodic-safety-update-report single-assessment procedure (PSUSA) http://t.co/6ucX0LxJFW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/AMjPioOXw4","expanded_url":"http://bit.ly/1nCfLdc","display_url":"bit.ly/1nCfLdc"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{},"hashtags":{}},"id":"488985888337453056","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T09:58:15.000Z","conversation_id":"488985888337453056","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @GCessak: Information on periodic-safety-update-report single-assessment procedure (PSUSA) http://t.co/AMjPioOXw4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/3MUWosBHqJ","expanded_url":"http://bit.ly/1tLJzIV","display_url":"bit.ly/1tLJzIV"}],"mentions":{},"annotations":{},"hashtags":[{"start":72,"end":82,"tag":"Myroxylon"},{"start":116,"end":123,"tag":"herbal"},{"start":124,"end":137,"tag":"consultation"}]},"id":"488970936654503936","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T08:58:50.000Z","conversation_id":"488970936654503936","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've released a call for scientific data for use in assessment work on #Myroxylon balsamum: http://t.co/3MUWosBHqJ #herbal #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/IW7KQoZAmn","expanded_url":"http://www.alz.org/aaic/releases_2014/sun-830am-smell-eye-tests.asp","display_url":"alz.org/aaic/releases_…"}],"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"}],"annotations":{},"hashtags":[{"start":60,"end":71,"tag":"biomarkers"},{"start":76,"end":85,"tag":"dementia"},{"start":89,"end":94,"tag":"AAIC"}]},"id":"488965924654174208","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T08:38:55.000Z","conversation_id":"488965924654174208","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @JeanGeorgesAE: Focus on eye sight and smell as possible #biomarkers for #dementia at #AAIC http://t.co/IW7KQoZAmn","referenced_tweets":[{"type":"retweeted","id":"488965292119560192"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":{},"hashtags":{}},"id":"488965802872565760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-15T08:38:26.000Z","conversation_id":"488965802872565760","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ICH_news: ICH M7 Guideline on Genotoxicity reaches Step 4 of the ICH Process and moves towards implementation! See http://t.co/O3DMQOKH…","referenced_tweets":[{"type":"retweeted","id":"488963615182307328"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/n85CZPKBy5","expanded_url":"http://bit.ly/1wkFMOJ","display_url":"bit.ly/1wkFMOJ"}],"mentions":{},"annotations":{},"hashtags":[{"start":45,"end":66,"tag":"pharmacoepidemiology"},{"start":86,"end":102,"tag":"pharmacogenetic"}]},"id":"488730124893057024","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T17:01:56.000Z","conversation_id":"488730124893057024","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Revised guide on methodological standards in #pharmacoepidemiology now has chapter on #pharmacogenetic studies: http://t.co/n85CZPKBy5","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":18,"end":32,"username":"HealthFirstEU","id":"216314816"},{"start":33,"end":42,"username":"it2014eu","id":"789311676982042628"}],"annotations":{},"hashtags":[{"start":43,"end":49,"tag":"EPSCO"},{"start":68,"end":82,"tag":"patientsafety"},{"start":84,"end":91,"tag":"health"},{"start":112,"end":119,"tag":"health"}]},"id":"488721405127979008","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T16:27:17.000Z","conversation_id":"488721405127979008","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: MT @HealthFirstEU @IT2014EU #EPSCO meets tomorrow on #patientsafety, #health system performance, #health strategy http://t.c…","referenced_tweets":[{"type":"retweeted","id":"488699078688378881"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/KDxOUYsQyN","expanded_url":"http://europa.eu/!RQ47Tw","display_url":"europa.eu/!RQ47Tw"}],"mentions":[{"start":3,"end":11,"username":"EU_EDPS","id":"596377986"}],"annotations":{},"hashtags":[{"start":27,"end":32,"tag":"data"},{"start":46,"end":61,"tag":"EUinstitutions"}]},"id":"488721001573015552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T16:25:41.000Z","conversation_id":"488721001573015552","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_EDPS: International #data transfers by #EUinstitutions &amp; bodies. Read more: http://t.co/KDxOUYsQyN","referenced_tweets":[{"type":"retweeted","id":"488713837009723392"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/hHUEHpcn1G","expanded_url":"http://bit.ly/1mC1RaJ","display_url":"bit.ly/1mC1RaJ"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":36,"end":46,"tag":"pesticide"},{"start":87,"end":101,"tag":"sulfosulfuron"}]},"id":"488720920476135424","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T16:25:22.000Z","conversation_id":"488720920476135424","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: Peer review of the #pesticide risk assessment of the active substance #sulfosulfuron http://t.co/hHUEHpcn1G","referenced_tweets":[{"type":"retweeted","id":"488714593196593152"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/IWuj9ayd2G","expanded_url":"http://bit.ly/1qvRho2","display_url":"bit.ly/1qvRho2"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":36,"end":39,"probability":0.3697,"type":"Organization","normalized_text":"EFSA"}],"hashtags":{}},"id":"488672149125996544","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T13:11:34.000Z","conversation_id":"488672149125996544","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Are you satisfied with EFSA’s support on regulated products? Last week to take the satisfaction survey http://t.co/IWuj9ayd2G","referenced_tweets":[{"type":"retweeted","id":"488620866205671424"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/jXbnqsmytv","expanded_url":"http://bit.ly/1oVvxOg","display_url":"bit.ly/1oVvxOg"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":49,"end":59,"tag":"Parkinson"}]},"id":"488670863391485952","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T13:06:27.000Z","conversation_id":"488670863391485952","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: High-frequency oscillations in #Parkinson's disease: Spatial distribution &amp; clinical relevance - http://t.co/jXbnqsmytv","referenced_tweets":[{"type":"retweeted","id":"488659694303449088"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/TzaTXjzBRV","expanded_url":"http://ht.ly/yZQup","display_url":"ht.ly/yZQup"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":40,"end":46,"probability":0.2214,"type":"Organization","normalized_text":"NIH/FDA"}],"hashtags":{}},"id":"488670548093075459","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T13:05:12.000Z","conversation_id":"488670548093075459","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: Last chance: register for NIH/FDA antimicrobial resistance workshop by July 14. http://t.co/TzaTXjzBRV","referenced_tweets":[{"type":"retweeted","id":"488666860955926530"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/vsNsP3Smyc","expanded_url":"http://bit.ly/1ozmWzl","display_url":"bit.ly/1ozmWzl"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":92,"end":97,"tag":"ANSM"}]},"id":"488670216566882304","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T13:03:53.000Z","conversation_id":"488670216566882304","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: Safety of health products: 10 pilot projects by patient associations supported by #ANSM http://t.co/vsNsP3Smyc","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/YgXKkxCOTV","expanded_url":"http://dlvr.it/6KB2sL","display_url":"dlvr.it/6KB2sL"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":14,"end":20,"tag":"H2020"}]},"id":"488616911358689280","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T09:32:04.000Z","conversation_id":"488616911358689280","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: #H2020 calls - Health Co-ordination Activities http://t.co/YgXKkxCOTV","referenced_tweets":[{"type":"retweeted","id":"488571611637768192"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/X0Zm9L6swU","expanded_url":"http://bit.ly/1nmXJqx","display_url":"bit.ly/1nmXJqx"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":126,"end":129,"username":"UN","id":"14159148"},{"start":130,"end":138,"username":"borgton","id":"1605512862"}],"annotations":{},"hashtags":[{"start":97,"end":102,"tag":"NCDs"}]},"id":"488616231961133057","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T09:29:22.000Z","conversation_id":"488616231961133057","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Non-communicable diseases claim 36 million lives each year: UN high level meeting #NCDs http://t.co/X0Zm9L6swU @UN @borgton …","referenced_tweets":[{"type":"retweeted","id":"488613377305223168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/LKTfe9A0ct","expanded_url":"http://bit.ly/1oK8SEp","display_url":"bit.ly/1oK8SEp"}],"mentions":{},"annotations":{},"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"},{"start":73,"end":78,"tag":"PRAC"}]},"id":"488613486650753024","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T09:18:27.000Z","conversation_id":"488613486650753024","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Highlights from last week's meeting of our #pharmacovigilance committee (#PRAC): http://t.co/LKTfe9A0ct","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/00rr6yMyVK","expanded_url":"http://bit.ly/1mnxrJe","display_url":"bit.ly/1mnxrJe"}],"mentions":{},"annotations":{},"hashtags":[{"start":57,"end":68,"tag":"veterinary"},{"start":69,"end":78,"tag":"medicine"},{"start":80,"end":85,"tag":"CVMP"}]},"id":"488613234761826304","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T09:17:27.000Z","conversation_id":"488613234761826304","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Highlights from last week's meeting of our committee for #veterinary #medicine (#CVMP): http://t.co/00rr6yMyVK","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/n85CZPKBy5","expanded_url":"http://bit.ly/1wkFMOJ","display_url":"bit.ly/1wkFMOJ"}],"mentions":{},"annotations":{},"hashtags":[{"start":15,"end":31,"tag":"pharmacogenetic"},{"start":88,"end":109,"tag":"pharmacoepidemiology"}]},"id":"488612641720762369","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-14T09:15:06.000Z","conversation_id":"488612641720762369","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"New chapter on #pharmacogenetic studies in revised guide on methodological standards in #pharmacoepidemiology: http://t.co/n85CZPKBy5","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/RjFqSwDMcX","expanded_url":"http://go.usa.gov/XdC5","display_url":"go.usa.gov/XdC5"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":33,"end":35,"probability":0.8939,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}]},"id":"487615876892745728","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T15:14:19.000Z","conversation_id":"487615876892745728","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: #FDAVoice: Learn how FDA is Protecting the Global Drug Supply through FDASIA Title VII  http://t.co/RjFqSwDMcX","referenced_tweets":[{"type":"retweeted","id":"487611624984182784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/7VVyhxKiMo","expanded_url":"http://bit.ly/HDIVINOCELL","display_url":"bit.ly/HDIVINOCELL"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"487610896710373376","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T14:54:31.000Z","conversation_id":"487610896710373376","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Could shining molecules pave the way to new antibiotics? EU-funded project DIVINOCELL explores: http://t.co/7VVyhxKiMo…","referenced_tweets":[{"type":"retweeted","id":"487610253052493824"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":{}},"id":"487605562612666368","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T14:33:20.000Z","conversation_id":"487605562612666368","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: EFSA publishes its list of upcoming grant and procurement calls: see how you could support our scientific work  http://t.co/x9…","referenced_tweets":[{"type":"retweeted","id":"487605147221381120"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/WkRslhHHzm","expanded_url":"http://bit.ly/1qriGEq","display_url":"bit.ly/1qriGEq"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":25,"end":36,"tag":"Vigilances"}]},"id":"487605446061342720","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T14:32:52.000Z","conversation_id":"487605446061342720","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @ansm: See the latest #Vigilances newsletter from the French medicines agency at http://t.co/WkRslhHHzm","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/1ZfEj0gY24","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":[{"start":0,"end":10,"username":"MVIHannah","id":"2364198660"}],"annotations":{},"hashtags":{}},"id":"487604704655183874","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T14:29:55.000Z","conversation_id":"487600229186019328","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@MVIHannah Sure. Please send your questions to us using our online form: http://t.co/1ZfEj0gY24","referenced_tweets":[{"type":"replied_to","id":"487600229186019328"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"2364198660"},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/sVY7W1NbCe","expanded_url":"http://bit.ly/1q3AHwM","display_url":"bit.ly/1q3AHwM"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{},"hashtags":{}},"id":"487598787586949120","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T14:06:24.000Z","conversation_id":"487598787586949120","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Bromocriptine - completion of safety review http://t.co/sVY7W1NbCe","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/9v4bzcpb1K","expanded_url":"http://bit.ly/1qree8B","display_url":"bit.ly/1qree8B"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{},"hashtags":{}},"id":"487598562864558080","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T14:05:31.000Z","conversation_id":"487598562864558080","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Methadone - completion of safety review  http://t.co/9v4bzcpb1K","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/8GDPSFCQBf","expanded_url":"http://bit.ly/1qrcMmL","display_url":"bit.ly/1qrcMmL"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{},"hashtags":{}},"id":"487596328764325888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T13:56:38.000Z","conversation_id":"487596328764325888","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"RT @LV_MPA: PRAC recommends suspension and reformulation of oral methadone solutions containing povidone http://t.co/8GDPSFCQBf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/00rr6yMyVK","expanded_url":"http://bit.ly/1mnxrJe","display_url":"bit.ly/1mnxrJe"}],"mentions":{},"annotations":{},"hashtags":[{"start":40,"end":51,"tag":"veterinary"},{"start":72,"end":77,"tag":"CVMP"}]},"id":"487590172352335872","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T13:32:10.000Z","conversation_id":"487590172352335872","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the highlights from our #veterinary medicine committee (#CVMP) meeting: http://t.co/00rr6yMyVK","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{},"hashtags":{}},"id":"487583603677986816","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T13:06:04.000Z","conversation_id":"487238733213995008","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@thedanalyst The discussion on this medicine is still ongoing. We will publish the PRAC's recommendation after a future meeting.","referenced_tweets":[{"type":"replied_to","id":"487580898158997504"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"614450788"},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/lAz5xxLOwO","expanded_url":"http://bit.ly/1rdOZIi","display_url":"bit.ly/1rdOZIi"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{},"hashtags":{}},"id":"487582190042357760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T13:00:27.000Z","conversation_id":"487582190042357760","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @LV_MPA: European investigation provides support for the possible use of paracetamol during pregnancy http://t.co/lAz5xxLOwO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/3tuGnro18C","expanded_url":"http://bit.ly/1rdO5LT","display_url":"bit.ly/1rdO5LT"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"487580687848185856","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T12:54:29.000Z","conversation_id":"487580687848185856","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Bromocriptine (Parlodel®) in inhibition of lactation: conditions of use\nhttp://t.co/3tuGnro18C","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/oSiMeOX9P7","expanded_url":"http://bit.ly/1rdNWrP","display_url":"bit.ly/1rdNWrP"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"487580486685171712","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T12:53:41.000Z","conversation_id":"487580486685171712","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Note on hospital use of the chickenpox vaccine http://t.co/oSiMeOX9P7","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/gGO2Z4M6Ls","expanded_url":"http://www.independent.co.uk/news/world/americas/hiv-reappears-in-child-previously-thought-to-be-functionally-cured-9599275.html","display_url":"independent.co.uk/news/world/ame…"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{},"hashtags":[{"start":20,"end":24,"tag":"HIV"},{"start":116,"end":121,"tag":"AIDS"}]},"id":"487577476487712768","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T12:41:43.000Z","conversation_id":"487577476487712768","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @nakosbalamotis: #HIV reappears in child previously thought to be 'functionally cured' :( http://t.co/gGO2Z4M6Ls #AIDS","referenced_tweets":[{"type":"retweeted","id":"487545081956560896"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/Xfox0bfYhJ","expanded_url":"http://ow.ly/3mXzbW","display_url":"ow.ly/3mXzbW"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{},"hashtags":{}},"id":"487577324788125696","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T12:41:07.000Z","conversation_id":"487577324788125696","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Baby Thought To Be Cured Of HIV Tests Positive For The Virus http://t.co/Xfox0bfYhJ","referenced_tweets":[{"type":"retweeted","id":"487576937162760192"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/ApT6QKLmir","expanded_url":"http://bit.ly/1mnkNtM","display_url":"bit.ly/1mnkNtM"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":{}},"id":"487576539996094464","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T12:38:00.000Z","conversation_id":"487576539996094464","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: 2013: Access to innovation: more than 6000 patients included in cohort temporary use authorisations http://t.co/ApT6QKLmir","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/ddONvmf4m5","expanded_url":"http://bit.ly/1s1EoD3","display_url":"bit.ly/1s1EoD3"}],"mentions":{},"annotations":{},"hashtags":[{"start":76,"end":91,"tag":"EudraVigilance"},{"start":116,"end":129,"tag":"consultation"}]},"id":"487554250411892736","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T11:09:26.000Z","conversation_id":"487554250411892736","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our guide on monitoring medical literature and #EudraVigilance: http://t.co/ddONvmf4m5 #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/6sS5jnkHe1","expanded_url":"http://bit.ly/1qVcuWs","display_url":"bit.ly/1qVcuWs"}],"mentions":{},"annotations":[{"start":32,"end":35,"probability":0.4356,"type":"Organization","normalized_text":"VICH"}],"hashtags":[{"start":124,"end":137,"tag":"consultation"}]},"id":"487554173014396928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T11:09:07.000Z","conversation_id":"487554173014396928","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week left to comment on the VICH guideline on file formats for electronic exchange of documents: http://t.co/6sS5jnkHe1 #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/LKTfe9A0ct","expanded_url":"http://bit.ly/1oK8SEp","display_url":"bit.ly/1oK8SEp"}],"mentions":{},"annotations":{},"hashtags":[{"start":53,"end":71,"tag":"pharmacovigilance"},{"start":83,"end":88,"tag":"PRAC"}]},"id":"487553753495916544","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T11:07:27.000Z","conversation_id":"487553753495916544","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We've just published the meeting highlights from our #pharmacovigilance committee (#PRAC) meeting: http://t.co/LKTfe9A0ct","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/LOShQeW5so","expanded_url":"http://bit.ly/nql9a4","display_url":"bit.ly/nql9a4"},{"start":99,"end":121,"url":"http://t.co/B0u47mkaY5","expanded_url":"http://bit.ly/1q3ktDK","display_url":"bit.ly/1q3ktDK"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"487552146372841472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T11:01:04.000Z","conversation_id":"487552146372841472","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: New section on clinical research with veterinary medicines on http://t.co/LOShQeW5so\nhttp://t.co/B0u47mkaY5","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/FflQq61Wra","expanded_url":"http://bit.ly/1jx9dwT","display_url":"bit.ly/1jx9dwT"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"487551712111382528","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T10:59:21.000Z","conversation_id":"487551712111382528","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"lang":"pt","text":"RT @AEMPSGOB: Strontium ranelate (▼Osseor®, ▼Protelos®): qualified as medicine of hospital diagnosis\nhttp://t.co/FflQq61Wra","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/FflQq61Wra","expanded_url":"http://bit.ly/1jx9dwT","display_url":"bit.ly/1jx9dwT"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"487537522369908736","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T10:02:58.000Z","conversation_id":"487537522369908736","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"pt","text":"RT @AEMPSGOB: Strontium ranelate (▼Osseor®, ▼Protelos®): qualified as medicine of hospital diagnosis http://t.co/FflQq61Wra","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/M167IOtRkV","expanded_url":"http://www.nejm.org/doi/full/10.1056/NEJMp1401767","display_url":"nejm.org/doi/full/10.10…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":26,"tag":"NEJM"}]},"id":"487536162886922241","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:57:33.000Z","conversation_id":"487536162886922241","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #NEJM Drug Safety in the Digital Age http://t.co/M167IOtRkV","referenced_tweets":[{"type":"retweeted","id":"487532978126729216"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/sQss4VsLzS","expanded_url":"http://www.nejm.org/doi/full/10.1056/NEJMp1402969","display_url":"nejm.org/doi/full/10.10…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":26,"tag":"NEJM"}]},"id":"487536018317258752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:56:59.000Z","conversation_id":"487536018317258752","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #NEJM Clinical Trial Transparency — Antidote to Weaker Off-Label-Promotion Rules? http://t.co/sQss4VsLzS","referenced_tweets":[{"type":"retweeted","id":"487531839478054913"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/9JyWUUeUVH","expanded_url":"http://www.bmj.com/content/348/bmj.g3710","display_url":"bmj.com/content/348/bm…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"BMJ"}]},"id":"487531165314985984","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:37:42.000Z","conversation_id":"487531165314985984","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #BMJ New EU clinical trials regulation http://t.co/9JyWUUeUVH","referenced_tweets":[{"type":"retweeted","id":"487530489885253632"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":111,"end":119,"username":"FOR_DMD","id":"1288202186"},{"start":120,"end":130,"username":"TREAT_NMD","id":"301911808"}],"annotations":{},"hashtags":[{"start":46,"end":55,"tag":"duchenne"}]},"id":"487529631286050816","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:31:36.000Z","conversation_id":"487529631286050816","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @BushbyKate: Review of status of trials in #duchenne, including issues of best use of steroids as tested by @FOR_DMD @TREAT_NMD http://t…","referenced_tweets":[{"type":"retweeted","id":"487529014018711552"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/HM0IxgDVJa","expanded_url":"http://www.bmj.com/content/349/bmj.g4506","display_url":"bmj.com/content/349/bm…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":64,"end":72,"probability":0.7152,"type":"Other","normalized_text":"Alzheimer"}],"hashtags":[{"start":21,"end":25,"tag":"BMJ"}]},"id":"487527387480223744","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:22:41.000Z","conversation_id":"487527387480223744","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #BMJ Blood test may predict progression to Alzheimer’s disease http://t.co/HM0IxgDVJa","referenced_tweets":[{"type":"retweeted","id":"487527167249891329"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":41,"end":45,"tag":"WHO"}]},"id":"487526582442283008","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:19:29.000Z","conversation_id":"487526582442283008","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: For the first time, #WHO strongly recommends men who have sex w/ men to take antiretroviral meds as additional method …","referenced_tweets":[{"type":"retweeted","id":"487525537121058817"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":{}},"id":"487526438825119744","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:18:55.000Z","conversation_id":"487526438825119744","public_metrics":{"retweet_count":199,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: For the first time, WHO strongly recommends men who have sex w/ men to take antiretroviral meds as additional method of preventing…","referenced_tweets":[{"type":"retweeted","id":"487514211967594496"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/2QX3JAJGn0","expanded_url":"http://www.bmj.com/content/349/bmj.g3308","display_url":"bmj.com/content/349/bm…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"BMJ"}]},"id":"487526368712749057","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:18:38.000Z","conversation_id":"487526368712749057","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #BMJ Antiviral treatment of hepatitis C (review) http://t.co/2QX3JAJGn0","referenced_tweets":[{"type":"retweeted","id":"487525407449960448"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/yQdN3h2LGl","expanded_url":"http://bit.ly/HJTICalls","display_url":"bit.ly/HJTICalls"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":[{"start":108,"end":121,"tag":"HorizonMagEU"},{"start":122,"end":135,"tag":"JTIcalls2014"}]},"id":"487526071336968192","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:17:27.000Z","conversation_id":"487526071336968192","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: 1st calls for projects for public-private partnerships launched http://t.co/yQdN3h2LGl #HorizonMagEU #JTIcalls2014 #Ho…","referenced_tweets":[{"type":"retweeted","id":"487524682296733696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/iweCs5Zwk6","expanded_url":"http://bit.ly/HJTICalls","display_url":"bit.ly/HJTICalls"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":101,"end":114,"tag":"HorizonMagEU"},{"start":115,"end":128,"tag":"JTIcalls2014"}]},"id":"487526046762545153","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:17:22.000Z","conversation_id":"487526046762545153","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: 1st calls for projects for public-private partnerships launched http://t.co/iweCs5Zwk6 #HorizonMagEU #JTIcalls2014 #Horizon20…","referenced_tweets":[{"type":"retweeted","id":"487524682238013440"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/UmURYpBgqz","expanded_url":"http://bit.ly/1qQ09Ux","display_url":"bit.ly/1qQ09Ux"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":50,"end":60,"tag":"medicines"}]},"id":"487525970086490112","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:17:03.000Z","conversation_id":"487525970086490112","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @ansm: 2013: 7 arbitrations on benefit-risk of #medicines taken to European level by the French medicines agency http://t.co/UmURYpBgqz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/ieWatfPuG5","expanded_url":"http://www.bmj.com/content/348/bmj.g2545/rapid-responses","display_url":"bmj.com/content/348/bm…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"BMJ"}]},"id":"487523602221518848","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T09:07:39.000Z","conversation_id":"487523602221518848","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #BMJ Response by the Cochrane tamiflu authors to Roche's criticism http://t.co/ieWatfPuG5","referenced_tweets":[{"type":"retweeted","id":"487523402631376896"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/ddONvmf4m5","expanded_url":"http://bit.ly/1s1EoD3","display_url":"bit.ly/1s1EoD3"}],"mentions":{},"annotations":{},"hashtags":[{"start":76,"end":91,"tag":"EudraVigilance"},{"start":116,"end":129,"tag":"consultation"}]},"id":"487515715659128832","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T08:36:18.000Z","conversation_id":"487515715659128832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our guide on monitoring medical literature and #EudraVigilance: http://t.co/ddONvmf4m5 #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/6sS5jnkHe1","expanded_url":"http://bit.ly/1qVcuWs","display_url":"bit.ly/1qVcuWs"}],"mentions":{},"annotations":[{"start":32,"end":35,"probability":0.4201,"type":"Organization","normalized_text":"VICH"}],"hashtags":[{"start":124,"end":137,"tag":"consultation"}]},"id":"487508322908905472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-11T08:06:56.000Z","conversation_id":"487508322908905472","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on the VICH guideline on file formats for electronic exchange of documents: http://t.co/6sS5jnkHe1 #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/SRDTBwxTNW","expanded_url":"http://bit.ly/VNWhYD","display_url":"bit.ly/VNWhYD"}],"mentions":{},"annotations":{},"hashtags":[{"start":56,"end":70,"tag":"neuromyelitis"}]},"id":"487279570023116800","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T16:57:57.000Z","conversation_id":"487279570023116800","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We're organising a workshop on clinical trial design in #neuromyelitis optica in October: http://t.co/SRDTBwxTNW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/ZaCgiMT3HN","expanded_url":"http://bit.ly/U5dETG","display_url":"bit.ly/U5dETG"}],"mentions":{},"annotations":{},"hashtags":[{"start":39,"end":49,"tag":"medicines"}]},"id":"487279400262856705","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T16:57:16.000Z","conversation_id":"487279400262856705","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published an update on the human #medicines we've recommended for approval so far in 2014: http://t.co/ZaCgiMT3HN","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/WHCQvIm8sT","expanded_url":"http://bit.ly/1jtQQJm","display_url":"bit.ly/1jtQQJm"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":60,"end":71,"tag":"pesticides"}]},"id":"487278802243190784","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T16:54:54.000Z","conversation_id":"487278802243190784","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Draft guidance for predicting concentration of #pesticides in soil: public consultation now open http://t.co/WHCQvIm8sT","referenced_tweets":[{"type":"retweeted","id":"487251450209509377"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/SLC50yaPmM","expanded_url":"http://bit.ly/1oK5rze","display_url":"bit.ly/1oK5rze"}],"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"}],"annotations":[{"start":43,"end":63,"probability":0.5261,"type":"Organization","normalized_text":"Joint Research Centre"}],"hashtags":[{"start":88,"end":101,"tag":"workfortheEU"},{"start":102,"end":108,"tag":"Italy"},{"start":109,"end":115,"tag":"Spain"},{"start":116,"end":128,"tag":"Netherlands"}]},"id":"487278776917975040","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T16:54:48.000Z","conversation_id":"487278776917975040","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Careers: Vacancies available at the Joint Research Centre http://t.co/SLC50yaPmM #workfortheEU #Italy #Spain #Netherlands","referenced_tweets":[{"type":"retweeted","id":"487252379293990912"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/9VlrfxYYus","expanded_url":"http://ow.ly/z0rlW","display_url":"ow.ly/z0rlW"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{},"hashtags":[{"start":24,"end":32,"tag":"eHealth"},{"start":69,"end":77,"tag":"mHealth"},{"start":79,"end":85,"tag":"H2020"},{"start":87,"end":95,"tag":"bigdata"}]},"id":"487278616469049344","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T16:54:10.000Z","conversation_id":"487278616469049344","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: The new #eHealth in Focus newsletter is out. Topics: #mHealth, #H2020, #bigdata, events &amp; more - http://t.co/9VlrfxYYus","referenced_tweets":[{"type":"retweeted","id":"487261226435878913"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{},"hashtags":{}},"id":"487240367495208960","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T14:22:10.000Z","conversation_id":"487238733213995008","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@thedanalyst PRAC highlights are due out this Friday.","referenced_tweets":[{"type":"replied_to","id":"487238733213995008"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"614450788"},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/hpMItUDVbr","expanded_url":"http://eepurl.com/YuXiv","display_url":"eepurl.com/YuXiv"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{},"hashtags":{}},"id":"487237617919197184","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T14:11:15.000Z","conversation_id":"487237617919197184","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe: What’s happening? Our newsletter provides events, news and progress in health. Read our July issue: http://t.co/hpMItUDVbr","referenced_tweets":[{"type":"retweeted","id":"487237581856583680"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/HZrlnJBIym","expanded_url":"http://bit.ly/1jpPTS4","display_url":"bit.ly/1jpPTS4"}],"mentions":{},"annotations":[{"start":0,"end":19,"probability":0.5591,"type":"Organization","normalized_text":"EMA Management Board"}],"hashtags":{}},"id":"487222110306451456","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T13:09:37.000Z","conversation_id":"487222110306451456","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA Management Board delays formal adoption of publication of clinical trial data policy to October 2014: http://t.co/HZrlnJBIym","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/Ciz4W10Lk5","expanded_url":"http://ow.ly/yXcsw","display_url":"ow.ly/yXcsw"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":98,"end":113,"username":"rzeczpospolita","id":"194399035"}],"annotations":{},"hashtags":[{"start":53,"end":61,"tag":"eHealth"}]},"id":"487218544850251777","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T12:55:27.000Z","conversation_id":"487218544850251777","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"pl","text":"RT @EU_eHealth: Poland to invest 25 Million zloty in #eHealth system - http://t.co/Ciz4W10Lk5 via @Rzeczpospolita","referenced_tweets":[{"type":"retweeted","id":"487192070566973440"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/PD2dLU0MXT","expanded_url":"http://bit.ly/1k8VfvP","display_url":"bit.ly/1k8VfvP"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":50,"end":55,"tag":"ANSM"}]},"id":"487217822507220994","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T12:52:35.000Z","conversation_id":"487217822507220994","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: Ensuring the safety of health products: #ANSM has conducted 623 inspections in 2013: http://t.co/PD2dLU0MXT","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/kLlMzCyVjV","expanded_url":"http://bit.ly/1w588fX","display_url":"bit.ly/1w588fX"}],"mentions":{},"annotations":[{"start":37,"end":50,"probability":0.9931,"type":"Person","normalized_text":"Declan O'Brien"},{"start":101,"end":106,"probability":0.9942,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":23,"end":34,"tag":"IFAHEurope"},{"start":75,"end":88,"tag":"AnimalHealth"}]},"id":"487216760106786816","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T12:48:22.000Z","conversation_id":"487216760106786816","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IFAHEurope: VIDEO: #IFAHEurope's Declan O'Brien gives an update on the #AnimalHealth industry in Europe http://t.co/kLlMzCyVjV","referenced_tweets":[{"type":"retweeted","id":"487211422523617280"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{},"hashtags":{}},"id":"487216695896182785","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T12:48:07.000Z","conversation_id":"487216695896182785","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDACBER: Draft Guidance: Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy &amp; Oncolytic Products http://t…","referenced_tweets":[{"type":"retweeted","id":"487213110856798208"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/KaADofHWaf","expanded_url":"http://bit.ly/1qmLcaq","display_url":"bit.ly/1qmLcaq"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":{}},"id":"487216636689387520","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T12:47:52.000Z","conversation_id":"487216636689387520","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Let’s talk: new services from EFSA to boost two-way communication with applicants http://t.co/KaADofHWaf","referenced_tweets":[{"type":"retweeted","id":"487214986889297920"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":{}},"id":"487216616208617472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T12:47:48.000Z","conversation_id":"487216616208617472","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: New public consultation on the harmonised classification and labelling of carbetamide, fenpyrazamine and spiroxamine http://t.…","referenced_tweets":[{"type":"retweeted","id":"487215102211674112"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/ZaCgiMT3HN","expanded_url":"http://bit.ly/U5dETG","display_url":"bit.ly/U5dETG"}],"mentions":{},"annotations":{},"hashtags":[{"start":27,"end":37,"tag":"medicines"}]},"id":"487182994583851009","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T10:34:11.000Z","conversation_id":"487182994583851009","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've recommended 39 human #medicines for approval so far in 2014: http://t.co/ZaCgiMT3HN","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/yAaanH7EX2","expanded_url":"http://bit.ly/1qVhj4D","display_url":"bit.ly/1qVhj4D"}],"mentions":{},"annotations":{},"hashtags":[{"start":29,"end":38,"tag":"Mekinist"},{"start":40,"end":51,"tag":"trametinib"},{"start":60,"end":69,"tag":"medicine"},{"start":74,"end":83,"tag":"melanoma"}]},"id":"487162602003628033","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T09:13:10.000Z","conversation_id":"487162602003628033","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Mekinist (#trametinib), a new #medicine for #melanoma: http://t.co/yAaanH7EX2","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/SRDTBwxTNW","expanded_url":"http://bit.ly/VNWhYD","display_url":"bit.ly/VNWhYD"}],"mentions":{},"annotations":{},"hashtags":[{"start":53,"end":67,"tag":"neuromyelitis"}]},"id":"487162149299834880","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-10T09:11:22.000Z","conversation_id":"487162149299834880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're holding a workshop on clinical trial design in #neuromyelitis optica in October: http://t.co/SRDTBwxTNW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/Kb3H6u32Rq","expanded_url":"http://go.usa.gov/Xn63","display_url":"go.usa.gov/Xn63"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":48,"end":50,"probability":0.7896,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"}]},"id":"486916395389964288","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T16:54:49.000Z","conversation_id":"486916395389964288","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: #FDA Webinar on “Overview of FDA’s Proprietary Name Review Process.”  – July 15th.  http://t.co/Kb3H6u32Rq","referenced_tweets":[{"type":"retweeted","id":"486916186605883393"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/b53j9lhyUT","expanded_url":"http://imi.efpia.eu/","display_url":"imi.efpia.eu"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":107,"end":112,"tag":"IMI2"}]},"id":"486903008358592512","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T16:01:38.000Z","conversation_id":"486903008358592512","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: FACT - IMI is developing new treatments for diseases where there is a high, unmet societal need #IMI2 http://t.co/b53j9lhyUT","referenced_tweets":[{"type":"retweeted","id":"486902968835657728"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/HZrlnJBIym","expanded_url":"http://bit.ly/1jpPTS4","display_url":"bit.ly/1jpPTS4"}],"mentions":{},"annotations":[{"start":0,"end":19,"probability":0.5591,"type":"Organization","normalized_text":"EMA Management Board"}],"hashtags":{}},"id":"486896877401812992","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T15:37:16.000Z","conversation_id":"486896877401812992","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EMA Management Board delays formal adoption of publication of clinical trial data policy to October 2014: http://t.co/HZrlnJBIym","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/MQ5KZVQ8lK","expanded_url":"http://youtu.be/D9AJ02oEK9k","display_url":"youtu.be/D9AJ02oEK9k"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":53,"end":58,"username":"ecdc","id":"2656990819"}],"annotations":[{"start":109,"end":114,"probability":0.9948,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":13,"end":35,"tag":"ScientificCooperation"}]},"id":"486890420010758144","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T15:11:36.000Z","conversation_id":"486890420010758144","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #ScientificCooperation between EFSA and @ECDC is fundamental to combat vector-borne diseases in Europe http://t.co/MQ5KZVQ8lK","referenced_tweets":[{"type":"retweeted","id":"486890062400192512"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":106,"end":128,"tag":"ScientificCooperation"}]},"id":"486890198010433536","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T15:10:43.000Z","conversation_id":"486890198010433536","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: EFSA strengthens its international scientific activities: check our Multiannual Programme on #ScientificCooperation http://t.c…","referenced_tweets":[{"type":"retweeted","id":"486889003015499776"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/L6xLMOFbTE","expanded_url":"http://go.usa.gov/Xnk3","display_url":"go.usa.gov/Xnk3"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":91,"end":93,"probability":0.7907,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"486888763189362689","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T15:05:01.000Z","conversation_id":"486888763189362689","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: Here's the latest Patient Network Newsletter with the latest developments from FDA. http://t.co/L6xLMOFbTE","referenced_tweets":[{"type":"retweeted","id":"486888658642169856"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"486887648233922561","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T15:00:35.000Z","conversation_id":"486887648233922561","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: IMI facilitates collaboration &amp; enables joint investments to tackle challenges that are too big for any 1 stakeholder to tackle …","referenced_tweets":[{"type":"retweeted","id":"486887591862894593"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"EC_AVService","id":"56392389"},{"start":30,"end":45,"username":"AlmuniaJoaquin","id":"825369480"}],"annotations":{},"hashtags":{}},"id":"486887459385790464","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:59:50.000Z","conversation_id":"486887459385790464","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EC_AVService: NEWs VIDEO: @AlmuniaJoaquin PC - fines to 6 comps for curbing entry of cheaper versions of cardiovascular medicine\nhttp:/…","referenced_tweets":[{"type":"retweeted","id":"486887187753889792"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/At6nOSyyjA","expanded_url":"http://bit.ly/1k5trbR","display_url":"bit.ly/1k5trbR"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":27,"end":37,"tag":"medicines"},{"start":38,"end":45,"tag":"online"}]},"id":"486886615797989376","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:56:29.000Z","conversation_id":"486886615797989376","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Buying #medicines #online: presenting the logo that will show authorised, safe websites http://t.co/At6nOSyyjA","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/jbxj9T1aO9","expanded_url":"http://ec.europa.eu/animals-in-science","display_url":"ec.europa.eu/animals-in-sci…"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":23,"username":"EU_ENV","id":"366037745"}],"annotations":{},"hashtags":[{"start":123,"end":140,"tag":"animalsinscience"}]},"id":"486882407229181952","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:39:46.000Z","conversation_id":"486882407229181952","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: .@EU_ENV new website on the 3Rs &amp; alternative approaches on laboratory animals http://t.co/jbxj9T1aO9 … #animalsinscience #a…","referenced_tweets":[{"type":"retweeted","id":"486882262693462016"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/okg82DXfGk","expanded_url":"http://www.pharmpro.com/news/2014/07/580m-eu-antitrust-fine-drug-makers#.U71SiLUb7Fc.twitter","display_url":"pharmpro.com/news/2014/07/5…"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{},"hashtags":[{"start":26,"end":29,"tag":"EU"},{"start":49,"end":54,"tag":"Drug"}]},"id":"486880992360402944","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:34:09.000Z","conversation_id":"486880992360402944","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @nakosbalamotis: $580M #EU Antitrust Fine for #Drug Makers http://t.co/okg82DXfGk","referenced_tweets":[{"type":"retweeted","id":"486880782648999936"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/fqk1t9R1gO","expanded_url":"http://content.govdelivery.com/accounts/UKMHRA/bulletins/c30d47","display_url":"content.govdelivery.com/accounts/UKMHR…"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{},"hashtags":{}},"id":"486880196092768256","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:30:59.000Z","conversation_id":"486880196092768256","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Class 4 Drug Alert (Caution in Use): Amoxicillin Sodium 250mg, 500g, &amp; 1m... http://t.co/fqk1t9R1gO","referenced_tweets":[{"type":"retweeted","id":"486880151829876736"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{},"hashtags":{}},"id":"486880167974174720","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:30:52.000Z","conversation_id":"486880167974174720","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Tomorrow's FREE Webinar: From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making by Cytel http://t.co/d…","referenced_tweets":[{"type":"retweeted","id":"486880008989069312"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/yAaanH7EX2","expanded_url":"http://bit.ly/1qVhj4D","display_url":"bit.ly/1qVhj4D"}],"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Mekinist"},{"start":53,"end":64,"tag":"trametinib"},{"start":73,"end":82,"tag":"medicine"},{"start":87,"end":96,"tag":"melanoma"}]},"id":"486874207050272768","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:07:11.000Z","conversation_id":"486874207050272768","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Mekinist (#trametinib), a new #medicine for #melanoma: http://t.co/yAaanH7EX2","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":37,"end":42,"tag":"IMI2"},{"start":43,"end":59,"tag":"JTIcalls2014bit"}]},"id":"486873215797846016","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T14:03:14.000Z","conversation_id":"486873215797846016","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"und","text":"RT @EFPIA: PREZI on IMI Achievements #IMI2 #JTIcalls2014bit.ly/1lx5Srq","referenced_tweets":[{"type":"retweeted","id":"486872992811474944"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":27,"end":32,"tag":"IMI2"},{"start":34,"end":41,"tag":"safety"},{"start":43,"end":61,"tag":"neurodegeneration"},{"start":63,"end":70,"tag":"immune"},{"start":82,"end":93,"tag":"infectious"},{"start":104,"end":113,"tag":"vaccines"},{"start":116,"end":129,"tag":"JTIcalls2014"}]},"id":"486864235277074432","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:27:33.000Z","conversation_id":"486864235277074432","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Priorities for #IMI2: #safety, #neurodegeneration, #immune disorders, #infectious diseases, #vaccines   #JTIcalls2014","referenced_tweets":[{"type":"retweeted","id":"486863250857152512"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/UhmJ3xLlsW","expanded_url":"http://evidence.nhs.uk/eyes-on-evidence-july-2014.pdf","display_url":"evidence.nhs.uk/eyes-on-eviden…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{}},"id":"486864182856679424","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:27:21.000Z","conversation_id":"486864182856679424","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: The July issue of NICE Eyes on Evidence is out now: http://t.co/UhmJ3xLlsW","referenced_tweets":[{"type":"retweeted","id":"486862344191238145"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/WDJi1010gI","expanded_url":"http://bit.ly/1ndGcpm","display_url":"bit.ly/1ndGcpm"}],"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":[{"start":16,"end":26,"probability":0.5525,"type":"Organization","normalized_text":"EU-industry"}],"hashtags":{}},"id":"486864095950680064","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:27:00.000Z","conversation_id":"486864095950680064","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: EU-industry partnerships seek innovation boost with first €1 billion for projects http://t.co/WDJi1010gI","referenced_tweets":[{"type":"retweeted","id":"486861923971911681"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/IZiHAR0Pv0","expanded_url":"http://webcast.streamdis.eu/mediasite/Viewer/?peid=2fa9e9a08b9d46ec8b8d95f841f435b81d","display_url":"webcast.streamdis.eu/mediasite/View…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":[{"start":41,"end":54,"tag":"JTIcalls2014"}]},"id":"486863987272056833","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:26:34.000Z","conversation_id":"486863987272056833","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Panel discussion on #JTIcalls2014 starting now http://t.co/IZiHAR0Pv0","referenced_tweets":[{"type":"retweeted","id":"486859870549729280"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/b53j9lhyUT","expanded_url":"http://imi.efpia.eu/","display_url":"imi.efpia.eu"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":92,"end":99,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":86,"end":91,"tag":"IMI2"}]},"id":"486863711463043072","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:25:28.000Z","conversation_id":"486863711463043072","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: IMI is the world’s biggest public-private partnership in the life sciences #IMI2 @IMI_JU http://t.co/b53j9lhyUT","referenced_tweets":[{"type":"retweeted","id":"486857408917299201"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":12,"end":18,"probability":0.9167,"type":"Person","normalized_text":"Barroso"}],"hashtags":[{"start":47,"end":56,"tag":"diabetes"},{"start":78,"end":91,"tag":"JTIcalls2014"}]},"id":"486863442578796544","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:24:24.000Z","conversation_id":"486863442578796544","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Barroso cites IMI breakthroughs in #diabetes and medicines safety #JTIcalls2014","referenced_tweets":[{"type":"retweeted","id":"486847223452684288"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":12,"end":18,"probability":0.9268,"type":"Person","normalized_text":"Barroso"}],"hashtags":[{"start":75,"end":88,"tag":"JTIcalls2014"}]},"id":"486863415403872256","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:24:18.000Z","conversation_id":"486863415403872256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Barroso on IMI: it's really impressive what they've been doing #JTIcalls2014","referenced_tweets":[{"type":"retweeted","id":"486846681825435648"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"486863261300961280","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:23:41.000Z","conversation_id":"486863261300961280","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: EC Pres. Barroso \"Public-private partnerships are about the joining of forces to make the lives of Europeans better\" #…","referenced_tweets":[{"type":"retweeted","id":"486846018869141504"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"486863246537027584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:23:38.000Z","conversation_id":"486863246537027584","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: \"By working together we will be able to do more research and innovation, and see better results\" @BarrosoEU at #JTIcalls2014 lau…","referenced_tweets":[{"type":"retweeted","id":"486845912325824513"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/pqxnvqZXeo","expanded_url":"http://europa.eu/rapid/press-release_MEMO-14-468_en.htm?locale=en","display_url":"europa.eu/rapid/press-re…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{},"hashtags":{}},"id":"486862935252541440","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T13:22:23.000Z","conversation_id":"486862935252541440","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Public-private partnerships under Horizon 2020: launch of activities and first calls: http://t.co/pqxnvqZXeo","referenced_tweets":[{"type":"retweeted","id":"486840615620321281"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"},{"start":25,"end":39,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":77,"end":82,"probability":0.9913,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"id":"486837482735292416","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:41:15.000Z","conversation_id":"486837482735292416","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DigitalAgendaEU: The @EU_Commission offers €1,3bn to boost innovation in Europe! Answer the call &amp; make your ideas real! http://t.co/i6…","referenced_tweets":[{"type":"retweeted","id":"486836610999517184"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":39,"end":46,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":17,"end":24,"probability":0.9815,"type":"Person","normalized_text":"Dr. Paul"},{"start":26,"end":34,"probability":0.6802,"type":"Person","normalized_text":"Peter Tak"}],"hashtags":{}},"id":"486833659639779328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:26:04.000Z","conversation_id":"486833659639779328","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: BLOG! Dr. Paul-Peter Tak on @IMI_JU - \"a step closer to the right treatment for the right patient at the right time\"  http://t.c…","referenced_tweets":[{"type":"retweeted","id":"486833301286813696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":14,"end":27,"tag":"JTICalls2014"},{"start":72,"end":77,"tag":"SMEs"},{"start":78,"end":91,"tag":"Universities"},{"start":92,"end":101,"tag":"research"}]},"id":"486833583857090560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:25:46.000Z","conversation_id":"486833583857090560","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: #JTICalls2014 will be open to participation of companies, #SMEs #Universities #research organisations + others http://t.co/pj…","referenced_tweets":[{"type":"retweeted","id":"486833107832950784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":[{"start":21,"end":34,"tag":"JTICalls2014"},{"start":79,"end":84,"tag":"SMEs"},{"start":85,"end":98,"tag":"Universities"},{"start":99,"end":108,"tag":"research"}]},"id":"486833562629709824","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:25:40.000Z","conversation_id":"486833562629709824","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: #JTICalls2014 will be open to participation of companies, #SMEs #Universities #research organisations + others http://…","referenced_tweets":[{"type":"retweeted","id":"486832142874202112"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/Ft2677wwek","expanded_url":"http://bit.ly/1swnv0D","display_url":"bit.ly/1swnv0D"}],"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":[{"start":100,"end":105,"probability":0.9969,"type":"Place","normalized_text":"France"}],"hashtags":{}},"id":"486833489258741760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:25:23.000Z","conversation_id":"486833489258741760","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: Antitrust: Commission closes investigation into generic pharmaceutical companies in France http://t.co/Ft2677wwek","referenced_tweets":[{"type":"retweeted","id":"486831493688217601"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":{},"hashtags":{}},"id":"486833444102893568","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:25:12.000Z","conversation_id":"486833444102893568","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: Antitrust: Commission fines Servier and five generic companies for curbing entry of cheaper versions of cardio... http://t.…","referenced_tweets":[{"type":"retweeted","id":"486831493101002753"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/b53j9lhyUT","expanded_url":"http://imi.efpia.eu/","display_url":"imi.efpia.eu"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"486830538385547265","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:13:39.000Z","conversation_id":"486830538385547265","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Want to know MORE about IMI? Check out EFPIA's new webpage: http://t.co/b53j9lhyUT","referenced_tweets":[{"type":"retweeted","id":"486826078082990080"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/dr5DGja8FJ","expanded_url":"http://bit.ly/1swmzcG","display_url":"bit.ly/1swmzcG"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":{}},"id":"486830380046356480","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:13:02.000Z","conversation_id":"486830380046356480","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency grants temporary-use authorisation for Translarna granules for oral suspension http://t.co/dr5DGja8FJ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/ODRB1UvzuD","expanded_url":"http://ow.ly/yWKWp","display_url":"ow.ly/yWKWp"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{},"hashtags":[{"start":37,"end":50,"tag":"JTIcalls2014"},{"start":82,"end":91,"tag":"diabetes"},{"start":98,"end":102,"tag":"eye"},{"start":136,"end":142,"tag":"H2020"}]},"id":"486829888721412097","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T11:11:05.000Z","conversation_id":"486829888721412097","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: 1st round of funding #JTIcalls2014 worth €1.13 billion 4 projects #diabetes &amp; #eye disease - http://t.co/ODRB1UvzuD #H2020","referenced_tweets":[{"type":"retweeted","id":"486819020096565248"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/Kn39KbuMkQ","expanded_url":"http://bit.ly/IMI2Call1","display_url":"bit.ly/IMI2Call1"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":20,"end":29,"tag":"diabetes"},{"start":34,"end":42,"tag":"retinal"},{"start":71,"end":76,"tag":"IMI2"},{"start":116,"end":129,"tag":"JTICalls2014"}]},"id":"486816762319872000","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:18:55.000Z","conversation_id":"486816762319872000","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Calling #diabetes and #retinal disease experts – the first #IMI2 Call is for YOU http://t.co/Kn39KbuMkQ #JTICalls2014","referenced_tweets":[{"type":"retweeted","id":"486816723828756480"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/F2vb0R07kM","expanded_url":"http://bit.ly/1xR9ZYs","display_url":"bit.ly/1xR9ZYs"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":35,"end":40,"tag":"IMI2"},{"start":117,"end":130,"tag":"JTIcalls2014"}]},"id":"486816729553981440","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:18:47.000Z","conversation_id":"486816729553981440","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Press release: €3.3 bn #IMI2 programme to pave way for next generation treatments http://t.co/F2vb0R07kM #JTIcalls2014","referenced_tweets":[{"type":"retweeted","id":"486816002370703360"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":{}},"id":"486816690668576768","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:18:38.000Z","conversation_id":"486816690668576768","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUlondonrep: EC kicks off £15.5bn public/priv. innovation p'ships in medicines (incl new antibix),biotech,transport,electronics http://…","referenced_tweets":[{"type":"retweeted","id":"486815804261138433"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":101,"end":108,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":109,"end":122,"tag":"JTIcalls2014"},{"start":123,"end":128,"tag":"IMI2"}]},"id":"486816676718325760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:18:35.000Z","conversation_id":"486816676718325760","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: PR: The World’s Largest Public Private Partnership in Healthcare just got over 50% BIGGER @IMI_JU #JTIcalls2014 #IMI2 http://t.c…","referenced_tweets":[{"type":"retweeted","id":"486815695733542912"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/XTbOO8x4Lm","expanded_url":"http://dlvr.it/6GTdC7","display_url":"dlvr.it/6GTdC7"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":14,"end":20,"tag":"H2020"}]},"id":"486816647966359552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:18:28.000Z","conversation_id":"486816647966359552","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: #H2020 calls - IMI2 1st Call for Proposals 2014 http://t.co/XTbOO8x4Lm","referenced_tweets":[{"type":"retweeted","id":"486815165183053824"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/d13mKfu2ud","expanded_url":"http://europa.eu/!Bw37Ub","display_url":"europa.eu/!Bw37Ub"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":{}},"id":"486816580215775232","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:18:12.000Z","conversation_id":"486816580215775232","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: EU-industry partnerships seek innovation boost w/ first €1 billion for projects http://t.co/d13mKfu2ud cc @ECSpokesScien…","referenced_tweets":[{"type":"retweeted","id":"486814714996215808"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/gxC7xEq2YT","expanded_url":"http://dlvr.it/6GTPBm","display_url":"dlvr.it/6GTPBm"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":14,"end":17,"tag":"EU"},{"start":45,"end":56,"tag":"Innovation"}]},"id":"486814555084189696","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T10:10:09.000Z","conversation_id":"486814555084189696","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: #EU-industry partnerships seek #Innovation boost with first €1 billion for projects: European... http://t.co/gxC7xEq2YT #JTIc…","referenced_tweets":[{"type":"retweeted","id":"486814270739726336"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{},"hashtags":{}},"id":"486809010587570176","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T09:48:07.000Z","conversation_id":"486809010587570176","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Human medicines highlights - Issue 64 - June 2014: The June 2014 issue of the European Medicines Agency's news... http://t.c…","referenced_tweets":[{"type":"retweeted","id":"486807646255595520"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":135,"end":140,"tag":"IMI2"}]},"id":"486808896129204224","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T09:47:39.000Z","conversation_id":"486808896129204224","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: IMI accelerates the development of, and patient access to, new treatments, especially in areas where treatments are lacking #IMI2","referenced_tweets":[{"type":"retweeted","id":"486805748429881344"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{},"hashtags":{}},"id":"486808756148506624","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T09:47:06.000Z","conversation_id":"486808756148506624","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: 10y after pivotal results of docetaxel in castr.-resistant prostate cancer: effects of chemohormonal therapy http://t.co/afMJzh…","referenced_tweets":[{"type":"retweeted","id":"486802490801664000"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":23,"end":36,"tag":"statistician"}]},"id":"486800919104086016","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T09:15:58.000Z","conversation_id":"486800919104086016","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Are you a #statistician with proven experience in survey/experiment design or quantitative risk assessment? http://t.co/707doN…","referenced_tweets":[{"type":"retweeted","id":"486800690812305408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/H6wuRdvG7T","expanded_url":"http://bit.ly/1meX6DL","display_url":"bit.ly/1meX6DL"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{},"hashtags":{}},"id":"486800796630388736","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T09:15:28.000Z","conversation_id":"486800796630388736","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Human medicines highlights - Issue 64 - June 2014 http://t.co/H6wuRdvG7T","referenced_tweets":[{"type":"retweeted","id":"486800244483444736"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/Urky3YLY9p","expanded_url":"http://bit.ly/1k2Pcc4","display_url":"bit.ly/1k2Pcc4"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":50,"end":63,"tag":"JTIcalls2014"}]},"id":"486794183223803904","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T08:49:12.000Z","conversation_id":"486794183223803904","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: Follow the live launch event of the #JTIcalls2014 today from 14:00 via http://t.co/Urky3YLY9p","referenced_tweets":[{"type":"retweeted","id":"486793156810133505"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":111,"end":117,"tag":"H2020"},{"start":118,"end":131,"tag":"JTICalls2014"}]},"id":"486789879251341312","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T08:32:06.000Z","conversation_id":"486789879251341312","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: Launching today - 7 research partnerships between the EU, private sector and Member States under #H2020 #JTICalls2014 http://…","referenced_tweets":[{"type":"retweeted","id":"486789414475923456"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/kXMkcrAXcX","expanded_url":"http://bit.ly/1zoHAe3","display_url":"bit.ly/1zoHAe3"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{},"hashtags":[{"start":87,"end":105,"tag":"safetyofmedicines"}]},"id":"486788626819588096","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T08:27:07.000Z","conversation_id":"486788626819588096","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Safety of medicine treatment means patients reading the package leaflet #safetyofmedicines http://t.co/kXMkcrAXcX","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/A2b45oYdSw","expanded_url":"http://bit.ly/1iDKssP","display_url":"bit.ly/1iDKssP"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":115,"end":120,"tag":"IMI2"}]},"id":"486787299200749568","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-09T08:21:50.000Z","conversation_id":"486787299200749568","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: TODAY is the IMI2 LAUNCH --&gt; Get back to basics! WATCH: What is the Innovative Medicines Initiative? #IMI2 http://t.co/A2b45oYdSw","referenced_tweets":[{"type":"retweeted","id":"486775598938075136"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":14,"end":36,"tag":"ScientificCooperation"}]},"id":"486554448047919104","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T16:56:34.000Z","conversation_id":"486554448047919104","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: “#ScientificCooperation plays a central role in EFSA work: EFSA cannot and does not work in isolation”Watch our video http://t…","referenced_tweets":[{"type":"retweeted","id":"486512033249370114"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/JXWAu62k1q","expanded_url":"http://ow.ly/yUxns","display_url":"ow.ly/yUxns"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":44,"end":57,"username":"epSOSproject","id":"554969048"}],"annotations":{},"hashtags":[{"start":29,"end":37,"tag":"eHealth"},{"start":104,"end":118,"tag":"ePrescription"},{"start":119,"end":136,"tag":"interoperability"}]},"id":"486554374144274432","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T16:56:17.000Z","conversation_id":"486554374144274432","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: Cross-border #eHealth pilot @epsosproject: what has it achieved? http://t.co/JXWAu62k1q #ePrescription #interoperability @E…","referenced_tweets":[{"type":"retweeted","id":"486517937705349120"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Dw0jKgya2F","expanded_url":"http://bit.ly/1mzYSk0","display_url":"bit.ly/1mzYSk0"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":101,"end":115,"tag":"international"},{"start":116,"end":130,"tag":"harmonisation"}]},"id":"486553853098467328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T16:54:12.000Z","conversation_id":"486553853098467328","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"RT @edqm_news: PDG signs off a new monograph on Glucose Monohydrate/Anhydrous http://t.co/Dw0jKgya2F #international #harmonisation","referenced_tweets":[{"type":"retweeted","id":"486530111890812928"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":82,"end":86,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":108,"end":116,"tag":"mhealth"},{"start":121,"end":131,"tag":"medicines"}]},"id":"486553680326688768","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T16:53:31.000Z","conversation_id":"486553680326688768","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: The latest EAHP EU looks at new MEPs with health responsibilities, @WHO AMR consultation and #mhealth and #medicines http://…","referenced_tweets":[{"type":"retweeted","id":"486541665960591361"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/Sq9qqEpOmB","expanded_url":"http://ow.ly/yU6co","display_url":"ow.ly/yU6co"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":20,"end":63,"probability":0.3051,"type":"Product","normalized_text":"ESMO-ESSO-ESTRO Clinical Practice Guidelines"}],"hashtags":[{"start":68,"end":79,"tag":"AnalCancer"}]},"id":"486481617352146945","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T12:07:10.000Z","conversation_id":"486481617352146945","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Updated ESMO-ESSO-ESTRO Clinical Practice Guidelines on #AnalCancer now available here http://t.co/Sq9qqEpOmB","referenced_tweets":[{"type":"retweeted","id":"486481417329999872"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/SBkPmze6Lw","expanded_url":"http://europa.eu/!nx36Ct","display_url":"europa.eu/!nx36Ct"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":68,"end":82,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":99,"end":106,"tag":"Cancer"}]},"id":"486464872327438336","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T11:00:38.000Z","conversation_id":"486464872327438336","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Call for expressions of interest to become member of @EU_Commission Expert Group on #Cancer Control http://t.co/SBkPmze6Lw .…","referenced_tweets":[{"type":"retweeted","id":"486238592507723776"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/rPaiRht5yC","expanded_url":"http://wqd.nl/reaGq","display_url":"wqd.nl/reaGq"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{},"hashtags":[{"start":95,"end":103,"tag":"mhealth"}]},"id":"486464774717575168","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T11:00:15.000Z","conversation_id":"486464774717575168","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: mHealth can act as bridge between patients &amp; doctors: things to know about #mhealth market. http://t.co/rPaiRht5yC @bdailyn…","referenced_tweets":[{"type":"retweeted","id":"486405626093129729"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/e3lwenFRGY","expanded_url":"http://bit.ly/1sqF3v2","display_url":"bit.ly/1sqF3v2"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":73,"end":92,"probability":0.8085,"type":"Organization","normalized_text":"Scientific Committee"}],"hashtags":{}},"id":"486464716349652992","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T11:00:01.000Z","conversation_id":"486464716349652992","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: An other open meeting at EFSA: today plenary meeting of the Scientific Committee, check the agenda http://t.co/e3lwenFRGY","referenced_tweets":[{"type":"retweeted","id":"486409385506533376"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{},"hashtags":[{"start":121,"end":130,"tag":"diabetes"}]},"id":"486463971063767041","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T10:57:03.000Z","conversation_id":"486463971063767041","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EASDnews: Study suggests consuming whey protein before meals could help improve blood glucose control in people with #diabetes  http://…","referenced_tweets":[{"type":"retweeted","id":"486443652655636480"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/pZXMyj9U1E","expanded_url":"http://www.eahp.eu/press-room/eahp-apps-involving-medicines-should-have-pharmacist-oversight","display_url":"eahp.eu/press-room/eah…"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":122,"end":138,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{},"hashtags":[{"start":36,"end":46,"tag":"medicines"},{"start":59,"end":70,"tag":"pharmacist"},{"start":104,"end":112,"tag":"mhealth"},{"start":113,"end":121,"tag":"ehealth"}]},"id":"486463621531447297","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T10:55:40.000Z","conversation_id":"486463621531447297","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: EAHP: Apps involving #medicines should have #pharmacist oversight http://t.co/pZXMyj9U1E #mhealth #ehealth @DigitalAgendaEU …","referenced_tweets":[{"type":"retweeted","id":"486457693318545408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/fK4ruZISEm","expanded_url":"http://bit.ly/1qOtU9E","display_url":"bit.ly/1qOtU9E"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":35,"end":53,"tag":"pharmacovigilance"},{"start":65,"end":70,"tag":"PRAC"}]},"id":"486463454291959808","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-08T10:55:00.000Z","conversation_id":"486463454291959808","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've pubslihed the #agenda of our #pharmacovigilance committee (#PRAC) meeting this week: http://t.co/fK4ruZISEm","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/fK4ruZISEm","expanded_url":"http://bit.ly/1qOtU9E","display_url":"bit.ly/1qOtU9E"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"},{"start":81,"end":86,"tag":"PRAC"}]},"id":"486187405645729792","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T16:38:05.000Z","conversation_id":"486187405645729792","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's #pharmacovigilance committee meeting (#PRAC): http://t.co/fK4ruZISEm","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":23,"end":26,"probability":0.4614,"type":"Organization","normalized_text":"EFSA"}],"hashtags":[{"start":74,"end":79,"tag":"EFSA"}]},"id":"486181796410056704","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T16:15:47.000Z","conversation_id":"486181796410056704","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: How could EFSA improve its regulated products service on the #EFSA website? Take part in our satisfaction survey http://t.co/I…","referenced_tweets":[{"type":"retweeted","id":"486150218220855297"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":48,"end":53,"probability":0.6038,"type":"Place","normalized_text":"Athens"}],"hashtags":[{"start":30,"end":38,"tag":"eHealth"}]},"id":"486181547264196609","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T16:14:48.000Z","conversation_id":"486181547264196609","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: 5th meeting of #eHealth Network (Athens, 13/05/2014): minutes, work programme &amp; list of participants available http://t.co/Q…","referenced_tweets":[{"type":"retweeted","id":"486162605137215488"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/8Uyd9LJ1xE","expanded_url":"http://bit.ly/1xGvMlF","display_url":"bit.ly/1xGvMlF"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":74,"end":92,"probability":0.3456,"type":"Other","normalized_text":"Substances Division"}],"hashtags":[{"start":56,"end":70,"tag":"Certification"},{"start":134,"end":138,"tag":"COS"}]},"id":"486181363301629952","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T16:14:04.000Z","conversation_id":"486181363301629952","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: The last monthly activity report for the #Certification of Substances Division is now available http://t.co/8Uyd9LJ1xE #COS …","referenced_tweets":[{"type":"retweeted","id":"486166676996915200"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":69,"end":83,"tag":"presentations"},{"start":90,"end":100,"tag":"workshops"},{"start":104,"end":115,"tag":"infectious"},{"start":116,"end":125,"tag":"diseases"}]},"id":"486181180858171392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T16:13:21.000Z","conversation_id":"486181180858171392","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: #ESCAIDE registration open,discount by 31 Aug. Over 300 #presentations &amp; #workshops on #infectious #diseases in 2014. http://t…","referenced_tweets":[{"type":"retweeted","id":"486171328341626880"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"annotations":{},"hashtags":[{"start":30,"end":41,"tag":"newsletter"},{"start":114,"end":122,"tag":"science"},{"start":126,"end":135,"tag":"dementia"}]},"id":"486139523085373441","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:27:49.000Z","conversation_id":"486139523085373441","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AlzheimerEurope: Our June #newsletter includes news on policy, our annual conference, members' activities and #science of #dementia : h…","referenced_tweets":[{"type":"retweeted","id":"486054472947625984"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/ZKttfz6XIV","expanded_url":"http://ow.ly/yQCNq","display_url":"ow.ly/yQCNq"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{},"hashtags":[{"start":27,"end":35,"tag":"eHealth"},{"start":36,"end":41,"tag":"SMEs"},{"start":66,"end":75,"tag":"medicine"}]},"id":"486139118137921536","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:26:12.000Z","conversation_id":"486139118137921536","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: Chance for #eHealth #SMEs: Competition to improve #medicine adherence; Deadline 10/7. http://t.co/ZKttfz6XIV via @Get_eHeal…","referenced_tweets":[{"type":"retweeted","id":"486077532093943808"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/lpLPyrg5sM","expanded_url":"http://bit.ly/1wEWBpQ","display_url":"bit.ly/1wEWBpQ"}],"mentions":[{"start":3,"end":12,"username":"escardio","id":"21572529"}],"annotations":{},"hashtags":[{"start":43,"end":58,"tag":"Cardiovascular"},{"start":118,"end":126,"tag":"Acute14"}]},"id":"486138750129672193","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:24:44.000Z","conversation_id":"486138750129672193","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @escardio: New Hotline Sessions @ Acute #Cardiovascular Care 2014. Submission is now open ! http://t.co/lpLPyrg5sM #Acute14 http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"486091509662351361"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/jL3gNPH9Gm","expanded_url":"http://ow.ly/yQKOr","display_url":"ow.ly/yQKOr"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":46,"end":61,"username":"TheChristieNHS","id":"437421261"}],"annotations":{},"hashtags":[{"start":62,"end":73,"tag":"lungcancer"},{"start":84,"end":96,"tag":"OncologyPRO"}]},"id":"486138572119212033","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:24:02.000Z","conversation_id":"486138572119212033","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Free access to webcasts from ESMO/@TheChristieNHS #lungcancer course on #OncologyPRO  http://t.co/jL3gNPH9Gm","referenced_tweets":[{"type":"retweeted","id":"486094175390408705"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":52,"end":67,"username":"TOBACCOTheater","id":"344626427"}],"annotations":{},"hashtags":[{"start":20,"end":29,"tag":"EFPC2015"},{"start":93,"end":105,"tag":"Netherlands"},{"start":106,"end":118,"tag":"PrimaryCare"},{"start":127,"end":136,"tag":"EFPC2014"}]},"id":"486138156677623808","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:22:23.000Z","conversation_id":"486138156677623808","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"nl","text":"RT @PrimaryCare4um: #EFPC2015 Amsterdam Aug31/Sept1 @TOBACCOTheater | Prof Chris van Weel on #Netherlands #PrimaryCare history #EFPC2014\n h…","referenced_tweets":[{"type":"retweeted","id":"486132005688455168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/KKbdoZVSvy","expanded_url":"http://go.usa.gov/XxMJ","display_url":"go.usa.gov/XxMJ"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":17,"end":18,"probability":0.6403,"type":"Place","normalized_text":"US"},{"start":25,"end":27,"probability":0.8503,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"486137942382231552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:21:32.000Z","conversation_id":"486137942382231552","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: JOIN US! for FDA’s Social Media Guidances for Industry webinar July 10 at 2PM ET. Register at: http://t.co/KKbdoZVSvy","referenced_tweets":[{"type":"retweeted","id":"486136393262198784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/Tue56NO6vD","expanded_url":"http://shar.es/Na0Av","display_url":"shar.es/Na0Av"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":104,"end":118,"username":"suzannewriter","id":"162060297"}],"annotations":{},"hashtags":{}},"id":"486137875671834625","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:21:16.000Z","conversation_id":"486137875671834625","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: The Falsified Medicines Directive - What Does It Really Mean? http://t.co/Tue56NO6vD via @suzannewriter of Life Science Lead…","referenced_tweets":[{"type":"retweeted","id":"486137604908130305"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"myESR","id":"79133815"}],"annotations":[{"start":24,"end":39,"probability":0.4223,"type":"Other","normalized_text":"EuroSafe Imaging"}],"hashtags":[{"start":77,"end":85,"tag":"MIR2014"}]},"id":"486137840527761409","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-07T13:21:07.000Z","conversation_id":"486137840527761409","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESR: Register for EuroSafe Imaging radiation protection session at the #MIR2014 meeting in October. More info here: http://t.co/tzJCV…","referenced_tweets":[{"type":"retweeted","id":"486137647568785408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/PF3x5cWly7","expanded_url":"http://europa.eu/!FQ78nb","display_url":"europa.eu/!FQ78nb"},{"start":88,"end":110,"url":"http://t.co/hSk0xZbwo7","expanded_url":"http://europa.eu/!Rp37pC","display_url":"europa.eu/!Rp37pC"},{"start":111,"end":133,"url":"http://t.co/RHukqCG1LV","expanded_url":"http://europa.eu/!fd84cN","display_url":"europa.eu/!fd84cN"}],"mentions":[{"start":3,"end":16,"username":"EC_AVService","id":"56392389"}],"annotations":{},"hashtags":{}},"id":"485088743788118016","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:52:23.000Z","conversation_id":"485088743788118016","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EC_AVService: 06/07 Word Zoonosis Day - avian flu prevention\nhttp://t.co/PF3x5cWly7\nhttp://t.co/hSk0xZbwo7\nhttp://t.co/RHukqCG1LV\n#avia…","referenced_tweets":[{"type":"retweeted","id":"485088484169117696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/6K3mca7gIF","expanded_url":"http://europa.eu/newsroom/calendar/events/2014/07/09-horizon_2020_en.htm","display_url":"europa.eu/newsroom/calen…"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":67,"end":73,"tag":"H2020"}]},"id":"485080305054019584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:18:51.000Z","conversation_id":"485080305054019584","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: First calls under our public-private partnerships in #H2020 launch on 9 July. Will be webstreamed! http://t.co/6K3mca7gIF #JT…","referenced_tweets":[{"type":"retweeted","id":"485078934695182336"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"ECspokesScience","id":"613378164"}],"annotations":{},"hashtags":[{"start":74,"end":86,"tag":"Horizon2020"}]},"id":"485077352507260928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:07:07.000Z","conversation_id":"485077352507260928","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECspokesScience: First calls under our public-private partnerships in #Horizon2020 happening on 9 July. Will be webstreamed! http://t.c…","referenced_tweets":[{"type":"retweeted","id":"485077195262795776"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"ECspokesScience","id":"613378164"},{"start":80,"end":91,"username":"science2_0","id":"162097001"}],"annotations":{},"hashtags":[{"start":45,"end":55,"tag":"science20"}]},"id":"485076429647147008","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:03:27.000Z","conversation_id":"485076429647147008","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECspokesScience: If you're answering our #science20 consultation, check out @science2_0 They've been doing this stuff for a while now..…","referenced_tweets":[{"type":"retweeted","id":"485076219286003713"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":{}},"id":"485076086028374016","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:02:05.000Z","conversation_id":"485076086028374016","public_metrics":{"retweet_count":129,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Antimicrobial resistance threatens effective prevention and treatment of a range of infections caused by bacteria, parasites, viru…","referenced_tweets":[{"type":"retweeted","id":"485076057587216384"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/oq6af6l8Et","expanded_url":"http://youtu.be/dIWqjhCYjjk","display_url":"youtu.be/dIWqjhCYjjk"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":42,"end":66,"probability":0.4481,"type":"Organization","normalized_text":"EFSA Scientific Committee"}],"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"}]},"id":"485076016826974208","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:01:49.000Z","conversation_id":"485076016826974208","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #EFSApanel renewal. Join the EFSA Scientific Committee and Panels! Watch our video http://t.co/oq6af6l8Et","referenced_tweets":[{"type":"retweeted","id":"485075566945918976"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":{}},"id":"485075968386940928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:01:37.000Z","conversation_id":"485075968386940928","public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Draft Global action plan on antimicrobial resistance: stakeholders, interest groups: your views by 1 Sept here http://t.co/ZMGP3Me…","referenced_tweets":[{"type":"retweeted","id":"485075234098511872"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/ZMGP3Mek7B","expanded_url":"http://goo.gl/8MffCz","display_url":"goo.gl/8MffCz"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":127,"end":131,"tag":"AMR"}]},"id":"485075709610971136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T15:00:36.000Z","conversation_id":"485075709610971136","public_metrics":{"retweet_count":55,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Draft Global action plan to address antimicrobial resistance: your views, contributions count: http://t.co/ZMGP3Mek7B #AMR","referenced_tweets":[{"type":"retweeted","id":"485073105363419136"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/ezNO6OBRs8","expanded_url":"http://bbc.in/1lCWqDa","display_url":"bbc.in/1lCWqDa"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":34,"end":42,"probability":0.5689,"type":"Other","normalized_text":"Alzheimer"}],"hashtags":[{"start":55,"end":65,"tag":"Alzheimer"}]},"id":"485070436833951746","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T14:39:38.000Z","conversation_id":"485070436833951746","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: \"Decline in trials for Alzheimer's disease\" #Alzheimer's research news http://t.co/ezNO6OBRs8","referenced_tweets":[{"type":"retweeted","id":"485070204549214208"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":28,"end":35,"tag":"health"},{"start":36,"end":44,"tag":"threats"},{"start":97,"end":103,"tag":"ebola"},{"start":108,"end":120,"tag":"chikungunya"}]},"id":"485064555308257281","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T14:16:16.000Z","conversation_id":"485064555308257281","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: CDTR: the main #health #threats detected and monitored by ECDC this week, including #ebola and #chikungunya http://t.co/Wsh0AB…","referenced_tweets":[{"type":"retweeted","id":"485062735521415168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":118,"end":127,"username":"TorbettR","id":"1393801172"}],"annotations":{},"hashtags":{}},"id":"485056820583890944","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:45:32.000Z","conversation_id":"485056820583890944","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: \"Opinion: Personalised medicine &amp; a European data-driven economy\"with contributing author, EFPIA's own @TorbettR !!! http://t.co…","referenced_tweets":[{"type":"retweeted","id":"485054412877221888"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/sRhtMhw7p9","expanded_url":"http://europa.eu/!PY64pp","display_url":"europa.eu/!PY64pp"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":55,"end":69,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":93,"end":103,"tag":"Science20"}]},"id":"485056591600050176","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:44:38.000Z","conversation_id":"485056591600050176","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Have your say on the future of science! @EU_Commission public consultation on #Science20 http://t.co/sRhtMhw7p9 http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"485054049453346816"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/Fk4yUfTBNv","expanded_url":"http://bit.ly/1pNr5Gh","display_url":"bit.ly/1pNr5Gh"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"eMA"},{"start":32,"end":50,"tag":"pharmacovigilance"},{"start":62,"end":67,"tag":"PRAC"}]},"id":"485049167036022784","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:15:07.000Z","conversation_id":"485049167036022784","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #eMA human #pharmacovigilance committee (#PRAC) meets next week. http://t.co/Fk4yUfTBNv","referenced_tweets":[{"type":"retweeted","id":"485049054276382721"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/IKIToU3cDi","expanded_url":"http://goo.gl/hmpxIt","display_url":"goo.gl/hmpxIt"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":22,"end":26,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":82,"end":86,"tag":"HCV"}]},"id":"485047698811539458","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:09:17.000Z","conversation_id":"485047698811539458","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: New @WHO factsheet highlights major recommendations from recent #HCV guidelines http://t.co/IKIToU3cDi","referenced_tweets":[{"type":"retweeted","id":"485040204949258240"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/pKmhJfAOZn","expanded_url":"http://bit.ly/1xr93d6","display_url":"bit.ly/1xr93d6"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{},"hashtags":{}},"id":"485047443835617280","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:08:17.000Z","conversation_id":"485047443835617280","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: New guidance for design of package leaflets and medicine packaging http://t.co/pKmhJfAOZn","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":23,"end":36,"tag":"statistician"}]},"id":"485046901252034560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:06:07.000Z","conversation_id":"485046901252034560","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Are you a #statistician with proven experience in quantitative data analysis and modeling? Apply by 30 July  http://t.co/707do…","referenced_tweets":[{"type":"retweeted","id":"485030270324973568"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.8343,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":{}},"id":"485046804493635584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T13:05:44.000Z","conversation_id":"485046804493635584","public_metrics":{"retweet_count":62,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Regulation is among public health's most powerful preventive tools","referenced_tweets":[{"type":"retweeted","id":"485026479412359168"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/6sS5jnkHe1","expanded_url":"http://bit.ly/1qVcuWs","display_url":"bit.ly/1qVcuWs"}],"mentions":{},"annotations":[{"start":33,"end":36,"probability":0.4324,"type":"Organization","normalized_text":"VICH"}],"hashtags":[{"start":126,"end":139,"tag":"consultation"}]},"id":"485018059296768000","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:11:31.000Z","conversation_id":"485018059296768000","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on the VICH guideline on file formats for electronic exchange of documents: http://t.co/6sS5jnkHe1  #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/hUpnRM83wU","expanded_url":"http://bit.ly/1klGQvb","display_url":"bit.ly/1klGQvb"}],"mentions":{},"annotations":{},"hashtags":[{"start":45,"end":54,"tag":"Planning"},{"start":112,"end":124,"tag":"recruitment"}]},"id":"485017966627803136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:11:09.000Z","conversation_id":"485017966627803136","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our vacancy for a #Planning Officer in Corporate Governance: http://t.co/hUpnRM83wU  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/toc0XYKNR1","expanded_url":"http://bit.ly/1u4E9DM","display_url":"bit.ly/1u4E9DM"}],"mentions":{},"annotations":[{"start":46,"end":83,"probability":0.4579,"type":"Organization","normalized_text":"Internal Corporate Relations Assistant"}],"hashtags":[{"start":110,"end":122,"tag":"recruitment"}]},"id":"485017853251579904","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:10:42.000Z","conversation_id":"485017853251579904","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our vacancy for an Internal Corporate Relations Assistant: http://t.co/toc0XYKNR1  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/49e0xMwZhq","expanded_url":"http://bit.ly/1oMQ0qG","display_url":"bit.ly/1oMQ0qG"}],"mentions":{},"annotations":{},"hashtags":[{"start":55,"end":63,"tag":"Auditor"},{"start":89,"end":101,"tag":"recruitment"}]},"id":"485017792207679489","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:10:27.000Z","conversation_id":"485017792207679489","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our vacancy for an Internal #Auditor: http://t.co/49e0xMwZhq  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"mentions":{},"annotations":{},"hashtags":[{"start":132,"end":144,"tag":"recruitment"}]},"id":"485017737631367168","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:10:14.000Z","conversation_id":"485017737631367168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"One more week to apply for our vacancy for a Scientific Officer in Risk Management &amp; Signal Management: http://t.co/S31YhJik3b  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/WT7ZpoUI4B","expanded_url":"http://bit.ly/1q23iyg","display_url":"bit.ly/1q23iyg"}],"mentions":{},"annotations":{},"hashtags":[{"start":24,"end":35,"tag":"veterinary"},{"start":57,"end":62,"tag":"CVMP"}]},"id":"485017617477169152","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:09:45.000Z","conversation_id":"485017617477169152","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The July meeting of our #veterinary medicines committee (#CVMP) is next week. Highlights out on Friday: http://t.co/WT7ZpoUI4B","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/a9vXkVi9cI","expanded_url":"http://bit.ly/1pNr5Gh","display_url":"bit.ly/1pNr5Gh"}],"mentions":{},"annotations":{},"hashtags":[{"start":10,"end":28,"tag":"pharmacovigilance"},{"start":40,"end":45,"tag":"PRAC"}]},"id":"485017508328771584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:09:19.000Z","conversation_id":"485017508328771584","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our human #pharmacovigilance committee (#PRAC) meets next week. Highlights out on Friday: http://t.co/a9vXkVi9cI","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/PNx76xNVn8","expanded_url":"http://bit.ly/1vvqRRz","display_url":"bit.ly/1vvqRRz"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":46,"end":70,"probability":0.2902,"type":"Organization","normalized_text":"Anti-Microbial Resistance"},{"start":91,"end":92,"probability":0.9495,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"id":"485017159115231232","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:07:56.000Z","conversation_id":"485017159115231232","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: In case you missed it: big news on Anti-Microbial Resistance this week from the UK http://t.co/PNx76xNVn8","referenced_tweets":[{"type":"retweeted","id":"485013040308690944"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.8852,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":52,"end":61,"tag":"vaccines"}]},"id":"485017032195592192","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:07:26.000Z","conversation_id":"485017032195592192","public_metrics":{"retweet_count":72,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Effective regulatory oversight of #vaccines is especially important... High quality must be assured","referenced_tweets":[{"type":"retweeted","id":"485009950893441024"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/D4u6IjzHdb","expanded_url":"http://ow.ly/yMcss","display_url":"ow.ly/yMcss"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{},"hashtags":[{"start":35,"end":46,"tag":"depression"},{"start":50,"end":57,"tag":"cancer"}]},"id":"485016946090717184","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T11:07:05.000Z","conversation_id":"485016946090717184","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Review of treatmts for #depression in #cancer patients: 2 classes of anti-depressants improve symptoms http://t.co/D4u6IjzHdb","referenced_tweets":[{"type":"retweeted","id":"485008851046240256"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/EFnnhpszJu","expanded_url":"http://content.govdelivery.com/accounts/UKMHRA/bulletins/c20a1f","display_url":"content.govdelivery.com/accounts/UKMHR…"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{},"hashtags":{}},"id":"485004182655864833","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T10:16:22.000Z","conversation_id":"485004182655864833","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Company-led drug recalls: Company-led drug recall: Docetaxol 20mg/0.72ml ... http://t.co/EFnnhpszJu","referenced_tweets":[{"type":"retweeted","id":"485004038857973760"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/WT7ZpoUI4B","expanded_url":"http://bit.ly/1q23iyg","display_url":"bit.ly/1q23iyg"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":37,"end":42,"tag":"CVMP"}]},"id":"484975152233730048","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T08:21:01.000Z","conversation_id":"484975152233730048","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #veterinary medicines committee (#CVMP) meets next week. Highlights out on Friday: http://t.co/WT7ZpoUI4B","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/a9vXkVi9cI","expanded_url":"http://bit.ly/1pNr5Gh","display_url":"bit.ly/1pNr5Gh"}],"mentions":{},"annotations":{},"hashtags":[{"start":30,"end":48,"tag":"pharmacovigilance"},{"start":60,"end":65,"tag":"PRAC"}]},"id":"484974049379229696","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T08:16:38.000Z","conversation_id":"484974049379229696","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The July meeting of our human #pharmacovigilance committee (#PRAC) is next week. Highlights out on Friday: http://t.co/a9vXkVi9cI","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/3RkpKNTXbk","expanded_url":"http://bit.ly/1qTuArU","display_url":"bit.ly/1qTuArU"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":35,"tag":"orphan"},{"start":57,"end":62,"tag":"COMP"}]},"id":"484972955030814720","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T08:12:17.000Z","conversation_id":"484972955030814720","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"The #agenda for next week's #orphan medicines committee (#COMP) meeting is available: http://t.co/3RkpKNTXbk","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/iKogywouP5","expanded_url":"http://bit.ly/1zcoeIM","display_url":"bit.ly/1zcoeIM"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":20,"end":25,"tag":"NICE"},{"start":55,"end":62,"tag":"atrial"},{"start":63,"end":76,"tag":"fibrillation"}]},"id":"484972491782496256","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T08:10:27.000Z","conversation_id":"484972491782496256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: #NICE has updated its guideline on #atrial #fibrillation http://t.co/iKogywouP5","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/6sS5jnkHe1","expanded_url":"http://bit.ly/1qVcuWs","display_url":"bit.ly/1qVcuWs"}],"mentions":{},"annotations":[{"start":33,"end":36,"probability":0.4219,"type":"Organization","normalized_text":"VICH"}],"hashtags":[{"start":125,"end":138,"tag":"consultation"}]},"id":"484972064118681600","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T08:08:45.000Z","conversation_id":"484972064118681600","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on the VICH guideline on file formats for electronic exchange of documents: http://t.co/6sS5jnkHe1 #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/toc0XYKNR1","expanded_url":"http://bit.ly/1u4E9DM","display_url":"bit.ly/1u4E9DM"}],"mentions":{},"annotations":[{"start":46,"end":83,"probability":0.5122,"type":"Organization","normalized_text":"Internal Corporate Relations Assistant"}],"hashtags":[{"start":109,"end":121,"tag":"recruitment"}]},"id":"484969290551271424","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T07:57:43.000Z","conversation_id":"484969290551271424","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our vacancy for an Internal Corporate Relations Assistant: http://t.co/toc0XYKNR1 #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/hUpnRM83wU","expanded_url":"http://bit.ly/1klGQvb","display_url":"bit.ly/1klGQvb"}],"mentions":{},"annotations":{},"hashtags":[{"start":45,"end":54,"tag":"Planning"},{"start":111,"end":123,"tag":"recruitment"}]},"id":"484969202630295552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T07:57:22.000Z","conversation_id":"484969202630295552","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our vacancy for a #Planning Officer in Corporate Governance: http://t.co/hUpnRM83wU #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/49e0xMwZhq","expanded_url":"http://bit.ly/1oMQ0qG","display_url":"bit.ly/1oMQ0qG"}],"mentions":{},"annotations":{},"hashtags":[{"start":55,"end":63,"tag":"Auditor"},{"start":88,"end":100,"tag":"recruitment"}]},"id":"484969095268687875","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T07:56:57.000Z","conversation_id":"484969095268687875","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our vacancy for an Internal #Auditor: http://t.co/49e0xMwZhq #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"mentions":{},"annotations":{},"hashtags":[{"start":131,"end":143,"tag":"recruitment"}]},"id":"484968976938979329","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T07:56:29.000Z","conversation_id":"484968976938979329","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our vacancy for a Scientific Officer in Risk Management &amp; Signal Management: http://t.co/S31YhJik3b #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":128,"end":131,"username":"FT","id":"18949452"}],"annotations":[{"start":72,"end":73,"probability":0.3973,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":49,"end":60,"tag":"antibiotic"}]},"id":"484968313181995009","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-04T07:53:50.000Z","conversation_id":"484968313181995009","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: PPPs ‘already beginning to stimulate #antibiotic R&amp;D’, with EU’s IMI ‘leading the way’ says none other than the @FT http://t.co…","referenced_tweets":[{"type":"retweeted","id":"484965757441556480"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/3RkpKNTXbk","expanded_url":"http://bit.ly/1qTuArU","display_url":"bit.ly/1qTuArU"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":50,"tag":"orphan"},{"start":72,"end":77,"tag":"COMP"}]},"id":"484740476525117440","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T16:48:30.000Z","conversation_id":"484740476525117440","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #agenda for next weeks #orphan medicines committee (#COMP) meeting: http://t.co/3RkpKNTXbk","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/nvwrFxXJFI","expanded_url":"http://ow.ly/yK6Hs","display_url":"ow.ly/yK6Hs"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{},"hashtags":[{"start":76,"end":88,"tag":"RareDisease"}]},"id":"484739377063796736","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T16:44:08.000Z","conversation_id":"484739377063796736","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: Lymphangioleiomyomatosis \nLAM: From Puzzle to Treatment Video\n#RareDisease\nhttp://t.co/nvwrFxXJFI","referenced_tweets":[{"type":"retweeted","id":"484729604041867264"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Wh2HJv3cZZ","expanded_url":"http://ow.ly/yBskF","display_url":"ow.ly/yBskF"},{"start":110,"end":132,"url":"http://t.co/dgKVImcixC","expanded_url":"https://twitter.com/FDAWomen/status/484728334304047104/photo/1","display_url":"pic.twitter.com/dgKVImcixC"}],"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":{},"hashtags":[{"start":28,"end":37,"tag":"diabetes"},{"start":101,"end":109,"tag":"2014ada"}]},"id":"484738805271113728","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T16:41:51.000Z","conversation_id":"484738805271113728","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAWomen: Our guides on #diabetes medicines, insulin, and glucose meters: http://t.co/Wh2HJv3cZZ #2014ada http://t.co/dgKVImcixC","referenced_tweets":[{"type":"retweeted","id":"484728334304047104"}],"attachments":{"media_keys":["3_483614853752320000"]}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/rMKw4jp5d3","expanded_url":"http://go.usa.gov/XY54","display_url":"go.usa.gov/XY54"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":33,"end":42,"tag":"Beleodaq"},{"start":89,"end":98,"tag":"lymphoma"}]},"id":"484738489406476288","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T16:40:36.000Z","conversation_id":"484738489406476288","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: #FDA approves #Beleodaq to treat rare, aggressive form of non-Hodgkin #lymphoma. http://t.co/rMKw4jp5d3","referenced_tweets":[{"type":"retweeted","id":"484715443777961984"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/MHCXmDoP91","expanded_url":"http://europa.eu/!kK46Py","display_url":"europa.eu/!kK46Py"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":88,"end":97,"probability":0.99,"type":"Place","normalized_text":"Luxembourg"}],"hashtags":[{"start":47,"end":60,"tag":"rarediseases"}]},"id":"484703022870962176","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T14:19:40.000Z","conversation_id":"484703022870962176","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: .@EU_Commission expert group on #rarediseases started its 2nd meeting in Luxembourg (3-4 Jul) http://t.co/MHCXmDoP91 http://…","referenced_tweets":[{"type":"retweeted","id":"484699760474226688"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/AAEknbIbq7","expanded_url":"http://bit.ly/1pZEQNT","display_url":"bit.ly/1pZEQNT"},{"start":122,"end":144,"url":"http://t.co/dssM88E3BD","expanded_url":"http://bit.ly/1iZT6Yv","display_url":"bit.ly/1iZT6Yv"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":87,"end":98,"username":"eupatients","id":"465674067"}],"annotations":{},"hashtags":{}},"id":"484702962951131136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T14:19:26.000Z","conversation_id":"484702962951131136","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Memorandum of understanding signed: Italian medicines agency &amp; @eupatients http://t.co/AAEknbIbq7 http://t.co/dssM88E3BD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":98,"end":100,"probability":0.8329,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"484701838533726208","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T14:14:58.000Z","conversation_id":"484701838533726208","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: When a biosimilar version of a drug becomes available, what should it be called?FDA urged not to give unique names http:/…","referenced_tweets":[{"type":"retweeted","id":"484695892076011520"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/ZbQwX2Yng8","expanded_url":"http://go.usa.gov/XrAx","display_url":"go.usa.gov/XrAx"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9324,"type":"Organization","normalized_text":"FDA"},{"start":18,"end":30,"probability":0.5782,"type":"Organization","normalized_text":"Europe Office"}],"hashtags":{}},"id":"484700959483109376","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T14:11:28.000Z","conversation_id":"484700959483109376","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: FDA’s Europe Office announces sharing of information with Italian Ministry of Health to Protect Consumers http://t.co/ZbQwX2Yng8","referenced_tweets":[{"type":"retweeted","id":"484687948487487491"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/eiZ906UFjW","expanded_url":"http://ow.ly/yJV4G","display_url":"ow.ly/yJV4G"}],"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{},"hashtags":[{"start":74,"end":84,"tag":"Science20"}]},"id":"484700784911998976","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T14:10:47.000Z","conversation_id":"484700784911998976","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DigitalAgendaEU: New way of doing research &amp; innovation is called #Science20! How should it look like? http://t.co/eiZ906UFjW http://t.…","referenced_tweets":[{"type":"retweeted","id":"484686305532866560"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/l3iZ8kw5Mg","expanded_url":"http://bit.ly/1iZQxps","display_url":"bit.ly/1iZQxps"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":89,"end":94,"tag":"CHMP"}]},"id":"484700071255359488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T14:07:56.000Z","conversation_id":"484700071255359488","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency has published a summary of the June meeting of the #CHMP http://t.co/l3iZ8kw5Mg","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/XDFNfoQ6Mv","expanded_url":"http://bit.ly/1lWcEw0","display_url":"bit.ly/1lWcEw0"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{},"hashtags":{}},"id":"484673671420989440","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T12:23:02.000Z","conversation_id":"484673671420989440","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: Tightened vigilance required when long-acting oxycodone medicine changes name http://t.co/XDFNfoQ6Mv","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/gJtpyGc2op","expanded_url":"http://bit.ly/1oc8qi0","display_url":"bit.ly/1oc8qi0"}],"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":{},"hashtags":{}},"id":"484647876392656896","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T10:40:32.000Z","conversation_id":"484647876392656896","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: Have your say on the future of science: public consultation on Science 2.0 http://t.co/gJtpyGc2op","referenced_tweets":[{"type":"retweeted","id":"484645799821721602"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/uO4gFmsBpP","expanded_url":"http://europa.eu/!PY64pp","display_url":"europa.eu/!PY64pp"},{"start":116,"end":138,"url":"http://t.co/JkKuL48gKg","expanded_url":"https://twitter.com/EU_Commission/status/484640436267778048/photo/1","display_url":"pic.twitter.com/JkKuL48gKg"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":82,"end":92,"tag":"Science20"}]},"id":"484641460189667328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T10:15:02.000Z","conversation_id":"484641460189667328","public_metrics":{"retweet_count":99,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: Have your say on the future of science! Public consultation on #Science20 http://t.co/uO4gFmsBpP http://t.co/JkKuL48gKg","referenced_tweets":[{"type":"retweeted","id":"484640436267778048"}],"attachments":{"media_keys":["3_484640435160506369"]}},{"source":"TweetDeck","entities":{"urls":{},"mentions":{},"annotations":{},"hashtags":{}},"id":"484641344812777472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T10:14:35.000Z","conversation_id":"484641344812777472","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUlondonrep: More open, data-driven and people-focused way of doing research. Commission launches public consultation http://t.co/6FtoK…","referenced_tweets":[{"type":"retweeted","id":"484639454716784641"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/RnftxTeQZ6","expanded_url":"http://ec.europa.eu/research/consultations/science-2.0/consultation_en.htm","display_url":"ec.europa.eu/research/consu…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":[{"start":83,"end":93,"tag":"Science20"}]},"id":"484629128843657216","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T09:26:02.000Z","conversation_id":"484629128843657216","public_metrics":{"retweet_count":62,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Take part in the European Commission's public consultation on #Science20 launched today http://t.co/RnftxTeQZ6 http://…","referenced_tweets":[{"type":"retweeted","id":"484624839685439488"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/JE73IWEnJc","expanded_url":"http://ec.europa.eu/research/consultations/science-2.0/consultation_en.htm","display_url":"ec.europa.eu/research/consu…"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":76,"end":86,"tag":"Science20"}]},"id":"484629114771763200","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T09:25:59.000Z","conversation_id":"484629114771763200","public_metrics":{"retweet_count":89,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: Take part in the European Commission's public consultation on #Science20 launched today http://t.co/JE73IWEnJc http://t.co/hT…","referenced_tweets":[{"type":"retweeted","id":"484624840201359361"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/rAmNjBD0Tf","expanded_url":"http://bit.ly/1jMojsR","display_url":"bit.ly/1jMojsR"},{"start":118,"end":140,"url":"http://t.co/STSMNu54qa","expanded_url":"http://bit.ly/1maYI0I","display_url":"bit.ly/1maYI0I"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{},"hashtags":[{"start":33,"end":39,"tag":"plant"}]},"id":"484628884307324928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T09:25:04.000Z","conversation_id":"484628884307324928","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @agesnews: Dwarf mallow, July #plant of the month, relieves throat &amp; stomach irritation http://t.co/rAmNjBD0Tf http://t.co/STSMNu54qa","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/vVtzANE1JK","expanded_url":"http://bit.ly/1kh5Pkd","display_url":"bit.ly/1kh5Pkd"},{"start":114,"end":136,"url":"http://t.co/CQkDYRPEE1","expanded_url":"http://bit.ly/1t0k5qS","display_url":"bit.ly/1t0k5qS"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":{}},"id":"484609657596805120","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-03T08:08:40.000Z","conversation_id":"484609657596805120","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Excellent results on web and social media to \"medicines and pregnancy\" http://t.co/vVtzANE1JK http://t.co/CQkDYRPEE1","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/2nmTQZDdbE","expanded_url":"http://bit.ly/1erfQbU","display_url":"bit.ly/1erfQbU"}],"mentions":{},"annotations":{},"hashtags":[{"start":58,"end":72,"tag":"sterilisation"},{"start":87,"end":97,"tag":"medicines"},{"start":122,"end":135,"tag":"consultation"}]},"id":"484380706001670144","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T16:58:54.000Z","conversation_id":"484380706001670144","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on our paper on the selection of #sterilisation processes for #medicines: http://t.co/2nmTQZDdbE #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/ZbIyVJTdeH","expanded_url":"http://bit.ly/1iXTPsT","display_url":"bit.ly/1iXTPsT"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":{}},"id":"484367956747747328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T16:08:14.000Z","conversation_id":"484367956747747328","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency will continue to monitor the risks associated with direct oral anticoagulants http://t.co/ZbIyVJTdeH","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/xTVNOskH4M","expanded_url":"http://www.bbc.com/news/health-28098838","display_url":"bbc.com/news/health-28…"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"annotations":[{"start":44,"end":50,"probability":0.9355,"type":"Person","normalized_text":"Cameron"}],"hashtags":{}},"id":"484360973630058496","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T15:40:29.000Z","conversation_id":"484360973630058496","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IlariaPassarani: Antibiotic resistance: Cameron warns of medical 'dark ages' http://t.co/xTVNOskH4M","referenced_tweets":[{"type":"retweeted","id":"484359493283631105"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/QLfTqs2dvo","expanded_url":"http://bit.ly/1lTg4j8","display_url":"bit.ly/1lTg4j8"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":10,"end":25,"tag":"Anticoagulants"}]},"id":"484355955413757952","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T15:20:33.000Z","conversation_id":"484355955413757952","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: #Anticoagulants:  no increased bleeding risk switching from anti-vitamin K treatment to a new anticoagulant http://t.co/QLfTqs2dvo","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/t8OIqhrgoj","expanded_url":"http://bit.ly/VczyVR","display_url":"bit.ly/VczyVR"},{"start":111,"end":133,"url":"http://t.co/ZFOY7f1icW","expanded_url":"https://twitter.com/ECDC_Flu/status/484339138058260480/photo/1","display_url":"pic.twitter.com/ZFOY7f1icW"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{},"hashtags":[{"start":27,"end":32,"tag":"MERS"},{"start":73,"end":76,"tag":"EU"}]},"id":"484350249188589569","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:57:52.000Z","conversation_id":"484350249188589569","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: 842 cases of #MERS-CoV reported as of 2 July 2014; risk to #EU unchanged: http://t.co/t8OIqhrgoj http://t.co/ZFOY7f1icW","referenced_tweets":[{"type":"retweeted","id":"484339138058260480"}],"attachments":{"media_keys":["3_484339135801331714"]}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/t8OIqhrgoj","expanded_url":"http://bit.ly/VczyVR","display_url":"bit.ly/VczyVR"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":68,"end":76,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":29,"end":34,"tag":"MERS"}]},"id":"484349989125373952","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:56:50.000Z","conversation_id":"484349989125373952","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Decline in new #MERS-CoV cases in recent weeks. A new @ECDC_EU update has the latest figures: http://t.co/t8OIqhrgoj http://t…","referenced_tweets":[{"type":"retweeted","id":"484335003208536064"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/2AtOJNsKzS","expanded_url":"http://goo.gl/d950Hd","display_url":"goo.gl/d950Hd"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":[{"start":18,"end":20,"probability":0.562,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":66,"end":76,"tag":"hepatitis"}]},"id":"484349674015686657","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:55:35.000Z","conversation_id":"484349674015686657","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: EMA approves new drug Daklinza to treat chronic #hepatitis C http://t.co/2AtOJNsKzS","referenced_tweets":[{"type":"retweeted","id":"484326052115005441"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/nWYPRA1ZOX","expanded_url":"http://ow.ly/yH9rl","display_url":"ow.ly/yH9rl"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":12,"end":14,"probability":0.8224,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":76,"end":86,"tag":"Carcinoma"}]},"id":"484349557351133184","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:55:07.000Z","conversation_id":"484349557351133184","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: FDA approves Lymphoseek for determining Extent of Squamous Cell #Carcinoma of the Oral Cavity http://t.co/nWYPRA1ZOX","referenced_tweets":[{"type":"retweeted","id":"484323895118675968"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/D44xXC2XXy","expanded_url":"http://bit.ly/1o1OOMb","display_url":"bit.ly/1o1OOMb"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{},"hashtags":{}},"id":"484349425993936897","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:54:36.000Z","conversation_id":"484349425993936897","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"it","text":"RT @LV_MPA: Approval no. 22, 2014 (2014-07-02) http://t.co/D44xXC2XXy","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":45,"end":49,"username":"NIH","id":"15134240"}],"annotations":{},"hashtags":{}},"id":"484349157730418688","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:53:32.000Z","conversation_id":"484349157730418688","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: Save the date - Sept 3-5, 2014 @NIH scientific workshop: Adverse Outcome Pathways: From Research to Regulation http://t.co/WI…","referenced_tweets":[{"type":"retweeted","id":"484318196170645504"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/FxejvlVI1K","expanded_url":"http://bit.ly/1o1OrkP","display_url":"bit.ly/1o1OrkP"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":92,"end":107,"tag":"anticoagulants"}]},"id":"484348709627785216","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T14:51:45.000Z","conversation_id":"484348709627785216","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency and CNAMTS present the results of two studies on oral #anticoagulants http://t.co/FxejvlVI1K","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/YDK5QUyM1j","expanded_url":"http://bit.ly/1jJ62Nb","display_url":"bit.ly/1jJ62Nb"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":{}},"id":"484295243383455744","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T11:19:18.000Z","conversation_id":"484295243383455744","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"fr","text":"RT @Aifa_ufficiale: Medicine-food interactions to enhance therapeutic activity and avoid dangerous combinations http://t.co/YDK5QUyM1j","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/2nmTQZDdbE","expanded_url":"http://bit.ly/1erfQbU","display_url":"bit.ly/1erfQbU"}],"mentions":{},"annotations":{},"hashtags":[{"start":58,"end":72,"tag":"sterilisation"},{"start":87,"end":97,"tag":"medicines"},{"start":123,"end":136,"tag":"consultation"}]},"id":"484294716163633153","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T11:17:12.000Z","conversation_id":"484294716163633153","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on our paper on the selection of #sterilisation processes for #medicines: http://t.co/2nmTQZDdbE  #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/lJ3kCZKKPp","expanded_url":"http://bit.ly/1kRsIu7","display_url":"bit.ly/1kRsIu7"}],"mentions":{},"annotations":{},"hashtags":[{"start":51,"end":62,"tag":"paediatric"},{"start":84,"end":94,"tag":"neurology"},{"start":120,"end":133,"tag":"consultation"}]},"id":"484294580125581312","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T11:16:40.000Z","conversation_id":"484294580125581312","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on our draft inventory of #paediatric therapeutic needs in #neurology: http://t.co/lJ3kCZKKPp  #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":124,"end":131,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":17,"end":18,"probability":0.5371,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":27,"end":31,"tag":"AMR"}]},"id":"484294286197137408","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T11:15:30.000Z","conversation_id":"484294286197137408","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUlondonrep: EU funded #AMR research by £636 *million* over 16 years, £80 mn more under Innovative Medicines Initiative @IMI_JU http://…","referenced_tweets":[{"type":"retweeted","id":"484287743858847744"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/Nt4zkdVsZQ","expanded_url":"https://www.youtube.com/watch?v=FqQ-JuRDkl8&feature=youtu.be","display_url":"youtube.com/watch?v=FqQ-Ju…"}],"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"annotations":{},"hashtags":{}},"id":"484294187349975041","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T11:15:06.000Z","conversation_id":"484294187349975041","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @nice_intl: Brilliant youtube video - choosing wisely! https://t.co/Nt4zkdVsZQ","referenced_tweets":[{"type":"retweeted","id":"484286933863268353"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":18,"end":22,"tag":"AMR"},{"start":100,"end":111,"tag":"antibiotic"}]},"id":"484278710942851072","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T10:13:36.000Z","conversation_id":"484278710942851072","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI’s #AMR programme is tackling the scientific, regulatory, and economic challenges of #antibiotic development http://t.co/WaK…","referenced_tweets":[{"type":"retweeted","id":"484276964199768064"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/LPCL84Wm5p","expanded_url":"http://bbc.in/1kd5sXW","display_url":"bbc.in/1kd5sXW"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":82,"end":93,"username":"BBCr4today","id":"8170292"}],"annotations":{},"hashtags":[{"start":32,"end":46,"tag":"antimicrobial"},{"start":47,"end":58,"tag":"resistance"},{"start":127,"end":131,"tag":"AMR"}]},"id":"484278434500464641","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T10:12:30.000Z","conversation_id":"484278434500464641","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Great to hear IMI’s #antimicrobial #resistance programme mentioned on @BBCr4today http://t.co/LPCL84Wm5p (at 2h20) #AMR","referenced_tweets":[{"type":"retweeted","id":"484266480247504896"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/daFyVlt2sJ","expanded_url":"https://www.federalregister.gov/articles/2014/07/02/2014-15548/schedules-of-controlled-substances-placement-of-tramadol-into-schedule-iv?utm_campaign=subscription+mailing+list&utm_medium=email&utm_source=federalregister.gov","display_url":"federalregister.gov/articles/2014/…"}],"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"annotations":[{"start":97,"end":98,"probability":0.7615,"type":"Place","normalized_text":"US"}],"hashtags":{}},"id":"484277695308902400","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T10:09:34.000Z","conversation_id":"484277695308902400","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @toxicovigilance: Tramadol to be added to Schedule IV of the Controlled Substances Act in the US https://t.co/daFyVlt2sJ","referenced_tweets":[{"type":"retweeted","id":"484251120181997568"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/E6CHjsIo6r","expanded_url":"http://bit.ly/1xbDh3E","display_url":"bit.ly/1xbDh3E"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":47,"end":57,"tag":"medicines"},{"start":69,"end":74,"tag":"CHMP"}]},"id":"484247114860724225","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T08:08:03.000Z","conversation_id":"484247114860724225","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes from the May meeting of our human #medicines committee (#CHMP) are now available: http://t.co/E6CHjsIo6r","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/lJ3kCZKKPp","expanded_url":"http://bit.ly/1kRsIu7","display_url":"bit.ly/1kRsIu7"}],"mentions":{},"annotations":{},"hashtags":[{"start":51,"end":62,"tag":"paediatric"},{"start":84,"end":94,"tag":"neurology"},{"start":120,"end":133,"tag":"consultation"}]},"id":"484246742209400832","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T08:06:34.000Z","conversation_id":"484246742209400832","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One more week to comment on our draft inventory of #paediatric therapeutic needs in #neurology: http://t.co/lJ3kCZKKPp  #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/nhIjz5zaVp","expanded_url":"http://bit.ly/1mT2o7Z","display_url":"bit.ly/1mT2o7Z"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":[{"start":63,"end":77,"probability":0.5046,"type":"Person","normalized_text":"Seretide Diskus"},{"start":83,"end":100,"probability":0.7974,"type":"Person","normalized_text":"Airflusal Forspiro"}],"hashtags":{}},"id":"484245930368323584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T08:03:21.000Z","conversation_id":"484245930368323584","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Legemiddelinfo: In the most recent \"News about medicines\": Seretide Diskus and Airflusal Forspiro are equivalent: http://t.co/nhIjz5zaVp","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/xtNu2DmuO9","expanded_url":"http://bit.ly/1vv2Nhv","display_url":"bit.ly/1vv2Nhv"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":41,"end":55,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":{}},"id":"484245517422329857","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-02T08:01:42.000Z","conversation_id":"484245517422329857","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: EFPIA PR - EFPIA head heralds @EU_Commission's strategic working agenda for the pharmaceutical industry http://t.co/xtNu2DmuO9","referenced_tweets":[{"type":"retweeted","id":"484241546423046144"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"FDArecalls","id":"18058609"}],"annotations":[{"start":16,"end":22,"probability":0.5658,"type":"Place","normalized_text":"Bristol"},{"start":24,"end":35,"probability":0.3586,"type":"Person","normalized_text":"Myers Squibb"}],"hashtags":{}},"id":"484006894861045760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:13:30.000Z","conversation_id":"484006894861045760","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDArecalls: Bristol-Myers Squibb Issues Voluntary Nationwide Recall of COUMADIN (Warfarin Sodium) for Injection Due to Pre... http://t.…","referenced_tweets":[{"type":"retweeted","id":"484006820407545860"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/E6CHjsIo6r","expanded_url":"http://bit.ly/1xbDh3E","display_url":"bit.ly/1xbDh3E"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":48,"end":58,"tag":"medicines"},{"start":70,"end":75,"tag":"CHMP"}]},"id":"484006491155083264","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:11:54.000Z","conversation_id":"484006491155083264","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes from our May human #medicines committee (#CHMP) meeting: http://t.co/E6CHjsIo6r","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":89,"end":91,"probability":0.4585,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"484006131229286400","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:10:28.000Z","conversation_id":"484006131229286400","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: Data about the human body come in from all over the world. The lab for these FDA scientists is a computer screen http://t.co/yF…","referenced_tweets":[{"type":"retweeted","id":"484003088844746755"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/E6RH75jF2U","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON432866","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{},"hashtags":{}},"id":"484005863724974080","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:09:24.000Z","conversation_id":"484005863724974080","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRApress: Bacillus cereus infections update: 1 July 2014 http://t.co/E6RH75jF2U","referenced_tweets":[{"type":"retweeted","id":"483998548380241922"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/lVJGQU76TE","expanded_url":"http://go.usa.gov/9SFd","display_url":"go.usa.gov/9SFd"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":19,"end":21,"probability":0.9039,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"484005573680443392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:08:15.000Z","conversation_id":"484005573680443392","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: FDA outlines expectations for human drug compounders, including registered outsourcing facilities. http://t.co/lVJGQU76TE","referenced_tweets":[{"type":"retweeted","id":"483993957693935616"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/ChZUenoYiQ","expanded_url":"http://www.sciencebusiness.net/news/76611/European-Commission-paves-the-way-for-investment-in-%E2%80%9CScience-2.0%E2%80%9D#.U7LGcrG2zgd.twitter","display_url":"sciencebusiness.net/news/76611/Eur…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":114,"end":121,"username":"scibus","id":"62499092"}],"annotations":{},"hashtags":[{"start":73,"end":83,"tag":"science20"}]},"id":"484005150437421056","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:06:34.000Z","conversation_id":"484005150437421056","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: European Commission paves the way for investment in #science20 - http://t.co/ChZUenoYiQ (via @scibus)","referenced_tweets":[{"type":"retweeted","id":"483982023502352384"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/lrhfOmXoTF","expanded_url":"http://1.usa.gov/LTFRc8","display_url":"1.usa.gov/LTFRc8"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{},"hashtags":[{"start":46,"end":51,"tag":"CBER"}]},"id":"484004855934361601","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:05:24.000Z","conversation_id":"484004855934361601","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDACBER: Check out the Guidance Documents #CBER is Planning to Publish During Calendar Year 2014 http://t.co/lrhfOmXoTF","referenced_tweets":[{"type":"retweeted","id":"483973818583891968"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/hZPiSzpCu8","expanded_url":"http://bit.ly/1z4SrcX","display_url":"bit.ly/1z4SrcX"},{"start":107,"end":129,"url":"http://t.co/NL88LdMVPK","expanded_url":"https://twitter.com/EFPIA/status/483967738969587712/photo/1","display_url":"pic.twitter.com/NL88LdMVPK"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":76,"end":83,"tag":"cancer"}]},"id":"484004605630906369","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:04:25.000Z","conversation_id":"484004605630906369","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Non-invasive genetic test could be a game changer for esophageal #cancer http://t.co/hZPiSzpCu8 http://t.co/NL88LdMVPK","referenced_tweets":[{"type":"retweeted","id":"483967738969587712"}],"attachments":{"media_keys":["3_483967737895473152"]}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":15,"end":19,"username":"NIH","id":"15134240"},{"start":26,"end":33,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{}},"id":"484004477939511296","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T16:03:54.000Z","conversation_id":"484004477939511296","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: .@NIH &amp; @US_FDA workshop July 30-31: The Development of New Antibacterial Products: Charting a Course for the Future http://t…","referenced_tweets":[{"type":"retweeted","id":"483966116146864128"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{},"hashtags":[{"start":96,"end":108,"tag":"raredisease"}]},"id":"483946864526757888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T12:14:58.000Z","conversation_id":"483946864526757888","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: EURORDIS at symposium to discuss new &amp; improved stat design methods for small #raredisease population clinical trials http://…","referenced_tweets":[{"type":"retweeted","id":"483946803633852416"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/lFqxGXSUc3","expanded_url":"http://bit.ly/1vruJmu","display_url":"bit.ly/1vruJmu"}],"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"},{"start":33,"end":42,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":91,"end":104,"tag":"workfortheEU"},{"start":105,"end":112,"tag":"London"},{"start":113,"end":117,"tag":"job"}]},"id":"483940405076316160","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T11:49:18.000Z","conversation_id":"483940405076316160","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Careers: Internal Auditor @EMA_News – apply before 11/07/14: http://t.co/lFqxGXSUc3 #workfortheEU #London #job","referenced_tweets":[{"type":"retweeted","id":"483940251564769280"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/FlDfoAsnYf","expanded_url":"http://bit.ly/1qe5zbs","display_url":"bit.ly/1qe5zbs"}],"mentions":{},"annotations":{},"hashtags":[{"start":56,"end":62,"tag":"renal"},{"start":100,"end":113,"tag":"consultation"}]},"id":"483929547419947008","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T11:06:09.000Z","conversation_id":"483929547419947008","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our draft guideline on developing medicines for chronic #renal insufficiency is now open for public #consultation: http://t.co/FlDfoAsnYf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/bO1Vfm1RAB","expanded_url":"http://ow.ly/yDU8N","display_url":"ow.ly/yDU8N"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":104,"end":111,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":[{"start":94,"end":99,"tag":"bcsm"}]},"id":"483922150416711680","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T10:36:46.000Z","conversation_id":"483922150416711680","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Breast Cancer - not enough men enrolled in clinical trials http://t.co/bO1Vfm1RAB #bcsm via @US_FDA","referenced_tweets":[{"type":"retweeted","id":"483919512107253761"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/Llp0BPokaF","expanded_url":"http://europa.eu/!bC73jn","display_url":"europa.eu/!bC73jn"}],"mentions":[{"start":3,"end":16,"username":"EC_AVService","id":"56392389"},{"start":90,"end":99,"username":"EU_H2020","id":"920249612329504768"}],"annotations":[{"start":28,"end":39,"probability":0.4382,"type":"Other","normalized_text":"Horizon 2020"}],"hashtags":[{"start":100,"end":106,"tag":"H2020"},{"start":107,"end":113,"tag":"video"}]},"id":"483911083724664832","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T09:52:47.000Z","conversation_id":"483911083724664832","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EC_AVService: NEW DOCU: Horizon 2020 introduction\nhttp://t.co/Llp0BPokaF (EN version)\n@EU_H2020 #H2020 #video","referenced_tweets":[{"type":"retweeted","id":"483898446982574080"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/J7PHjEJAZ8","expanded_url":"http://europa.eu/!Hv38qh","display_url":"europa.eu/!Hv38qh"}],"mentions":[{"start":3,"end":16,"username":"EC_AVService","id":"56392389"},{"start":98,"end":107,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":108,"end":114,"tag":"H2020"},{"start":115,"end":121,"tag":"video"}]},"id":"483911017442066432","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T09:52:31.000Z","conversation_id":"483911017442066432","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EC_AVService: NEW DOCU: Horizon2020 application procedure\nhttp://t.co/J7PHjEJAZ8 (EN version)\n@EU_H2020 #H2020 #video","referenced_tweets":[{"type":"retweeted","id":"483897976616517632"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/UBGgIwpf3c","expanded_url":"http://bit.ly/1raNgWs","display_url":"bit.ly/1raNgWs"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"483901234186047488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T09:13:39.000Z","conversation_id":"483901234186047488","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: More than 40 melanoma-specific genes that determine aggressiveness identified http://t.co/UBGgIwpf3c","referenced_tweets":[{"type":"retweeted","id":"483897840125890561"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/fUC3MguVDg","expanded_url":"http://www.surveymonkey.com/s/YNT6676","display_url":"surveymonkey.com/s/YNT6676"}],"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"id":"483901078225051648","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T09:13:02.000Z","conversation_id":"483901078225051648","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EMCDDA: What do you think we should focus on over the next three years? Take our short survey and tell us: http://t.co/fUC3MguVDg","referenced_tweets":[{"type":"retweeted","id":"483895836431364096"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/NZ8520Q3ch","expanded_url":"http://bit.ly/1vqZ30z","display_url":"bit.ly/1vqZ30z"}],"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":{},"hashtags":{}},"id":"483888478229626880","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T08:22:58.000Z","conversation_id":"483888478229626880","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: Scientists develop nanoparticle system for bone cancer treatment http://t.co/NZ8520Q3ch","referenced_tweets":[{"type":"retweeted","id":"483888286620864513"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/FlDfoAsnYf","expanded_url":"http://bit.ly/1qe5zbs","display_url":"bit.ly/1qe5zbs"}],"mentions":{},"annotations":{},"hashtags":[{"start":67,"end":73,"tag":"renal"},{"start":99,"end":112,"tag":"consultation"}]},"id":"483884006300475392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T08:05:11.000Z","conversation_id":"483884006300475392","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've released a guideline on medicines to prevent or slow chronic #renal insufficiency for public #consultation: http://t.co/FlDfoAsnYf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/EW6fcjUl55","expanded_url":"http://bit.ly/1mDKXU7","display_url":"bit.ly/1mDKXU7"}],"mentions":{},"annotations":{},"hashtags":[{"start":17,"end":25,"tag":"Vaccine"}]},"id":"483881977456910337","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T07:57:08.000Z","conversation_id":"483881977456910337","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Eurovaccine: #Vaccine safety systematically reviewed http://t.co/EW6fcjUl55","referenced_tweets":[{"type":"retweeted","id":"483881290497011712"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/r6jZUVLLUr","expanded_url":"http://bit.ly/1mddpC9","display_url":"bit.ly/1mddpC9"}],"mentions":{},"annotations":{},"hashtags":[{"start":62,"end":75,"tag":"consultation"}]},"id":"483878078276718592","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-07-01T07:41:38.000Z","conversation_id":"483878078276718592","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We've revised our guidance on classifying advanced therapies: #consultation now open: http://t.co/r6jZUVLLUr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":69,"end":88,"probability":0.642,"type":"Organization","normalized_text":"Scientific Committee"}],"hashtags":[{"start":54,"end":64,"tag":"EFSApanel"}]},"id":"483650852780273666","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:38:43.000Z","conversation_id":"483650852780273666","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: One week to go.Call for experts to renew #EFSApanel and Scientific Committee closes on 7 July. http://t.co/osrcX2XG6R http://t…","referenced_tweets":[{"type":"retweeted","id":"483649205689671680"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/SxbOOyraYC","expanded_url":"http://bit.ly/1voeZka","display_url":"bit.ly/1voeZka"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":81,"end":96,"username":"pharmexecutive","id":"22938073"}],"annotations":{},"hashtags":{}},"id":"483650585263345665","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:37:39.000Z","conversation_id":"483650585263345665","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Key Clinical Trial Themes from DIA 2014 http://t.co/SxbOOyraYC @PharmExecutive","referenced_tweets":[{"type":"retweeted","id":"483640004099706880"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":35,"end":57,"url":"http://t.co/ivwuh4PKZO","expanded_url":"http://bit.ly/1jCSXoE","display_url":"bit.ly/1jCSXoE"}],"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"},{"start":119,"end":131,"username":"TM_Momentum","id":"758001024"}],"annotations":{},"hashtags":[{"start":22,"end":33,"tag":"Newsletter"},{"start":58,"end":65,"tag":"EP2014"},{"start":66,"end":80,"tag":"Elections2014"},{"start":81,"end":89,"tag":"mHealth"},{"start":90,"end":103,"tag":"clinicaldata"},{"start":104,"end":118,"tag":"patientsafety"}]},"id":"483649788060389377","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:34:29.000Z","conversation_id":"483649788060389377","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"pt","text":"RT @CPME_EUROPA: CPME #Newsletter: http://t.co/ivwuh4PKZO #EP2014 #Elections2014 #mHealth #clinicaldata #patientsafety @TM_Momentum @WHO_Eu…","referenced_tweets":[{"type":"retweeted","id":"483630282260905984"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/C1wduF1XeV","expanded_url":"http://www.scientificamerican.com/article/psychotropic-drugs-affect-men-and-women-differently/","display_url":"scientificamerican.com/article/psycho…"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{},"hashtags":[{"start":20,"end":33,"tag":"Psychotropic"},{"start":34,"end":40,"tag":"Drugs"}]},"id":"483649083996131328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:31:42.000Z","conversation_id":"483649083996131328","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @nakosbalamotis: #Psychotropic #Drugs Affect Men and Women Differently http://t.co/C1wduF1XeV","referenced_tweets":[{"type":"retweeted","id":"483619002594234369"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":{}},"id":"483648958229925888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:31:12.000Z","conversation_id":"483648958229925888","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: The June IMI newsletter is out, with updates on IMI 2 info sessions &amp; success stories from our amazing projects http://t.co/EQm…","referenced_tweets":[{"type":"retweeted","id":"483617314093686784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/XQ9JvFt9uj","expanded_url":"http://bit.ly/V2nk1R","display_url":"bit.ly/V2nk1R"}],"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"},{"start":29,"end":37,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":88,"end":101,"tag":"workfortheEU"}]},"id":"483648682232127488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:30:06.000Z","conversation_id":"483648682232127488","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Careers: Statistician @EFSA_EU – apply before 18/07/2014: http://t.co/XQ9JvFt9uj #workfortheEU","referenced_tweets":[{"type":"retweeted","id":"483613711798902784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/A313Eb1GQX","expanded_url":"http://go.usa.gov/97qB","display_url":"go.usa.gov/97qB"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":60,"end":62,"probability":0.6836,"type":"Organization","normalized_text":"FDA"},{"start":82,"end":94,"probability":0.5085,"type":"Organization","normalized_text":"OTC Medicines"}],"hashtags":{}},"id":"483648450379390976","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:29:11.000Z","conversation_id":"483648450379390976","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: REMINDER: JOIN US TODAY, June 30 1PM ET for the FDA Basics Webinar on OTC Medicines and Drowsy Driving. http://t.co/A313Eb1GQX","referenced_tweets":[{"type":"retweeted","id":"483608999930388480"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{},"hashtags":{}},"id":"483648386823110657","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:28:55.000Z","conversation_id":"483648386823110657","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Calling all Young Oncologists: we have 3 open positions on our YO Committee. Find out how you can apply here http://t.co/b9ubjw…","referenced_tweets":[{"type":"retweeted","id":"483608932170993664"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":41,"end":55,"username":"EU_enterprise","id":"2562735307"},{"start":84,"end":98,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":17,"end":34,"probability":0.7934,"type":"Person","normalized_text":"Salvatore D'Acunto"}],"hashtags":[{"start":69,"end":75,"tag":"EGA20"},{"start":99,"end":114,"tag":"pharmaceutical"}]},"id":"483647951026528256","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:27:11.000Z","conversation_id":"483647951026528256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: Salvatore D'Acunto from @EU_enterprise presented at #EGA20 the new @EU_Commission #pharmaceutical industrial paper http://…","referenced_tweets":[{"type":"retweeted","id":"483607923893891072"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/KYgbXAC18a","expanded_url":"http://shar.es/My5qC","display_url":"shar.es/My5qC"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":124,"end":132,"username":"RAPSorg","id":"111425542"}],"annotations":[{"start":20,"end":22,"probability":0.7835,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":46,"end":59,"tag":"BreastCancer"},{"start":60,"end":66,"tag":"Drugs"}]},"id":"483647881820512256","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T16:26:55.000Z","conversation_id":"483647881820512256","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @nakosbalamotis: FDA: Companies Developing #BreastCancer #Drugs Should Also Enroll Men | RAPS http://t.co/KYgbXAC18a via @RAPSorg","referenced_tweets":[{"type":"retweeted","id":"483606996990447616"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/HM6e7GVqiu","expanded_url":"http://1.usa.gov/1z1XcnF","display_url":"1.usa.gov/1z1XcnF"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":[{"start":38,"end":70,"probability":0.8211,"type":"Organization","normalized_text":"Blood Products Advisory Committee"}],"hashtags":[{"start":13,"end":18,"tag":"CBER"}]},"id":"483595700161486848","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T12:59:34.000Z","conversation_id":"483595700161486848","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDACBER: #CBER announces the next Blood Products Advisory Committee (BPAC) Meeting to be held July 31, 2014  http://t.co/HM6e7GVqiu","referenced_tweets":[{"type":"retweeted","id":"483593817418125312"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/hZTHgaYZnm","expanded_url":"http://bit.ly/1ohGyuk","display_url":"bit.ly/1ohGyuk"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":20,"end":34,"tag":"AIFAEditorial"}]},"id":"483590094096695296","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T12:37:17.000Z","conversation_id":"483590094096695296","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: #AIFAEditorial Patients and the \"right to try\", true compassion or false hope? http://t.co/hZTHgaYZnm","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/r6jZUVLLUr","expanded_url":"http://bit.ly/1mddpC9","display_url":"bit.ly/1mddpC9"}],"mentions":{},"annotations":{},"hashtags":[{"start":35,"end":44,"tag":"advanced"},{"start":79,"end":92,"tag":"consultation"}]},"id":"483573368994926592","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T11:30:50.000Z","conversation_id":"483573368994926592","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've released revised guidance on #advanced-therapy classification for public #consultation: http://t.co/r6jZUVLLUr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/uBvRlKIWxT","expanded_url":"http://bit.ly/1qqlkxQ","display_url":"bit.ly/1qqlkxQ"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":44,"end":62,"tag":"pharmacovigilance"},{"start":74,"end":79,"tag":"PRAC"}]},"id":"483570434055897088","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T11:19:10.000Z","conversation_id":"483570434055897088","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: EMA Minutes from human #pharmacovigilance committee (#PRAC) May meeting are available http://t.co/uBvRlKIWxT","referenced_tweets":[{"type":"retweeted","id":"483570362006114304"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/c7i6pFnl8G","expanded_url":"http://bit.ly/1qqlkxQ","display_url":"bit.ly/1qqlkxQ"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":28,"end":46,"tag":"pharmacovigilance"},{"start":58,"end":63,"tag":"PRAC"}]},"id":"483567597787815936","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T11:07:54.000Z","conversation_id":"483567597787815936","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes from our human #pharmacovigilance committee (#PRAC) May meeting are available on our website: http://t.co/c7i6pFnl8G","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Qvex1NC40T","expanded_url":"http://bit.ly/1iMbeou","display_url":"bit.ly/1iMbeou"}],"mentions":{},"annotations":{},"hashtags":[{"start":25,"end":38,"tag":"benzalkonium"},{"start":57,"end":70,"tag":"consultation"},{"start":95,"end":105,"tag":"excipient"}]},"id":"483566335180673024","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T11:02:53.000Z","conversation_id":"483566335180673024","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Questions and answers on #benzalkonium chloride open for #consultation, related to revision of #excipient guideline: http://t.co/Qvex1NC40T","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/n6F067uODT","expanded_url":"http://bit.ly/1pDUCCr","display_url":"bit.ly/1pDUCCr"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":91,"end":100,"tag":"Erwinase"}]},"id":"483553113039962112","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T10:10:20.000Z","conversation_id":"483553113039962112","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency has granted a cohort temporary-use authorisation for #Erwinase 10,000 UI/vial http://t.co/n6F067uODT","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/c7i6pFnl8G","expanded_url":"http://bit.ly/1qqlkxQ","display_url":"bit.ly/1qqlkxQ"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":44,"end":62,"tag":"pharmacovigilance"},{"start":74,"end":79,"tag":"PRAC"}]},"id":"483549961091813376","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T09:57:49.000Z","conversation_id":"483549961091813376","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the #minutes from our human #pharmacovigilance committee (#PRAC) May meeting: http://t.co/c7i6pFnl8G","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/B9RhwRbWJn","expanded_url":"http://bit.ly/TIY0x8","display_url":"bit.ly/TIY0x8"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":67,"end":80,"tag":"tuberculosis"}]},"id":"483543758664114176","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T09:33:10.000Z","conversation_id":"483543758664114176","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Scientists establish proof-of-concept for host-directed #tuberculosis therapy http://t.co/B9RhwRbWJn","referenced_tweets":[{"type":"retweeted","id":"483539770757242882"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/Qvex1NC40T","expanded_url":"http://bit.ly/1iMbeou","display_url":"bit.ly/1iMbeou"}],"mentions":{},"annotations":{},"hashtags":[{"start":27,"end":40,"tag":"benzalkonium"},{"start":54,"end":67,"tag":"consultation"},{"start":100,"end":110,"tag":"excipient"}]},"id":"483543259722301441","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T09:31:11.000Z","conversation_id":"483543259722301441","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've released Q&amp;As on #benzalkonium chloride for #consultation, related to the revision of the #excipient guideline: http://t.co/Qvex1NC40T","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/NhMTmVg0wA","expanded_url":"http://bit.ly/1lUpNFu","display_url":"bit.ly/1lUpNFu"}],"mentions":{},"annotations":{},"hashtags":[{"start":37,"end":46,"tag":"Daklinza"},{"start":48,"end":60,"tag":"daclatasvir"},{"start":73,"end":84,"tag":"hepatitisC"}]},"id":"483527554348101632","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T08:28:47.000Z","conversation_id":"483527554348101632","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last week we recommended approval of #Daklinza (#daclatasvir) in chronic #hepatitisC: http://t.co/NhMTmVg0wA","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":125,"end":147,"url":"http://t.co/xvUug3MDnD","expanded_url":"http://bit.ly/1lV0UcN","display_url":"bit.ly/1lV0UcN"}],"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"}]},"id":"483525961905090560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T08:22:27.000Z","conversation_id":"483525961905090560","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation open on qualification &amp; reporting of physiologically-based pharmacokinetic modelling &amp; analyses paper: http://t.co/xvUug3MDnD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nz2i1morUv","expanded_url":"http://bit.ly/1lvOXuq","display_url":"bit.ly/1lvOXuq"}],"mentions":{},"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"Vectra"},{"start":44,"end":57,"tag":"pyriproxyfen"},{"start":60,"end":72,"tag":"dinotefuran"},{"start":77,"end":88,"tag":"veterinary"},{"start":106,"end":112,"tag":"fleas"}]},"id":"483525638813659136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T08:21:10.000Z","conversation_id":"483525638813659136","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Vectra Felis (#pyriproxyfen / #dinotefuran), a #veterinary medicine against #fleas: http://t.co/Nz2i1morUv","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/HySUsM9jmP","expanded_url":"http://bit.ly/1mkTj34","display_url":"bit.ly/1mkTj34"}],"mentions":{},"annotations":{},"hashtags":{}},"id":"483525364304842752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T08:20:04.000Z","conversation_id":"483525364304842752","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last Friday we published the June CHMP meeting highlights: http://t.co/HySUsM9jmP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/uJM99aZmNN","expanded_url":"http://bit.ly/1z0oxGy","display_url":"bit.ly/1z0oxGy"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":25,"end":35,"tag":"medicines"},{"start":43,"end":52,"tag":"European"},{"start":53,"end":64,"tag":"Commission"},{"start":76,"end":81,"tag":"logo"}]},"id":"483524844861276160","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-30T08:18:01.000Z","conversation_id":"483524844861276160","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: Buying #medicines online?#European #Commission introduces #logo 2 make sure consumers are safe: http://t.co/uJM99aZmNN","referenced_tweets":[{"type":"retweeted","id":"483522891699331075"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":124,"end":146,"url":"http://t.co/xvUug3MDnD","expanded_url":"http://bit.ly/1lV0UcN","display_url":"bit.ly/1lV0UcN"}],"mentions":{},"annotations":{},"hashtags":[{"start":109,"end":122,"tag":"consultation"}]},"id":"482548650472931328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T15:38:58.000Z","conversation_id":"482548650472931328","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Paper on qualification &amp; reporting of physiologically-based pharmacokinetic modelling &amp; analyses for #consultation: http://t.co/xvUug3MDnD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":32,"end":36,"tag":"FDA"}]},"id":"482540465427066881","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T15:06:26.000Z","conversation_id":"482540465427066881","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: New! Podcast #FDA warns of rare but serious hypersensitivity reactions w/ certain OTC topical acne products http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"482540349018365954"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{},"hashtags":{}},"id":"482539737941807105","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T15:03:33.000Z","conversation_id":"482539737941807105","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Safety warnings and messages for medicines: Information sent to healthcare professionals in June about the saf... http:/…","referenced_tweets":[{"type":"retweeted","id":"482539523625082881"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/LyiMuNgsFe","expanded_url":"http://ow.ly/ywijg","display_url":"ow.ly/ywijg"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{},"hashtags":[{"start":18,"end":22,"tag":"FDA"}]},"id":"482527166123761664","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T14:13:36.000Z","conversation_id":"482527166123761664","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: #FDA warns against lidocaine as painkiller for teething babies http://t.co/LyiMuNgsFe","referenced_tweets":[{"type":"retweeted","id":"482523871405674497"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/UX9DJbhXpH","expanded_url":"http://go.usa.gov/9ftw","display_url":"go.usa.gov/9ftw"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":[{"start":117,"end":133,"tag":"MensHealthMonth"}]},"id":"482519960896671744","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T13:44:58.000Z","conversation_id":"482519960896671744","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: Though rare, men get breast cancer too. Learn more about diagnosis and treatments http://t.co/UX9DJbhXpH #MensHealthMonth","referenced_tweets":[{"type":"retweeted","id":"482519787831300097"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/Nz2i1morUv","expanded_url":"http://bit.ly/1lvOXuq","display_url":"bit.ly/1lvOXuq"}],"mentions":{},"annotations":{},"hashtags":[{"start":13,"end":20,"tag":"Vectra"},{"start":28,"end":41,"tag":"pyriproxyfen"},{"start":44,"end":56,"tag":"dinotefuran"},{"start":61,"end":72,"tag":"veterinary"},{"start":105,"end":111,"tag":"fleas"}]},"id":"482519678292873216","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T13:43:50.000Z","conversation_id":"482519678292873216","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Vectra Felis (#pyriproxyfen / #dinotefuran), a #veterinary medicine to treat &amp; prevent #fleas, is live: http://t.co/Nz2i1morUv","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":33,"end":35,"probability":0.7314,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"482517298880987137","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T13:34:23.000Z","conversation_id":"482517298880987137","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: New! Podcast: FDA review of CV risks for diabetics taking olmesartan not conclusive; require label updates http://t.co/I…","referenced_tweets":[{"type":"retweeted","id":"482516963990978562"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":37,"probability":0.8423,"type":"Organization","normalized_text":"European Medicines Agency"}],"hashtags":{}},"id":"482498669670064128","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T12:20:21.000Z","conversation_id":"482498669670064128","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: European Medicines Agency welcomes publication of pharmacovigilance fee Regulation in Official Journal of the EU: http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"482498562035843072"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"BettinaRyll","id":"810969654"}],"annotations":{},"hashtags":{}},"id":"482497618829131777","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T12:16:11.000Z","conversation_id":"482433901571633152","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@BettinaRyll However, we can't release specifics on the medicines we have selected to take part in the pilot yet.","referenced_tweets":[{"type":"replied_to","id":"482497427124269056"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/ozoaP8w2zO","expanded_url":"http://bit.ly/1pGKjsR","display_url":"bit.ly/1pGKjsR"}],"mentions":[{"start":0,"end":12,"username":"BettinaRyll","id":"810969654"}],"annotations":{},"hashtags":{}},"id":"482497427124269056","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T12:15:25.000Z","conversation_id":"482433901571633152","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@BettinaRyll The principles for how medicines are selected for the pilot are explained on our website: http://t.co/ozoaP8w2zO.","referenced_tweets":[{"type":"replied_to","id":"482496662657855488"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"810969654"},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/y205KozAQy","expanded_url":"http://ow.ly/yvOQR","display_url":"ow.ly/yvOQR"}],"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{},"hashtags":[{"start":21,"end":33,"tag":"Horizon2020"},{"start":117,"end":123,"tag":"H2020"}]},"id":"482496730207105024","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T12:12:39.000Z","conversation_id":"482496730207105024","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DigitalAgendaEU: #Horizon2020 video - How to apply? - Now with subtitles in 23 languages: http://t.co/y205KozAQy #H2020","referenced_tweets":[{"type":"retweeted","id":"482493837521465345"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":{}},"id":"482496301960265729","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T12:10:57.000Z","conversation_id":"482496301960265729","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Interested in taking your career to another level? Join#EFSApanel. http://t.co/osrcX2XG6R","referenced_tweets":[{"type":"retweeted","id":"482482228396830720"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/NhMTmVg0wA","expanded_url":"http://bit.ly/1lUpNFu","display_url":"bit.ly/1lUpNFu"}],"mentions":{},"annotations":{},"hashtags":[{"start":30,"end":39,"tag":"Daklinza"},{"start":51,"end":61,"tag":"hepatitis"}]},"id":"482482649806958592","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:16:42.000Z","conversation_id":"482482649806958592","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've recommended approval of #Daklinza in chronic #hepatitis C: http://t.co/NhMTmVg0wA","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/HySUsM9jmP","expanded_url":"http://bit.ly/1mkTj34","display_url":"bit.ly/1mkTj34"}],"mentions":{},"annotations":{},"hashtags":{}},"id":"482482240061190144","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:15:04.000Z","conversation_id":"482482240061190144","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've just published the June CHMP meeting highlights: http://t.co/HySUsM9jmP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/Mtmwh7eQD0","expanded_url":"http://bit.ly/1mkHucY","display_url":"bit.ly/1mkHucY"}],"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":19,"end":23,"tag":"fee"}]},"id":"482479807713005568","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:05:24.000Z","conversation_id":"482479807713005568","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"#Pharmacovigilance #fee Regulation was published today: procedure-based fees start in August, annual fees in January: http://t.co/Mtmwh7eQD0","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/toc0XYKNR1","expanded_url":"http://bit.ly/1u4E9DM","display_url":"bit.ly/1u4E9DM"}],"mentions":{},"annotations":[{"start":47,"end":84,"probability":0.487,"type":"Organization","normalized_text":"Internal Corporate Relations Assistant"}],"hashtags":[{"start":111,"end":123,"tag":"recruitment"}]},"id":"482479375942942720","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:03:41.000Z","conversation_id":"482479375942942720","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for an Internal Corporate Relations Assistant: http://t.co/toc0XYKNR1  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/hUpnRM83wU","expanded_url":"http://bit.ly/1klGQvb","display_url":"bit.ly/1klGQvb"}],"mentions":{},"annotations":{},"hashtags":[{"start":46,"end":55,"tag":"Planning"},{"start":113,"end":125,"tag":"recruitment"}]},"id":"482479306518839297","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:03:25.000Z","conversation_id":"482479306518839297","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for a #Planning Officer in Corporate Governance: http://t.co/hUpnRM83wU  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/49e0xMwZhq","expanded_url":"http://bit.ly/1oMQ0qG","display_url":"bit.ly/1oMQ0qG"}],"mentions":{},"annotations":{},"hashtags":[{"start":56,"end":64,"tag":"Auditor"},{"start":89,"end":101,"tag":"recruitment"}]},"id":"482479137198993408","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:02:45.000Z","conversation_id":"482479137198993408","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for an Internal #Auditor: http://t.co/49e0xMwZhq #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"mentions":{},"annotations":{},"hashtags":[{"start":132,"end":144,"tag":"recruitment"}]},"id":"482479029757685760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T11:02:19.000Z","conversation_id":"482479029757685760","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for a Scientific Officer in Risk Management &amp; Signal Management: http://t.co/S31YhJik3b #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":0,"end":12,"username":"BettinaRyll","id":"810969654"}],"annotations":{},"hashtags":{}},"id":"482473466298662912","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T10:40:12.000Z","conversation_id":"482433901571633152","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@BettinaRyll We're afraid we can't name the medicines or give specific information on why we selected them, as the process is confidential.","referenced_tweets":[{"type":"replied_to","id":"482469322791845888"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"810969654"},{"source":"Bitly","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/Mtmwh7eQD0","expanded_url":"http://bit.ly/1mkHucY","display_url":"bit.ly/1mkHucY"}],"mentions":{},"annotations":{},"hashtags":[{"start":30,"end":48,"tag":"pharmacovigilance"},{"start":49,"end":53,"tag":"fee"}]},"id":"482468478621081600","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T10:20:23.000Z","conversation_id":"482468478621081600","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We welcome the publication of #pharmacovigilance #fee Regulation in Official Journal of the EU today: http://t.co/Mtmwh7eQD0","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/wgpJRVNDdl","expanded_url":"http://ow.ly/yvOQR","display_url":"ow.ly/yvOQR"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{},"hashtags":[{"start":16,"end":28,"tag":"Horizon2020"}]},"id":"482466959238635520","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T10:14:21.000Z","conversation_id":"482466959238635520","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: #Horizon2020 video - How to apply - Now with professionally translated subtitles in 23 languages: http://t.co/wgpJRVNDdl #H…","referenced_tweets":[{"type":"retweeted","id":"482465940412854272"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/X7LxDtOmJQ","expanded_url":"http://bit.ly/ToOpLq","display_url":"bit.ly/ToOpLq"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":20,"end":29,"tag":"Clinical"},{"start":30,"end":37,"tag":"trials"}]},"id":"482466856436264960","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T10:13:57.000Z","conversation_id":"482466856436264960","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: #Clinical #trials in epilepsy: collaboration between companies, regulators and clinicians... http://t.co/X7LxDtOmJQ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/hCZOm5gYAE","expanded_url":"http://bit.ly/1qNOwP5","display_url":"bit.ly/1qNOwP5"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":70,"end":80,"tag":"idealisib"}]},"id":"482466581784821760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T10:12:51.000Z","conversation_id":"482466581784821760","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: French medicines agency cohort temporary-use authorisation: #idealisib 100 &amp; 150mg film-coated tablets http://t.co/hCZOm5gYAE","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":51,"end":65,"username":"EU_enterprise","id":"2562735307"},{"start":112,"end":128,"username":"antoniotajanieu","id":"3029538799"}],"annotations":{},"hashtags":[{"start":87,"end":96,"tag":"patients"}]},"id":"482456222567002112","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T09:31:41.000Z","conversation_id":"482456222567002112","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @cancereu: What are biosimilars? Are they safe? @EU_enterprise gives its answers to #patients in 5 languages @AntonioTajaniEU http://t.c…","referenced_tweets":[{"type":"retweeted","id":"482455679173951488"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/IIRNYICqiQ","expanded_url":"http://bit.ly/1sobaiL","display_url":"bit.ly/1sobaiL"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":46,"end":55,"tag":"diabetes"},{"start":112,"end":116,"tag":"t1d"}]},"id":"482453166953611265","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T09:19:33.000Z","conversation_id":"482453166953611265","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Interested in IMI’s Call topic on #diabetes? Sign up for our webinar on 11/7 http://t.co/IIRNYICqiQ #t1d","referenced_tweets":[{"type":"retweeted","id":"482450401867096064"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/ghLTiv3LaF","expanded_url":"http://nyti.ms/1jqK69p","display_url":"nyti.ms/1jqK69p"},{"start":72,"end":94,"url":"http://t.co/HKGa83n5Cy","expanded_url":"https://twitter.com/EFPIA/status/482448063068635136/photo/1","display_url":"pic.twitter.com/HKGa83n5Cy"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":39,"end":48,"tag":"Medicine"}]},"id":"482448590930198529","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T09:01:22.000Z","conversation_id":"482448590930198529","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Living With Cancer: The New #Medicine http://t.co/ghLTiv3LaF http://t.co/HKGa83n5Cy","referenced_tweets":[{"type":"retweeted","id":"482448063068635136"}],"attachments":{"media_keys":["3_482448061969358849"]}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/JxFOo1Y37B","expanded_url":"http://www.epifemcare.eu","display_url":"epifemcare.eu"}],"mentions":[{"start":3,"end":19,"username":"ECspokesScience","id":"613378164"}],"annotations":[{"start":34,"end":42,"probability":0.3685,"type":"Organization","normalized_text":"EU-funded"}],"hashtags":[{"start":73,"end":86,"tag":"breastcancer"},{"start":134,"end":138,"tag":"FP7"}]},"id":"482448555450568704","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T09:01:13.000Z","conversation_id":"482448555450568704","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECspokesScience: Great to see EU-funded research on a blood test for #breastcancer risk in the news today! http://t.co/JxFOo1Y37B #FP7","referenced_tweets":[{"type":"retweeted","id":"482447753348677632"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":18,"end":54,"probability":0.7338,"type":"Organization","normalized_text":"IRDiRC Therapies Scientific Committee"}],"hashtags":[{"start":90,"end":102,"tag":"raredisease"}]},"id":"482444774046449664","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:46:12.000Z","conversation_id":"482444774046449664","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: The IRDiRC Therapies Scientific Committee is developing recommendations for #raredisease medicines development http://t.co/3U…","referenced_tweets":[{"type":"retweeted","id":"482443719980113920"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/9dAneUSiXt","expanded_url":"http://bit.ly/1wEpRwV","display_url":"bit.ly/1wEpRwV"}],"mentions":[{"start":0,"end":14,"username":"RoseTran88hus","id":"1607376014"}],"annotations":{},"hashtags":{}},"id":"482444539672944641","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:45:16.000Z","conversation_id":"482360323584716800","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@RoseTran88hus In the EU, GMP is only applicable to medicinal products and active substances. More info here: http://t.co/9dAneUSiXt","referenced_tweets":[{"type":"replied_to","id":"482360323584716800"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"1607376014"},{"source":"Twitter Web Client","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/Fwj15GwZ0v","expanded_url":"http://bit.ly/1o6UpU9","display_url":"bit.ly/1o6UpU9"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":41,"end":52,"tag":"Paediatric"}]},"id":"482441118777614336","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:31:40.000Z","conversation_id":"482441118777614336","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes from the May meeting of our #Paediatric Committee are published on our website: http://t.co/Fwj15GwZ0v","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/Nl64m2VvLq","expanded_url":"http://bit.ly/TmvgcX","display_url":"bit.ly/TmvgcX"}],"mentions":{},"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Vimizim"},{"start":23,"end":34,"tag":"elosulfase"},{"start":44,"end":53,"tag":"medicine"},{"start":58,"end":80,"tag":"mucopolysaccharidosis"}]},"id":"482440987902758912","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:31:09.000Z","conversation_id":"482440987902758912","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Vimizim (#elosulfase alfa), a #medicine for #mucopolysaccharidosis type IVA, is now available: http://t.co/Nl64m2VvLq","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/toc0XYKNR1","expanded_url":"http://bit.ly/1u4E9DM","display_url":"bit.ly/1u4E9DM"}],"mentions":{},"annotations":[{"start":47,"end":84,"probability":0.5031,"type":"Organization","normalized_text":"Internal Corporate Relations Assistant"}],"hashtags":[{"start":110,"end":122,"tag":"recruitment"}]},"id":"482440369649745920","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:28:42.000Z","conversation_id":"482440369649745920","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for an Internal Corporate Relations Assistant: http://t.co/toc0XYKNR1 #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/hUpnRM83wU","expanded_url":"http://bit.ly/1klGQvb","display_url":"bit.ly/1klGQvb"}],"mentions":{},"annotations":{},"hashtags":[{"start":46,"end":55,"tag":"Planning"},{"start":112,"end":124,"tag":"recruitment"}]},"id":"482438727810445312","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:22:10.000Z","conversation_id":"482438727810445312","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for a #Planning Officer in Corporate Governance: http://t.co/hUpnRM83wU #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/49e0xMwZhq","expanded_url":"http://bit.ly/1oMQ0qG","display_url":"bit.ly/1oMQ0qG"}],"mentions":{},"annotations":{},"hashtags":[{"start":56,"end":64,"tag":"Auditor"},{"start":89,"end":101,"tag":"recruitment"}]},"id":"482437935946821632","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:19:01.000Z","conversation_id":"482437935946821632","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for an Internal #Auditor: http://t.co/49e0xMwZhq #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"mentions":{},"annotations":{},"hashtags":[{"start":132,"end":144,"tag":"recruitment"}]},"id":"482437696984743936","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:18:04.000Z","conversation_id":"482437696984743936","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for a Scientific Officer in Risk Management &amp; Signal Management: http://t.co/S31YhJik3b #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/NrWFMziB3j","expanded_url":"http://bit.ly/SApXGS","display_url":"bit.ly/SApXGS"}],"mentions":[{"start":0,"end":12,"username":"BettinaRyll","id":"810969654"}],"annotations":{},"hashtags":{}},"id":"482436808241074177","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:14:32.000Z","conversation_id":"482433901571633152","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@BettinaRyll Thanks for letting us know! We'll try to get it fixed. You can use this shortened URL instead: http://t.co/NrWFMziB3j","referenced_tweets":[{"type":"replied_to","id":"482433901571633152"}],"attachments":{"media_keys":{}},"in_reply_to_user_id":"810969654"},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/dNfBj0HItr","expanded_url":"http://bit.ly/1yTHVoC","display_url":"bit.ly/1yTHVoC"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"trials"},{"start":40,"end":49,"tag":"epilepsy"}]},"id":"482436332292435968","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:12:39.000Z","conversation_id":"482436332292435968","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Clinical #trials in #epilepsy: cooperation between companies, regulators and clinicians http://t.co/dNfBj0HItr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/IIRNYICqiQ","expanded_url":"http://bit.ly/1sobaiL","display_url":"bit.ly/1sobaiL"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":46,"end":54,"tag":"retinal"}]},"id":"482435928993312769","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:11:03.000Z","conversation_id":"482435928993312769","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Interested in IMI’s Call topic on #retinal diseases? Sign up for our webinar on 15/7 http://t.co/IIRNYICqiQ #DiabeticRetinopath…","referenced_tweets":[{"type":"retweeted","id":"482435340528271360"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/1rMqY42RNs","expanded_url":"http://bit.ly/1nKxD2F","display_url":"bit.ly/1nKxD2F"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":60,"end":64,"tag":"HTA"},{"start":65,"end":77,"tag":"Biosimilars"},{"start":78,"end":85,"tag":"metoos"},{"start":86,"end":98,"tag":"EFPIAEvents"},{"start":99,"end":112,"tag":"EUCommission"}]},"id":"482435521097248768","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:09:26.000Z","conversation_id":"482435521097248768","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Happy Friday! EFPIA's weekly Newsletter is here! #HTA #Biosimilars #metoos #EFPIAEvents #EUCommission http://t.co/1rMqY42RNs","referenced_tweets":[{"type":"retweeted","id":"482434600380407808"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":39,"end":43,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":33,"end":37,"tag":"OIE"}]},"id":"482435387961651200","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-27T08:08:54.000Z","conversation_id":"482435387961651200","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IFAHEurope: MT IFAH supports #OIE, @WHO &amp; @FAOAnimalHealth- Joining forces against #antimicrobialresistance http://t.co/qAfjlrO4fN  #Re…","referenced_tweets":[{"type":"retweeted","id":"482433200174931968"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/9tRDRqVUGh","expanded_url":"https://www.youtube.com/watch?v=mmN0NccQCD0&index=2&list=PLvpwIjZTs-LiDRHZLsjkpM-xVGzV7b2Zv","display_url":"youtube.com/watch?v=mmN0Nc…"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":{}},"id":"482212274489552896","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T17:22:19.000Z","conversation_id":"482212274489552896","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_H2020: Horizon 2020 - How to apply - Now with professionally translated subtitles in 23 languages!  https://t.co/9tRDRqVUGh","referenced_tweets":[{"type":"retweeted","id":"482200716300546048"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/i0T1rlDmhP","expanded_url":"https://www.youtube.com/watch?v=mmN0NccQCD0&index=2&list=PLvpwIjZTs-LiDRHZLsjkpM-xVGzV7b2Zv","display_url":"youtube.com/watch?v=mmN0Nc…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"482212151860674560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T17:21:50.000Z","conversation_id":"482212151860674560","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Horizon 2020 - How to apply - Now with professionally translated subtitles in 23 languages!  https://t.co/i0T1rlDmhP","referenced_tweets":[{"type":"retweeted","id":"482200716338286592"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/814rdKT3H9","expanded_url":"http://bit.ly/1pn51SL","display_url":"bit.ly/1pn51SL"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":{}},"id":"482211923749265409","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T17:20:56.000Z","conversation_id":"482211923749265409","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Subscribe to the French medicines agency's information feed: information by health-product type http://t.co/814rdKT3H9","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/vXBFicqR0r","expanded_url":"http://ow.ly/ytD1B","display_url":"ow.ly/ytD1B"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":30,"tag":"FDAWomen"}]},"id":"482211678046937088","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T17:19:57.000Z","conversation_id":"482211678046937088","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #FDAWomen: Acne products can cause severe allergic reactions http://t.co/vXBFicqR0r","referenced_tweets":[{"type":"retweeted","id":"482198417045987330"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":27,"end":30,"probability":0.8742,"type":"Place","normalized_text":"U.S."},{"start":88,"end":94,"probability":0.9886,"type":"Place","normalized_text":"America"}],"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":72,"end":86,"tag":"acetaminophen"}]},"id":"482211617342750720","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T17:19:43.000Z","conversation_id":"482211617342750720","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #FDA: U.S. health coalition releases new report on #acetaminophen, America’s most common drug ingredient http://t.co/G…","referenced_tweets":[{"type":"retweeted","id":"482198225261461504"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":55,"end":69,"tag":"acetaminophen"}]},"id":"482198055878676482","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T16:25:50.000Z","conversation_id":"482198055878676482","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #FDA Who’s at risk for accidental #acetaminophen overdose? New report sheds light on risk fact, prevention strategies …","referenced_tweets":[{"type":"retweeted","id":"482197821387726848"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/Nl64m2VvLq","expanded_url":"http://bit.ly/TmvgcX","display_url":"bit.ly/TmvgcX"}],"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":50,"tag":"Vimizim"},{"start":52,"end":63,"tag":"elosulfase"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":107,"tag":"mucopolysaccharidosis"}]},"id":"482193653163905024","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T16:08:20.000Z","conversation_id":"482193653163905024","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Vimizim (#elosulfase alfa), #medicine for #mucopolysaccharidosis type IVA: http://t.co/Nl64m2VvLq","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/Fwj15GwZ0v","expanded_url":"http://bit.ly/1o6UpU9","display_url":"bit.ly/1o6UpU9"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":57,"end":68,"tag":"Paediatric"}]},"id":"482191794709725184","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T16:00:57.000Z","conversation_id":"482191794709725184","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #minutes from the May meeting of our #Paediatric Committee: http://t.co/Fwj15GwZ0v","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/k8HgBVlA67","expanded_url":"http://bit.ly/1pEb9St","display_url":"bit.ly/1pEb9St"},{"start":96,"end":118,"url":"http://t.co/9whJgANsnP","expanded_url":"https://twitter.com/EFPIA/status/482179391997636609/photo/1","display_url":"pic.twitter.com/9whJgANsnP"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"482189625113718784","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T15:52:19.000Z","conversation_id":"482189625113718784","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Fungus molecule shows promise against drug-resistant bacteria http://t.co/k8HgBVlA67 http://t.co/9whJgANsnP","referenced_tweets":[{"type":"retweeted","id":"482179391997636609"}],"attachments":{"media_keys":["3_482179390906712064"]}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":50,"end":70,"probability":0.5249,"type":"Organization","normalized_text":"Regulatory Rapporteur"}],"hashtags":{}},"id":"482177830353403905","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T15:05:27.000Z","conversation_id":"482177830353403905","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Free access to the lead article of Regulatory Rapporteur: Regulatory responses to lean stability strategies http://t.co/xSyD…","referenced_tweets":[{"type":"retweeted","id":"482177499217264640"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{}},"id":"482177611498811392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T15:04:35.000Z","conversation_id":"482177611498811392","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: For baby teething, avoid lidocaine or benzocaine products except under supervision of a health care professional. http://t.co/s…","referenced_tweets":[{"type":"retweeted","id":"482174981267537920"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":121,"end":123,"probability":0.5479,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":63,"end":73,"tag":"lidocaine"}]},"id":"482174048164921345","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T14:50:26.000Z","conversation_id":"482174048164921345","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: For teething babies and kids, avoid viscous #lidocaine and local anesthetics. Use safer alternatives, FDA says. http://t…","referenced_tweets":[{"type":"retweeted","id":"482169364838625280"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"}],"annotations":[{"start":40,"end":58,"probability":0.3209,"type":"Organization","normalized_text":"HelpNet Secretariat"},{"start":62,"end":90,"probability":0.4511,"type":"Organization","normalized_text":"The European Chemicals Agency"}],"hashtags":{}},"id":"482174017861066752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T14:50:18.000Z","conversation_id":"482174017861066752","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Careers: Head of Unit - Helpdesk&amp;HelpNet Secretariat @ The European Chemicals Agency -  apply before 18/08/2014: http://t.co/Q70L9m6…","referenced_tweets":[{"type":"retweeted","id":"482170209638547456"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/AhKkWgH1Ss","expanded_url":"http://go.usa.gov/9pSR","display_url":"go.usa.gov/9pSR"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":45,"end":55,"tag":"lidocaine"}]},"id":"482173978740809728","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T14:50:09.000Z","conversation_id":"482173978740809728","public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: #FDA recommends not using #lidocaine to treat teething pain &amp; requires new Boxed Warning: http://t.co/AhKkWgH1Ss . http:…","referenced_tweets":[{"type":"retweeted","id":"482171155043078144"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/okFtwZd0x4","expanded_url":"http://bit.ly/1qen64R","display_url":"bit.ly/1qen64R"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":{}},"id":"482158665894731776","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T13:49:18.000Z","conversation_id":"482158665894731776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: Subscribe to the French medicines agency's information feed for information by health-product type http://t.co/okFtwZd0x4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/Rn2fHBezJg","expanded_url":"http://ow.ly/ytD1B","display_url":"ow.ly/ytD1B"}],"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":{},"hashtags":{}},"id":"482158295831293953","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T13:47:50.000Z","conversation_id":"482158295831293953","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAWomen: Acne products can cause severe allergic reactions http://t.co/Rn2fHBezJg","referenced_tweets":[{"type":"retweeted","id":"482156855305592836"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":48,"end":62,"tag":"acetaminophen"}]},"id":"482158084807462913","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T13:47:00.000Z","conversation_id":"482158084807462913","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: Who’s at risk for accidental #acetaminophen overdose? New report sheds light on risk factors, prevention strategies http…","referenced_tweets":[{"type":"retweeted","id":"482155673724387328"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/Q70L9m6OTj","expanded_url":"http://bit.ly/1plKXAc","display_url":"bit.ly/1plKXAc"}],"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"}],"annotations":[{"start":67,"end":95,"probability":0.5323,"type":"Organization","normalized_text":"The European Chemicals Agency"}],"hashtags":[{"start":121,"end":134,"tag":"workfortheEU"}]},"id":"482158066071506945","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T13:46:55.000Z","conversation_id":"482158066071506945","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Careers: Seconded National Experts, 14 different profiles @ The European Chemicals Agency: http://t.co/Q70L9m6OTj #workfortheEU #Hel…","referenced_tweets":[{"type":"retweeted","id":"482155089835356160"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/U55oVqKikK","expanded_url":"http://bit.ly/ZmWInS","display_url":"bit.ly/ZmWInS"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":15,"probability":0.9043,"type":"Place","normalized_text":"U.S."},{"start":73,"end":79,"probability":0.9899,"type":"Place","normalized_text":"America"}],"hashtags":[{"start":57,"end":71,"tag":"acetaminophen"}]},"id":"482157930863919104","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T13:46:23.000Z","conversation_id":"482157930863919104","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: U.S. health coalition releases new report on #acetaminophen, America’s most common drug ingredient http://t.co/U55oVqKikK","referenced_tweets":[{"type":"retweeted","id":"482154990014709760"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/0aXmpaYhtY","expanded_url":"http://ht.ly/ytzj7","display_url":"ht.ly/ytzj7"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":27,"end":29,"probability":0.4439,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"482157563505819648","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T13:44:55.000Z","conversation_id":"482157563505819648","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: July 30-31 - FDA/NIH workshop on development of new antibacterial products. Info: http://t.co/0aXmpaYhtY Register: http://t.c…","referenced_tweets":[{"type":"retweeted","id":"482150979471966208"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/95tQvv4RBZ","expanded_url":"http://bit.ly/1o6nnUd","display_url":"bit.ly/1o6nnUd"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":18,"end":27,"tag":"Imperial"},{"start":28,"end":36,"tag":"College"},{"start":37,"end":44,"tag":"London"},{"start":75,"end":84,"tag":"genetics"},{"start":88,"end":98,"tag":"Parkinson"}]},"id":"482144923853275136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T12:54:42.000Z","conversation_id":"482144923853275136","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: #Imperial #College #London initiates study 2 investigate #genetics of #Parkinson’s disease: http://t.co/95tQvv4RBZ","referenced_tweets":[{"type":"retweeted","id":"482144509133074432"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/bxNbIsZERl","expanded_url":"http://go.usa.gov/9pQC","display_url":"go.usa.gov/9pQC"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":23,"end":27,"tag":"FDA"}]},"id":"482144688930308096","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T12:53:46.000Z","conversation_id":"482144688930308096","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: New #FDA Consumer Update \"Topical Acne Products Can Cause Dangerous Side Effects\" http://t.co/bxNbIsZERl","referenced_tweets":[{"type":"retweeted","id":"482142994460852224"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":108,"end":130,"tag":"ScientificCooperation"}]},"id":"482126144553377793","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T11:40:05.000Z","conversation_id":"482126144553377793","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #EFSA’s 61st Management Board meeting today. On the agenda: progress on Board recommendations, #ScientificCooperation http://t…","referenced_tweets":[{"type":"retweeted","id":"482125882380009472"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/r4TFeBnXqh","expanded_url":"http://bit.ly/TzO0pK","display_url":"bit.ly/TzO0pK"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{},"hashtags":{}},"id":"482102727640895488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T10:07:01.000Z","conversation_id":"482102727640895488","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: New Director General at the Swedish medicines agency http://t.co/r4TFeBnXqh","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/VQ5ejOY63U","expanded_url":"http://bit.ly/1pAdT3c","display_url":"bit.ly/1pAdT3c"}],"mentions":{},"annotations":[{"start":99,"end":101,"probability":0.781,"type":"Organization","normalized_text":"HTA"}],"hashtags":{}},"id":"482095982784811008","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-26T09:40:13.000Z","conversation_id":"482095982784811008","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Yesterday we highlighted the outcome report on first European collaboration between regulators and HTA organisations: http://t.co/VQ5ejOY63U","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{},"hashtags":{}},"id":"481837129128218624","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T16:31:38.000Z","conversation_id":"481837129128218624","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Great webinar on 6/26 for those working in the CMC industry: Variations in the European Union: CMC/Quality Changes http:/…","referenced_tweets":[{"type":"retweeted","id":"481836962668892160"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/HxX3IMLpqb","expanded_url":"http://www.youtube.com/watch?v=CimJI88c4fE&list=PLvpwIjZTs-LiDRHZLsjkpM-xVGzV7b2Zv&feature=share","display_url":"youtube.com/watch?v=CimJI8…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"481836999205478400","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T16:31:07.000Z","conversation_id":"481836999205478400","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Now with subtitles in 23 languages!\nhttp://t.co/HxX3IMLpqb","referenced_tweets":[{"type":"retweeted","id":"481836654395920384"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/JJolJPU3gK","expanded_url":"http://bit.ly/1o3lQ1b","display_url":"bit.ly/1o3lQ1b"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":[{"start":18,"end":36,"probability":0.4957,"type":"Organization","normalized_text":"European Commission"}],"hashtags":{}},"id":"481823276420071424","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T15:36:35.000Z","conversation_id":"481823276420071424","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: The European Commission approves the logo to identify websites of pharmacies selling medicines online http://t.co/JJolJPU3gK","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/B181pAWsU5","expanded_url":"http://bit.ly/1q9Oilo","display_url":"bit.ly/1q9Oilo"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":20,"end":30,"tag":"medicines"},{"start":49,"end":60,"tag":"innovation"}]},"id":"481822941840420864","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T15:35:15.000Z","conversation_id":"481822941840420864","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: Access to #medicines &amp; therapeutic #innovation: summary of 20 June meeting of the French medicines agency http://t.co/B181pAWsU5","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"}]},"id":"481808305573335040","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:37:06.000Z","conversation_id":"481808305573335040","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: #FDA: Get the latest on product safety, approvals, announcements and more in the latest Patient Network Newsletter: ht…","referenced_tweets":[{"type":"retweeted","id":"481806347458342912"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/ubDE8Bz2zE","expanded_url":"http://bit.ly/1g40utE","display_url":"bit.ly/1g40utE"}],"mentions":{},"annotations":{},"hashtags":[{"start":115,"end":126,"tag":"IEAnConf14"}]},"id":"481804133536923648","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:20:31.000Z","conversation_id":"481804133536923648","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IFAHEurope: Presentations from our annual conference are now available on our website: http://t.co/ubDE8Bz2zE  #IEAnConf14","referenced_tweets":[{"type":"retweeted","id":"481804056189763584"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":44,"end":58,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":109,"end":120,"tag":"BIOSIMILAR"}]},"id":"481803633177415680","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:18:32.000Z","conversation_id":"481803633177415680","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: Translated versions of the @EU_Commission Consensus document will reduce information gap on #BIOSIMILAR medicines http://t…","referenced_tweets":[{"type":"retweeted","id":"481800135736037376"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":64,"end":71,"tag":"animal"},{"start":92,"end":103,"tag":"Biological"}]},"id":"481803578085220352","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:18:19.000Z","conversation_id":"481803578085220352","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #EFSApanel renewal: EFSA is looking for experts in #animal-by-products for its #Biological hazards panel. http://t.co/osrcX2XG…","referenced_tweets":[{"type":"retweeted","id":"481798980549214208"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/9miHhB4yCV","expanded_url":"http://bit.ly/Tw9J1K","display_url":"bit.ly/Tw9J1K"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":14,"end":23,"tag":"European"},{"start":58,"end":73,"tag":"clinicaltrials"}]},"id":"481803488473923584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:17:57.000Z","conversation_id":"481803488473923584","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"RT @ansm: New #European regulation: summary of results of #clinicaltrials will be available in European database http://t.co/9miHhB4yCV","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/QRp57XIU3H","expanded_url":"http://bit.ly/1ry90J3","display_url":"bit.ly/1ry90J3"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"481803173364248576","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:16:42.000Z","conversation_id":"481803173364248576","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: PR - Industry welcomes translated versions of the European consensus document of biosimilar medicines http://t.co/QRp57XIU3H","referenced_tweets":[{"type":"retweeted","id":"481793919718789120"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/u0iqEEooss","expanded_url":"http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/process_on_corporate_responsibility/platform_access/index_en.htm#h2-6","display_url":"ec.europa.eu/enterprise/sec…"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{},"hashtags":[{"start":17,"end":24,"tag":"Pharma"},{"start":101,"end":113,"tag":"BIOSIMILARS"}]},"id":"481802723177009154","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T14:14:55.000Z","conversation_id":"481802723177009154","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: #Pharma INDUSTRY WELCOMES TRANSLATED VERSIONS OF THE EUROPEAN CONSENSUS DOCUMENT ON #BIOSIMILARS http://t.co/u0iqEEooss","referenced_tweets":[{"type":"retweeted","id":"481792372607836160"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/LBoHpQsTso","expanded_url":"http://bit.ly/I7noXO","display_url":"bit.ly/I7noXO"}],"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":37,"end":48,"username":"GeneticsEd","id":"1069681909209419777"},{"start":88,"end":98,"username":"ConnectRD","id":"1227295489"}],"annotations":{},"hashtags":{}},"id":"481791674776293377","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T13:31:01.000Z","conversation_id":"481791674776293377","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @BushbyKate: Great resources from @geneticsed on the place of genomics in healthcare @ConnectRD http://t.co/LBoHpQsTso","referenced_tweets":[{"type":"retweeted","id":"481790401276567553"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":114,"end":128,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":46,"end":57,"tag":"Biosimilar"}]},"id":"481790766789197824","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T13:27:24.000Z","conversation_id":"481790766789197824","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: “What you need to know about #Biosimilar Medicinal Products” now available in DE, EN, ES, FR, IT @EU_Commission http://t.c…","referenced_tweets":[{"type":"retweeted","id":"481788534337339392"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/5s2rb0U7LY","expanded_url":"http://bit.ly/1lRLZBw","display_url":"bit.ly/1lRLZBw"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":36,"end":45,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":19,"end":28,"probability":0.5175,"type":"Organization","normalized_text":"EU Monitor"},{"start":100,"end":106,"probability":0.666,"type":"Organization","normalized_text":"EU Govs"}],"hashtags":{}},"id":"481787050300301312","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T13:12:38.000Z","conversation_id":"481787050300301312","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: New EU Monitor looks @EMA_News trial results policy &amp; joint medicines procurement by EU Govs http://t.co/5s2rb0U7LY http://t…","referenced_tweets":[{"type":"retweeted","id":"481786806695120897"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/u0iqEEooss","expanded_url":"http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/process_on_corporate_responsibility/platform_access/index_en.htm#h2-6","display_url":"ec.europa.eu/enterprise/sec…"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":99,"end":113,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":48,"end":59,"tag":"BIOSIMILAR"}]},"id":"481785950570565632","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T13:08:16.000Z","conversation_id":"481785950570565632","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"RT @egagenerics: EUROPEAN CONSENSUS DOCUMENT ON #BIOSIMILAR MEDICINES NOW AVAILABLE IN 5 LANGUAGES @EU_Commission http://t.co/u0iqEEooss","referenced_tweets":[{"type":"retweeted","id":"481785612455116800"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{}},"id":"481780014380503040","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:44:41.000Z","conversation_id":"481780014380503040","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: Get the latest on product safety, approvals, announcements and more in the latest Patient Network Newsletter: http://t.co/4bdAE…","referenced_tweets":[{"type":"retweeted","id":"481778249073438720"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/lJ3kCZKKPp","expanded_url":"http://bit.ly/1kRsIu7","display_url":"bit.ly/1kRsIu7"}],"mentions":{},"annotations":{},"hashtags":[{"start":52,"end":63,"tag":"paediatric"},{"start":85,"end":95,"tag":"neurology"},{"start":120,"end":133,"tag":"consultation"}]},"id":"481775077001035776","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:25:03.000Z","conversation_id":"481775077001035776","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our draft inventory of #paediatric therapeutic needs in #neurology: http://t.co/lJ3kCZKKPp #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/2nmTQZDdbE","expanded_url":"http://bit.ly/1erfQbU","display_url":"bit.ly/1erfQbU"}],"mentions":{},"annotations":{},"hashtags":[{"start":59,"end":73,"tag":"sterilisation"},{"start":88,"end":98,"tag":"medicines"},{"start":123,"end":136,"tag":"consultation"}]},"id":"481774925641187328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:24:27.000Z","conversation_id":"481774925641187328","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our paper on the selection of #sterilisation processes for #medicines: http://t.co/2nmTQZDdbE #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":29,"end":44,"username":"SignUpToSafety","id":"2546341543"}],"annotations":{},"hashtags":{}},"id":"481774388740902912","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:22:19.000Z","conversation_id":"481774388740902912","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: MHRA supports @SignUpToSafety &amp; encourages HCPs &amp; patients to report suspected adverse drug reactions to Yellow Card https:/…","referenced_tweets":[{"type":"retweeted","id":"481761984359440384"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"}]},"id":"481774221908275200","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:21:40.000Z","conversation_id":"481774221908275200","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: #FDA Webinar on “Drug Supply Chain Security Act Implementation: ID of Suspect Product &amp; Notification”- July 1st. http://…","referenced_tweets":[{"type":"retweeted","id":"481759751911784448"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/sEPohgdkJl","expanded_url":"http://europa.eu/!Tv43yN","display_url":"europa.eu/!Tv43yN"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":14,"probability":0.5765,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"id":"481774124432633856","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:21:16.000Z","conversation_id":"481774124432633856","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EU health newsletter: \"Joint purchasing of vaccines and medicines becomes a reality in the EU\" http://t.co/sEPohgdkJl","referenced_tweets":[{"type":"retweeted","id":"481757805750538240"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/M3EtSh3eBm","expanded_url":"http://bit.ly/1pNrgz2","display_url":"bit.ly/1pNrgz2"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":40,"end":55,"tag":"clinicaltrials"},{"start":61,"end":70,"tag":"European"}]},"id":"481773868236148736","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:20:15.000Z","conversation_id":"481773868236148736","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: Requests for authorisation of #clinicaltrials; new #European regulation implements coordinated assessment http://t.co/M3EtSh3eBm","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/IdHPwNLNrJ","expanded_url":"http://www.emcdda.europa.eu/publications/insights/2014/drugs-and-driving","display_url":"emcdda.europa.eu/publications/i…"}],"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{}},"id":"481770193749041152","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:05:39.000Z","conversation_id":"481770193749041152","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EMCDDA: Just published: Drug use, impaired driving and traffic accidents: http://t.co/IdHPwNLNrJ","referenced_tweets":[{"type":"retweeted","id":"481748669746937856"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/VkUOiL4Pxb","expanded_url":"http://bit.ly/1rxPTPk","display_url":"bit.ly/1rxPTPk"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":[{"start":56,"end":68,"probability":0.8663,"type":"Organization","normalized_text":"EU Commission"}],"hashtags":{}},"id":"481770004422344704","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T12:04:54.000Z","conversation_id":"481770004422344704","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @agesnews: Medicine safety: buying medicines online? EU Commission adopts safety logo for pharmacies from 2015 http://t.co/VkUOiL4Pxb","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":40,"end":43,"tag":"EU"},{"start":44,"end":51,"tag":"health"},{"start":93,"end":102,"tag":"vaccines"},{"start":109,"end":119,"tag":"medicines"}]},"id":"481745355189784576","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T10:26:57.000Z","conversation_id":"481745355189784576","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Have you seen our latest #EU #health newsletter? Focus on joint purchasing of #vaccines &amp; #medicines by Member States http:/…","referenced_tweets":[{"type":"retweeted","id":"481744094562369536"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":56,"end":60,"probability":0.9843,"type":"Place","normalized_text":"China"}],"hashtags":{}},"id":"481740081997545472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T10:06:00.000Z","conversation_id":"481740081997545472","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Managing Drug Clinical Development in China: Global Clinical Trials and Quality webinar begins in just 3 hours http://t.c…","referenced_tweets":[{"type":"retweeted","id":"481738861681598465"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/z2iDH7LIBP","expanded_url":"http://bit.ly/1pN27V4","display_url":"bit.ly/1pN27V4"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"annotations":{},"hashtags":[{"start":34,"end":43,"tag":"European"},{"start":44,"end":55,"tag":"regulation"},{"start":59,"end":74,"tag":"clinicaltrials"}]},"id":"481739870411685888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T10:05:10.000Z","conversation_id":"481739870411685888","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @ansm: Key elements of the new #European #regulation on #clinicaltrials presented by the French medicines agency http://t.co/z2iDH7LIBP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":104,"end":109,"probability":0.981,"type":"Place","normalized_text":"Russia"}],"hashtags":{}},"id":"481737064002912256","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T09:54:00.000Z","conversation_id":"481737064002912256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Varied edition of Regulatory Rapporteur: focus on CMC plus biosimilars, clinical trials, Russia, due diligence http://t.co/x…","referenced_tweets":[{"type":"retweeted","id":"481737021392977921"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/xSyD4CgQ9n","expanded_url":"http://bit.ly/1nFnfrR","display_url":"bit.ly/1nFnfrR"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":38,"end":58,"probability":0.4052,"type":"Organization","normalized_text":"Regulatory Rapporteur"}],"hashtags":{}},"id":"481737045967388673","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T09:53:56.000Z","conversation_id":"481737045967388673","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: July/August edition of Regulatory Rapporteur looks at Chemistry, Manufacturing and Controls (CMC) http://t.co/xSyD4CgQ9n #re…","referenced_tweets":[{"type":"retweeted","id":"481736327676059648"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/wUU3pSgRzS","expanded_url":"http://bit.ly/1lP05lC","display_url":"bit.ly/1lP05lC"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":[{"start":32,"end":44,"tag":"trastuzumab"}]},"id":"481730317922107392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T09:27:12.000Z","conversation_id":"481730317922107392","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Efficacy of #trastuzumab in advanced-stage breast cancer demonstrated in an independent study http://t.co/wUU3pSgRzS","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/VKiNyJPDmr","expanded_url":"http://bit.ly/1yMVZ3s","display_url":"bit.ly/1yMVZ3s"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":[{"start":18,"end":36,"probability":0.6868,"type":"Organization","normalized_text":"European Commission"}],"hashtags":{}},"id":"481728783117213696","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T09:21:06.000Z","conversation_id":"481728783117213696","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EuropeanLung: European Commission introduces logo to help protect people from fake medicines online http://t.co/VKiNyJPDmr","referenced_tweets":[{"type":"retweeted","id":"481728466807963648"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/v3PDpciF4I","expanded_url":"https://beta.nice.org.uk/Guidance","display_url":"beta.nice.org.uk/Guidance"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{}},"id":"481726216668717056","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T09:10:54.000Z","conversation_id":"481726216668717056","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: Here’s a full list of guidance published this month https://t.co/v3PDpciF4I","referenced_tweets":[{"type":"retweeted","id":"481726158887993344"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/12jvjKYaaG","expanded_url":"https://twitter.com/EFPIA/status/481723177421537280/photo/1","display_url":"pic.twitter.com/12jvjKYaaG"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":53,"end":61,"username":"nytimes","id":"807095"}],"annotations":{},"hashtags":[{"start":62,"end":67,"tag":"H7N9"}]},"id":"481723233532903424","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:59:03.000Z","conversation_id":"481723233532903424","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Mapping the Risk of Bird Flu’s Spread via @nytimes #H7N9 http://t.co/12jvjKYaaG","referenced_tweets":[{"type":"retweeted","id":"481723177421537280"}],"attachments":{"media_keys":["3_481723176443842560"]}},{"source":"Bitly","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/lJ3kCZKKPp","expanded_url":"http://bit.ly/1kRsIu7","display_url":"bit.ly/1kRsIu7"}],"mentions":{},"annotations":{},"hashtags":[{"start":52,"end":63,"tag":"paediatric"},{"start":85,"end":95,"tag":"neurology"},{"start":120,"end":133,"tag":"consultation"}]},"id":"481722158985773056","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:54:47.000Z","conversation_id":"481722158985773056","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft inventory of #paediatric therapeutic needs in #neurology: http://t.co/lJ3kCZKKPp #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/2nmTQZDdbE","expanded_url":"http://bit.ly/1erfQbU","display_url":"bit.ly/1erfQbU"}],"mentions":{},"annotations":{},"hashtags":[{"start":59,"end":73,"tag":"sterilisation"},{"start":88,"end":98,"tag":"medicines"},{"start":123,"end":136,"tag":"consultation"}]},"id":"481721476400574465","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:52:04.000Z","conversation_id":"481721476400574465","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our paper on the selection of #sterilisation processes for #medicines: http://t.co/2nmTQZDdbE #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/LWudZfsxgT","expanded_url":"http://bit.ly/V8KcNu","display_url":"bit.ly/V8KcNu"},{"start":118,"end":140,"url":"http://t.co/7QbtD8f2FU","expanded_url":"https://twitter.com/EMA_News/status/481720310748966912/photo/1","display_url":"pic.twitter.com/7QbtD8f2FU"}],"mentions":[{"start":14,"end":28,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":62,"end":73,"tag":"pharmacies"},{"start":98,"end":117,"tag":"falsifiedmedicines"}]},"id":"481720310748966912","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:47:26.000Z","conversation_id":"481720310748966912","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Yesterday the @EU_Commission launched a logo for legal online #pharmacies: http://t.co/LWudZfsxgT #falsifiedmedicines http://t.co/7QbtD8f2FU","referenced_tweets":{},"attachments":{"media_keys":["16_481720308874088449"]}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.81,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":19,"end":31,"tag":"Antibiotics"},{"start":121,"end":127,"tag":"AMR14"}]},"id":"481719202567712768","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:43:02.000Z","conversation_id":"481719202567712768","public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: [#Antibiotics] can be purchased over the Internet, adding to the [antimicrobial resistance] challenges #AMR14","referenced_tweets":[{"type":"retweeted","id":"481717273821196288"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9109,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":113,"end":125,"tag":"antibiotics"},{"start":126,"end":132,"tag":"AMR14"}]},"id":"481719166161137664","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:42:53.000Z","conversation_id":"481719166161137664","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Financial &amp; other incentives undermine the responsible &amp; prudent use of antimicrobials #antibiotics #AMR14","referenced_tweets":[{"type":"retweeted","id":"481716305863929856"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.8193,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":83,"end":95,"tag":"antibiotics"},{"start":118,"end":124,"tag":"AMR14"}]},"id":"481719130387918848","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:42:45.000Z","conversation_id":"481719130387918848","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: As in medicine, veterinary services depend on safe and effective #antibiotics to treat sick animals #AMR14","referenced_tweets":[{"type":"retweeted","id":"481715783291404288"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9364,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":97,"end":111,"tag":"climatechange"},{"start":112,"end":124,"tag":"antibiotics"},{"start":125,"end":131,"tag":"AMR14"}]},"id":"481718989308325889","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:42:11.000Z","conversation_id":"481718989308325889","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Some analysts have compared threat of antimicrobial resistance with threat of  #climatechange #antibiotics #AMR14","referenced_tweets":[{"type":"retweeted","id":"481714984112914432"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.8919,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":{}},"id":"481718885440581634","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:41:46.000Z","conversation_id":"481718885440581634","public_metrics":{"retweet_count":75,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Hospitals have become hotbeds for transmission of highly resistant superbugs, increasing the risk that hosp kill rather t…","referenced_tweets":[{"type":"retweeted","id":"481713340956545024"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9445,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":68,"end":80,"tag":"antibiotics"},{"start":81,"end":85,"tag":"AMR"}]},"id":"481718855954608128","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:41:39.000Z","conversation_id":"481718855954608128","public_metrics":{"retweet_count":70,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Drugs that were once lifesavers are now worthless #antibiotics #AMR","referenced_tweets":[{"type":"retweeted","id":"481711376327798784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9417,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":23,"end":36,"tag":"Scandinavian"},{"start":55,"end":67,"tag":"Netherlands"},{"start":110,"end":122,"tag":"antibiotics"},{"start":123,"end":127,"tag":"AMR"}]},"id":"481718794843594752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:41:25.000Z","conversation_id":"481718794843594752","public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: [The #Scandinavian countries and the #Netherlands] have the lowest rates of drug resistance #antibiotics #AMR","referenced_tweets":[{"type":"retweeted","id":"481710611823624192"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9376,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":37,"end":50,"tag":"Scandinavian"},{"start":66,"end":78,"tag":"Netherlands"}]},"id":"481718756226641920","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:41:16.000Z","conversation_id":"481718756226641920","public_metrics":{"retweet_count":56,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: In human meds, the #Scandinavian countries, the #Netherlands have the strictest policies governing prescribing of #antibi…","referenced_tweets":[{"type":"retweeted","id":"481710366138040320"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.8928,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":34,"end":46,"tag":"Netherlands"},{"start":123,"end":135,"tag":"antibiotics"},{"start":136,"end":140,"tag":"AMR"}]},"id":"481718736345645056","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:41:11.000Z","conversation_id":"481718736345645056","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan: Since 2009, the #Netherlands has reduced the use of antimicrobials in animal husbandry by more than half #antibiotics #AMR","referenced_tweets":[{"type":"retweeted","id":"481709869058514944"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9719,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":78,"end":87,"tag":"TheHague"},{"start":88,"end":100,"tag":"antibiotics"},{"start":101,"end":105,"tag":"AMR"}]},"id":"481718724588994560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:41:08.000Z","conversation_id":"481718724588994560","public_metrics":{"retweet_count":76,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Chan addresses antimicrobial resistance ministerial conference in #TheHague #antibiotics #AMR","referenced_tweets":[{"type":"retweeted","id":"481709724682186752"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/ENbT1VXFlF","expanded_url":"http://bit.ly/1nClzkf","display_url":"bit.ly/1nClzkf"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":88,"end":94,"tag":"Metoo"},{"start":95,"end":102,"tag":"Pharma"}]},"id":"481718597291900928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:40:38.000Z","conversation_id":"481718597291900928","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: EFPIA DG Blog of Today! \"From \"me-toos\" to \"too much\" http://t.co/ENbT1VXFlF #Metoo #Pharma","referenced_tweets":[{"type":"retweeted","id":"481711571841081344"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/zthumrL9jH","expanded_url":"http://bit.ly/1v4xNEN","display_url":"bit.ly/1v4xNEN"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":51,"end":65,"username":"Pharma2015_16","id":"2515510789"},{"start":66,"end":74,"username":"Nefarma","id":"796311090095423488"}],"annotations":{},"hashtags":[{"start":75,"end":85,"tag":"EFPIACode"}]},"id":"481717901997899776","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:37:52.000Z","conversation_id":"481717901997899776","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: PharmaDisclosure.EU Newsletter is OUT!  @Pharma2015_16 @Nefarma #EFPIACode http://t.co/zthumrL9jH","referenced_tweets":[{"type":"retweeted","id":"481703568425373696"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/VQ5ejOY63U","expanded_url":"http://bit.ly/1pAdT3c","display_url":"bit.ly/1pAdT3c"}],"mentions":{},"annotations":[{"start":92,"end":94,"probability":0.7229,"type":"Organization","normalized_text":"HTA"}],"hashtags":{}},"id":"481715079592050689","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-25T08:26:39.000Z","conversation_id":"481715079592050689","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We've highlighted the outcome report on first European collaboration between regulators and HTA organisations:  http://t.co/VQ5ejOY63U","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":67,"end":97,"probability":0.6384,"type":"Organization","normalized_text":"Scientific Committee and Panels"}],"hashtags":[{"start":42,"end":52,"tag":"EFSApanel"}]},"id":"481483055660810240","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T17:04:40.000Z","conversation_id":"481483055660810240","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Don’t miss this opportunity. #EFSApanel call to renew Scientific Committee and Panels closes on 7 July. http://t.co/osrcX2XG6R","referenced_tweets":[{"type":"retweeted","id":"481481891041009664"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/2eC9xIfoim","expanded_url":"http://bit.ly/avsNQt","display_url":"bit.ly/avsNQt"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{},"hashtags":[{"start":33,"end":38,"tag":"Flea"},{"start":43,"end":48,"tag":"Tick"},{"start":61,"end":66,"tag":"Pets"},{"start":91,"end":96,"tag":"dogs"}]},"id":"481471202540945409","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T16:17:34.000Z","conversation_id":"481471202540945409","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: Safe Use of #Flea and #Tick Products in #Pets  http://t.co/2eC9xIfoim #dogs","referenced_tweets":[{"type":"retweeted","id":"481471040733057025"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":74,"end":85,"username":"PROTECT_BR","id":"2354960784"}],"annotations":{},"hashtags":[{"start":12,"end":25,"tag":"breastcancer"},{"start":26,"end":30,"tag":"t1d"},{"start":31,"end":50,"tag":"atrialfibrillation"}]},"id":"481462695137644544","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T15:43:46.000Z","conversation_id":"481462695137644544","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: #breastcancer #t1d #atrialfibrillation patients/pros pls take @PROTECT_BR survey on communicating meds benefits/risks http://t.…","referenced_tweets":[{"type":"retweeted","id":"481462623100493824"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/RN3AyVtF5U","expanded_url":"http://bit.ly/Vdwyc0","display_url":"bit.ly/Vdwyc0"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":{}},"id":"481462226130579456","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T15:41:54.000Z","conversation_id":"481462226130579456","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Watch the corporate campaign video from the Italian medicines agency; Medicines and paediatrics http://t.co/RN3AyVtF5U","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/650drzyX9o","expanded_url":"http://cordis.europa.eu/research-eu/magazine_en.html","display_url":"cordis.europa.eu/research-eu/ma…"},{"start":105,"end":127,"url":"http://t.co/MmcJ0STm1Q","expanded_url":"https://twitter.com/myCORDIS/status/481446642680606720/photo/1","display_url":"pic.twitter.com/MmcJ0STm1Q"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{},"hashtags":{}},"id":"481449675200143360","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T14:52:02.000Z","conversation_id":"481449675200143360","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Research*eu results magazine Issue 33 'The heartbeat of EU science' http://t.co/650drzyX9o http://t.co/MmcJ0STm1Q","referenced_tweets":[{"type":"retweeted","id":"481446642680606720"}],"attachments":{"media_keys":["3_481446642475077633"]}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"annotations":{},"hashtags":{}},"id":"481449497659473920","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T14:51:19.000Z","conversation_id":"481449497659473920","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EATGx: EATG Training Academy Module 5: On 11 September, EATG will organize Module 5 of its Training Academy STEP-UP, ... http://t.co/w5…","referenced_tweets":[{"type":"retweeted","id":"481444802123149312"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/L6yvSruuwj","expanded_url":"http://bit.ly/1pxJHFK","display_url":"bit.ly/1pxJHFK"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{},"hashtags":{}},"id":"481449341388087299","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T14:50:42.000Z","conversation_id":"481449341388087299","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: In the news: Growth hormone treatment for children may exacerbate feelings of depression http://t.co/L6yvSruuwj","referenced_tweets":[{"type":"retweeted","id":"481444250991984641"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/d11lmSnveF","expanded_url":"http://bit.ly/1jL9GFW","display_url":"bit.ly/1jL9GFW"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":{}},"id":"481448644923891713","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T14:47:56.000Z","conversation_id":"481448644923891713","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Check out the Italian medicines agency's campaign \"medicines and paediatrics\" http://t.co/d11lmSnveF","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/DuBLpJ8Jkw","expanded_url":"http://bit.ly/1v1ATtj","display_url":"bit.ly/1v1ATtj"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{},"hashtags":{}},"id":"481437204091502592","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T14:02:28.000Z","conversation_id":"481437204091502592","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Falsified medicine - Kaletra, film-coated tablet, 200 mg 50 mg  http://t.co/DuBLpJ8Jkw","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/5sezj5fyee","expanded_url":"http://1.usa.gov/1nYE6Zw","display_url":"1.usa.gov/1nYE6Zw"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{},"hashtags":{}},"id":"481437030455713793","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T14:01:47.000Z","conversation_id":"481437030455713793","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDACBER: Draft Guidance: Environmental Assessments for Recombinant Viral or Microbial Products http://t.co/5sezj5fyee","referenced_tweets":[{"type":"retweeted","id":"481432091792773120"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/wgJbwwNMDg","expanded_url":"http://europa.eu/!GP63XJ","display_url":"europa.eu/!GP63XJ"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":111,"end":119,"username":"borgton","id":"1605512862"}],"annotations":{},"hashtags":{}},"id":"481429784124456960","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T13:32:59.000Z","conversation_id":"481429784124456960","public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: How can we be sure that an online pharmacy is authentic and safe? http://t.co/wgJbwwNMDg cc @borgton http://t.co/uZYoOng…","referenced_tweets":[{"type":"retweeted","id":"481422040487165952"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/YbR3Jil9vN","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/06/news_detail_002130.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":31,"probability":0.6891,"type":"Organization","normalized_text":"European Commission"}],"hashtags":{}},"id":"481415116744065025","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T12:34:42.000Z","conversation_id":"481415116744065025","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: European Commission launches logo for online pharmacies to protect patients from falsified medicines http://t.co/YbR3Jil9vN","referenced_tweets":[{"type":"retweeted","id":"481413891793379329"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/LWudZfsxgT","expanded_url":"http://bit.ly/V8KcNu","display_url":"bit.ly/V8KcNu"}],"mentions":[{"start":4,"end":18,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":50,"end":61,"tag":"pharmacies"},{"start":87,"end":106,"tag":"falsifiedmedicines"}]},"id":"481400293348114432","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T11:35:48.000Z","conversation_id":"481400293348114432","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"The @EU_Commission has launched a logo for online #pharmacies to protect patients from #falsifiedmedicines: http://t.co/LWudZfsxgT","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/FDHFjNzVlL","expanded_url":"http://bit.ly/1mid5kk","display_url":"bit.ly/1mid5kk"}],"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":{},"hashtags":{}},"id":"481393389662130176","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T11:08:22.000Z","conversation_id":"481393389662130176","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: Commission introduces safety logo for buying medicines online http://t.co/FDHFjNzVlL","referenced_tweets":[{"type":"retweeted","id":"481392055122264064"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/e8w1DDXHDL","expanded_url":"http://ow.ly/i/60ybp","display_url":"ow.ly/i/60ybp"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":44,"end":58,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":{}},"id":"481386891103969280","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T10:42:33.000Z","conversation_id":"481386891103969280","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: Buying medicines online? @EU_Commission introduces logo to make sure consumers are safe http://t.co/e8w1DDXHDL cc @Borgt…","referenced_tweets":[{"type":"retweeted","id":"481386330447159297"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":56,"end":67,"tag":"pharmacies"}]},"id":"481386858447130625","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T10:42:25.000Z","conversation_id":"481386858447130625","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #EU regulation on common logo for online #pharmacies: Member States have 1 year to prepare for its application http://t.co/y…","referenced_tweets":[{"type":"retweeted","id":"481386259571810306"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":24,"username":"borgton","id":"1605512862"}],"annotations":{},"hashtags":[{"start":37,"end":47,"tag":"medicines"},{"start":127,"end":130,"tag":"EU"}]},"id":"481386565168824320","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T10:41:15.000Z","conversation_id":"481386565168824320","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: .@borgton: \"Falsified #medicines can be ineffective, harmful or even deadly:\" Common logo for online pharmacies #EU http://t…","referenced_tweets":[{"type":"retweeted","id":"481381357768433664"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/yHxL0Iel8Z","expanded_url":"http://europa.eu/!GP63XJ","display_url":"europa.eu/!GP63XJ"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":122,"end":131,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":22,"end":32,"tag":"medicines"},{"start":61,"end":72,"tag":"pharmacies"},{"start":73,"end":80,"tag":"safety"},{"start":95,"end":98,"tag":"EU"}]},"id":"481379050490195968","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T10:11:23.000Z","conversation_id":"481379050490195968","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Buying #medicines online? New logo for online #pharmacies #safety introduced by #EU http://t.co/yHxL0Iel8Z @EMA_News http://…","referenced_tweets":[{"type":"retweeted","id":"481378586876973056"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{},"hashtags":{}},"id":"481363599722811392","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T09:10:00.000Z","conversation_id":"481363599722811392","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: EQA for influenza virus detection, isolation &amp; culture for  European Reference Laboratory Network for Human Influenza http://…","referenced_tweets":[{"type":"retweeted","id":"481363245912326145"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/JHu1uiSnfY","expanded_url":"http://bit.ly/1q0D6Hv","display_url":"bit.ly/1q0D6Hv"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":62,"end":72,"tag":"medicines"},{"start":74,"end":79,"tag":"CHMP"}]},"id":"481361434530840576","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T09:01:23.000Z","conversation_id":"481361434530840576","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our committee for human #medicines (#CHMP) is available on our website: http://t.co/JHu1uiSnfY","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/rhfFBHi5ME","expanded_url":"http://bit.ly/1szeJCP","display_url":"bit.ly/1szeJCP"}],"mentions":[{"start":3,"end":14,"username":"EUExpo2015","id":"2202869202"}],"annotations":{},"hashtags":[{"start":66,"end":75,"tag":"Expo2015"}]},"id":"481357357478588416","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T08:45:11.000Z","conversation_id":"481357357478588416","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUExpo2015: New pan-EU network of government science advisers #Expo2015 http://t.co/rhfFBHi5ME","referenced_tweets":[{"type":"retweeted","id":"481347377555857408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/GCefeGGdUQ","expanded_url":"http://bit.ly/3HepC","display_url":"bit.ly/3HepC"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":22,"end":29,"username":"TheEIU","id":"29994840"}],"annotations":{},"hashtags":[{"start":30,"end":41,"tag":"HepCReport"}]},"id":"481357188536213504","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-24T08:44:31.000Z","conversation_id":"481357188536213504","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: New @TheEIU #HepCReport  'Tackling Hepatitis C: Moving towards an integrated policy approach' http://t.co/GCefeGGdUQ http…","referenced_tweets":[{"type":"retweeted","id":"481347202695303168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":71,"end":79,"probability":0.8806,"type":"Place","normalized_text":"W. Africa"},{"start":98,"end":106,"probability":0.8583,"type":"Place","normalized_text":"Caribbean"}],"hashtags":[{"start":27,"end":34,"tag":"threat"},{"start":61,"end":67,"tag":"Ebola"},{"start":82,"end":94,"tag":"chikungunya"},{"start":109,"end":118,"tag":"WestNile"},{"start":120,"end":125,"tag":"MERS"}]},"id":"481116695864803328","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T16:48:53.000Z","conversation_id":"481116695864803328","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: ECDC’s weekly #threat report/CDTR w/ updates on #Ebola in W. Africa, #chikungunya in Caribbean, #WestNile, #MERS-CoV: http://t…","referenced_tweets":[{"type":"retweeted","id":"481070019397578752"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/Ad2FumkmIn","expanded_url":"http://bit.ly/1l3C7i4","display_url":"bit.ly/1l3C7i4"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":60,"end":65,"probability":0.9961,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":38,"end":48,"tag":"influenza"}]},"id":"481116493426749441","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T16:48:05.000Z","conversation_id":"481116493426749441","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Overview of circulating #influenza viruses in Europe: May update\nhttp://t.co/Ad2FumkmIn","referenced_tweets":[{"type":"retweeted","id":"481077784908140545"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":54,"end":69,"tag":"RiskAssessment"},{"start":74,"end":78,"tag":"Bee"},{"start":113,"end":122,"tag":"ESOF2014"}]},"id":"481116371305381888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T16:47:36.000Z","conversation_id":"481116371305381888","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Don’t miss EFSA seminar on environmental #RiskAssessment and #Bee Health, 25 June, EuroScience room #ESOF2014 http://t.co/VHBS…","referenced_tweets":[{"type":"retweeted","id":"481084523468165120"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/Pj0o1k7thZ","expanded_url":"http://bit.ly/1nvZBz8","display_url":"bit.ly/1nvZBz8"}],"mentions":{},"annotations":{},"hashtags":[{"start":17,"end":26,"tag":"workshop"},{"start":30,"end":35,"tag":"dose"}]},"id":"481106729904918528","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T16:09:17.000Z","conversation_id":"481106729904918528","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Register for our #workshop on #dose finding and dose selection in December: http://t.co/Pj0o1k7thZ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/94KMDq8Wov","expanded_url":"http://bit.ly/SMW0mH","display_url":"bit.ly/SMW0mH"}],"mentions":{},"annotations":{},"hashtags":[{"start":48,"end":66,"tag":"pharmacovigilance"},{"start":92,"end":103,"tag":"veterinary"},{"start":104,"end":114,"tag":"medicines"}]},"id":"481106101589786625","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T16:06:47.000Z","conversation_id":"481106101589786625","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on a recommendation on #pharmacovigilance and signal detection for #veterinary #medicines: http://t.co/94KMDq8Wov","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/JHu1uiSnfY","expanded_url":"http://bit.ly/1q0D6Hv","display_url":"bit.ly/1q0D6Hv"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":89,"end":94,"tag":"CHMP"}]},"id":"481033878556393472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T11:19:48.000Z","conversation_id":"481033878556393472","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our committee for human medicines (#CHMP): http://t.co/JHu1uiSnfY","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/XKslWs2nD2","expanded_url":"http://bit.ly/1rpb8my","display_url":"bit.ly/1rpb8my"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":22,"end":31,"tag":"genetics"},{"start":35,"end":45,"tag":"Parkinson"}]},"id":"481027927061311488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T10:56:09.000Z","conversation_id":"481027927061311488","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: The #genetics of #Parkinson’s disease: review of current &amp; emerging candidates - http://t.co/XKslWs2nD2","referenced_tweets":[{"type":"retweeted","id":"481017595923922944"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{},"hashtags":[{"start":21,"end":29,"tag":"eHealth"},{"start":74,"end":82,"tag":"mHealth"},{"start":84,"end":91,"tag":"stroke"},{"start":93,"end":99,"tag":"brain"}]},"id":"481027822547632128","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T10:55:44.000Z","conversation_id":"481027822547632128","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: The \"#eHealth in Focus\" newsletter is out. Topics include #mHealth, #stroke, #brain, eHealth manifesto &amp; events: http://t.c…","referenced_tweets":[{"type":"retweeted","id":"481020353377230848"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/0JuwgWuhPD","expanded_url":"http://bit.ly/OhjvlP","display_url":"bit.ly/OhjvlP"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":{},"hashtags":[{"start":13,"end":22,"tag":"EPHA2014"}]},"id":"481027803677474816","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T10:55:40.000Z","conversation_id":"481027803677474816","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EPHA_EU: #EPHA2014 Annual Conference,4-5 Sept:http://t.co/0JuwgWuhPD» Check our partnership,sponsorship &amp; stands opportunities:http://t…","referenced_tweets":[{"type":"retweeted","id":"481020584844087296"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"}],"annotations":{},"hashtags":[{"start":87,"end":96,"tag":"diabetes"}]},"id":"481027544939245570","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T10:54:38.000Z","conversation_id":"481027544939245570","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IDFEuropeBxl: You are an organization striving to make life better for people with #diabetes? Apply to our 2014 Diabetes Prize! http://…","referenced_tweets":[{"type":"retweeted","id":"481025155976925184"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/Pj0o1k7thZ","expanded_url":"http://bit.ly/1nvZBz8","display_url":"bit.ly/1nvZBz8"}],"mentions":{},"annotations":{},"hashtags":[{"start":16,"end":25,"tag":"workshop"}]},"id":"481009141000204288","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T09:41:30.000Z","conversation_id":"481009141000204288","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"We're holding a #workshop on dose finding in December. Register via our website: http://t.co/Pj0o1k7thZ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/94KMDq8Wov","expanded_url":"http://bit.ly/SMW0mH","display_url":"bit.ly/SMW0mH"}],"mentions":{},"annotations":{},"hashtags":[{"start":48,"end":66,"tag":"pharmacovigilance"},{"start":92,"end":103,"tag":"veterinary"},{"start":104,"end":114,"tag":"medicines"}]},"id":"480994479043014656","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-23T08:43:14.000Z","conversation_id":"480994479043014656","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on a recommendation on #pharmacovigilance and signal detection for #veterinary #medicines: http://t.co/94KMDq8Wov","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/8tzDMakOfI","expanded_url":"http://nyti.ms/1iQbZYd","display_url":"nyti.ms/1iQbZYd"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"480001332955602944","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T14:56:50.000Z","conversation_id":"480001332955602944","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: A Test for the Early Detection of Alzheimer’s Disease http://t.co/8tzDMakOfI","referenced_tweets":[{"type":"retweeted","id":"479997936731185152"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":{},"hashtags":[{"start":51,"end":54,"tag":"EU"},{"start":101,"end":108,"tag":"health"},{"start":109,"end":115,"tag":"EPSCO"}]},"id":"480001130798538752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T14:56:02.000Z","conversation_id":"480001130798538752","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @borgton: Joint Purchasing of vaccines protects #EU citizens from serious cross border threats to #health #EPSCO @gr2014euhttp://europa.…","referenced_tweets":[{"type":"retweeted","id":"479997779910352896"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":{},"hashtags":[{"start":13,"end":25,"tag":"Procurement"},{"start":53,"end":62,"tag":"vaccines"},{"start":94,"end":101,"tag":"health"},{"start":115,"end":121,"tag":"EPSCO"}]},"id":"480001108291887104","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T14:55:56.000Z","conversation_id":"480001108291887104","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @borgton: #Procurement agreement ensures pandemic #vaccines availability in a cross border #health threat event #EPSCO http://t.co/WeQXt…","referenced_tweets":[{"type":"retweeted","id":"479997611110584320"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/dvJPXmqQE0","expanded_url":"http://go.usa.gov/9bt5","display_url":"go.usa.gov/9bt5"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":19,"end":21,"probability":0.7522,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"479992666407849984","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T14:22:24.000Z","conversation_id":"479992666407849984","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: FDA warns docetaxel may cause symptoms of alcohol intoxication after treatment. http://t.co/dvJPXmqQE0 http://t.co/A0NIG…","referenced_tweets":[{"type":"retweeted","id":"479992592403554304"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/aVdnQK3sRz","expanded_url":"http://bit.ly/1mxa6TU","display_url":"bit.ly/1mxa6TU"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":84,"end":86,"probability":0.4051,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"id":"479980887426490369","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T13:35:35.000Z","conversation_id":"479980887426490369","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: The minutes of our March Management Board meeting are now available on EMA website: http://t.co/aVdnQK3sRz","referenced_tweets":[{"type":"retweeted","id":"479974923125800960"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/I1m5YVVlIY","expanded_url":"http://1.usa.gov/1ifAu6q","display_url":"1.usa.gov/1ifAu6q"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"}]},"id":"479980579489071104","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T13:34:22.000Z","conversation_id":"479980579489071104","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: #FDA Announces Minor Use/Minor Species (MUMS) Grant Program, Applications due August 15, 2014 http://t.co/I1m5YVVlIY #…","referenced_tweets":[{"type":"retweeted","id":"479973141918121984"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/JqR9hqM5AL","expanded_url":"http://bit.ly/1nnXb4c","display_url":"bit.ly/1nnXb4c"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{},"hashtags":{}},"id":"479980136386011136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T13:32:36.000Z","conversation_id":"479980136386011136","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Report on therapeutic positioning of ivacaftor (Kalydeco®) http://t.co/JqR9hqM5AL","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/kQMMLKVxIe","expanded_url":"http://bit.ly/1m3i08B","display_url":"bit.ly/1m3i08B"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"479964481725161472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T12:30:24.000Z","conversation_id":"479964481725161472","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom’s law http://t.co/kQMMLKVxIe @MagdaE…","referenced_tweets":[{"type":"retweeted","id":"479962668154228736"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/6mBCTfNfg4","expanded_url":"http://bit.ly/1jCNfCE","display_url":"bit.ly/1jCNfCE"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{},"hashtags":{}},"id":"479955597576912896","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T11:55:06.000Z","conversation_id":"479955597576912896","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: AIFA GUEST EDITORIAL MDR-TB: Italian medcines agency supports compassionate use in children http://t.co/6mBCTfNfg4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/qB81nBBUmo","expanded_url":"http://bit.ly/1nSej5t","display_url":"bit.ly/1nSej5t"}],"mentions":{},"annotations":{},"hashtags":[{"start":30,"end":39,"tag":"medicine"}]},"id":"479947529879289856","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T11:23:02.000Z","conversation_id":"479947529879289856","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The June meeting of our human #medicine committee, CHMP, is next week. Highlights out on Friday: http://t.co/qB81nBBUmo","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{},"hashtags":{}},"id":"479946865698701313","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T11:20:24.000Z","conversation_id":"479946865698701313","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: New members being sought for the expert advisory groups and panels of experts of the British Pharmacopoeia Commission http:/…","referenced_tweets":[{"type":"retweeted","id":"479944271232253952"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/R7yByAtjt7","expanded_url":"http://go.usa.gov/9T9Y","display_url":"go.usa.gov/9T9Y"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":50,"end":63,"tag":"testosterone"}]},"id":"479946782689210368","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T11:20:04.000Z","conversation_id":"479946782689210368","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: #FDA adding general warning to #testosterone products about potential for venous blood clots. http://t.co/R7yByAtjt7","referenced_tweets":[{"type":"retweeted","id":"479943407679582208"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/etd7sliA2l","expanded_url":"http://europa.eu/rapid/press-release_IP-14-418_en.htm","display_url":"europa.eu/rapid/press-re…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{},"hashtags":[{"start":122,"end":128,"tag":"EPSCO"}]},"id":"479946400789438464","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T11:18:33.000Z","conversation_id":"479946400789438464","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Public health: Joint purchasing of vaccines and medicines becomes a reality in the EU http://t.co/etd7sliA2l #EPSCO","referenced_tweets":[{"type":"retweeted","id":"479936511195230208"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/u2FWRmN6bk","expanded_url":"http://bit.ly/1oNxQaG","display_url":"bit.ly/1oNxQaG"},{"start":92,"end":114,"url":"http://t.co/Rst0dAwWw4","expanded_url":"https://twitter.com/EFPIA/status/479916984231288832/photo/1","display_url":"pic.twitter.com/Rst0dAwWw4"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":11,"end":12,"probability":0.9222,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"id":"479917426164133888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T09:23:25.000Z","conversation_id":"479917426164133888","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: UK commits to new action to find breakthrough on dementia http://t.co/u2FWRmN6bk http://t.co/Rst0dAwWw4","referenced_tweets":[{"type":"retweeted","id":"479916984231288832"}],"attachments":{"media_keys":["3_479916983291371520"]}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/u54Mnl2M1G","expanded_url":"http://bit.ly/1uJ2kIc","display_url":"bit.ly/1uJ2kIc"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":99,"end":113,"username":"medtecheurope","id":"183254309"}],"annotations":{},"hashtags":{}},"id":"479914568840642560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T09:12:04.000Z","conversation_id":"479914568840642560","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Superbugs: How diagnostics can help doctors reduce over-prescription of antibiotics via @medtecheurope http://t.co/u54Mnl2M1G","referenced_tweets":[{"type":"retweeted","id":"479913734224490496"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/EhYpYlvmNK","expanded_url":"http://ec.europa.eu/public_opinion/archives/eb_special_419_400_en.htm#411","display_url":"ec.europa.eu/public_opinion…"}],"mentions":[{"start":3,"end":19,"username":"EurobarometerEU","id":"304876789"}],"annotations":{},"hashtags":{}},"id":"479914307724267521","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T09:11:02.000Z","conversation_id":"479914307724267521","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EurobarometerEU: Patient Safety and Quality of Care http://t.co/EhYpYlvmNK","referenced_tweets":[{"type":"retweeted","id":"479911595032977408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/WeQXtKrFHZ","expanded_url":"http://europa.eu/!XG46VF","display_url":"europa.eu/!XG46VF"}],"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"},{"start":102,"end":111,"username":"gr2014eu","id":"1397477076"}],"annotations":{},"hashtags":[{"start":35,"end":47,"tag":"procurement"},{"start":95,"end":101,"tag":"EPSCO"}]},"id":"479908677668061184","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:48:39.000Z","conversation_id":"479908677668061184","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @borgton: Ground breaking Joint #procurement agreement on vaccines: I will sign later today #EPSCO @gr2014eu http://t.co/WeQXtKrFHZ","referenced_tweets":[{"type":"retweeted","id":"479907625069715456"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/pF1fZosqJc","expanded_url":"http://bit.ly/1mxa6TU","display_url":"bit.ly/1mxa6TU"}],"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"}]},"id":"479906076020981760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:38:19.000Z","conversation_id":"479906076020981760","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of our March Management Board meeting are now available on our website: http://t.co/pF1fZosqJc","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/pM2BRw9K5O","expanded_url":"http://bit.ly/UggQMo","display_url":"bit.ly/UggQMo"}],"mentions":{},"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Sylvant"},{"start":23,"end":34,"tag":"siltuximab"},{"start":43,"end":52,"tag":"medicine"},{"start":57,"end":67,"tag":"Castleman"}]},"id":"479905825092534272","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:37:19.000Z","conversation_id":"479905825092534272","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Sylvant (#siltuximab), a new #medicine for #Castleman’s disease, is now available on our website: http://t.co/pM2BRw9K5O","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/9p3p4LWkY1","expanded_url":"http://europa.eu/!nx36Ct","display_url":"europa.eu/!nx36Ct"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":68,"end":82,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":99,"end":106,"tag":"Cancer"}]},"id":"479903948552536064","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:29:52.000Z","conversation_id":"479903948552536064","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Call for expressions of interest to become member of @EU_Commission Expert Group on #Cancer Control http://t.co/9p3p4LWkY1. …","referenced_tweets":[{"type":"retweeted","id":"479903778217664512"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/qB81nBBUmo","expanded_url":"http://bit.ly/1nSej5t","display_url":"bit.ly/1nSej5t"}],"mentions":{},"annotations":{},"hashtags":[{"start":10,"end":19,"tag":"medicine"}]},"id":"479899914450001920","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:13:50.000Z","conversation_id":"479899914450001920","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our human #medicine committee, CHMP, meets next week. Highlights published on Friday: 23-26 June 2014 http://t.co/qB81nBBUmo","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/6fTnVpDMIQ","expanded_url":"http://chemicalwatch.com/20206/eu-science-committee-explains-potential-nanosilver-risks","display_url":"chemicalwatch.com/20206/eu-scien…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":50,"end":69,"probability":0.4513,"type":"Organization","normalized_text":"EU science committee"}],"hashtags":{}},"id":"479899077237547008","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:10:30.000Z","conversation_id":"479899077237547008","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Chemical Watch | News Item | EU science committee explains potential nanosilver risks http://t.co/6fTnVpDMIQ","referenced_tweets":[{"type":"retweeted","id":"479896912317788160"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/2mdJi1dn1v","expanded_url":"http://ow.ly/yfvLX","display_url":"ow.ly/yfvLX"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":109,"end":119,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":37,"end":51,"probability":0.4713,"type":"Organization","normalized_text":"EC Expert Group"}],"hashtags":[{"start":56,"end":63,"tag":"Cancer"},{"start":120,"end":127,"tag":"health"},{"start":128,"end":137,"tag":"patients"}]},"id":"479898160534679552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-20T08:06:52.000Z","conversation_id":"479898160534679552","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: Call for experts for EC Expert Group on #Cancer Control launched: http://t.co/2mdJi1dn1v via @EU_Health #health #patients #…","referenced_tweets":[{"type":"retweeted","id":"479894148414451712"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/4l07lmHifY","expanded_url":"http://bit.ly/1qvnXOs","display_url":"bit.ly/1qvnXOs"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":18,"end":24,"tag":"Smell"},{"start":35,"end":43,"tag":"imaging"},{"start":53,"end":63,"tag":"Parkinson"}]},"id":"479674158553759744","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T17:16:45.000Z","conversation_id":"479674158553759744","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: #Smell test plus #imaging may spot #Parkinson's early: http://t.co/4l07lmHifY","referenced_tweets":[{"type":"retweeted","id":"479650332666912768"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/IWuj9ayd2G","expanded_url":"http://bit.ly/1qvRho2","display_url":"bit.ly/1qvRho2"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":27,"end":40,"tag":"Stakeholders"}]},"id":"479674115004309504","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T17:16:35.000Z","conversation_id":"479674115004309504","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: EFSA launches #Stakeholders satisfaction survey. Have your say! http://t.co/IWuj9ayd2G","referenced_tweets":[{"type":"retweeted","id":"479651641415970816"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/oiS8CE07Om","expanded_url":"http://bit.ly/1sqdGFi","display_url":"bit.ly/1sqdGFi"}],"mentions":{},"annotations":{},"hashtags":[{"start":30,"end":45,"tag":"clinicaltrials"},{"start":86,"end":94,"tag":"EudraCT"}]},"id":"479673836787748865","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T17:15:29.000Z","conversation_id":"479673836787748865","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"It will soon be mandatory for #clinicaltrials sponsors to post summary results in the #EudraCT database: http://t.co/oiS8CE07Om","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/pM2BRw9K5O","expanded_url":"http://bit.ly/UggQMo","display_url":"bit.ly/UggQMo"}],"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":50,"tag":"Sylvant"},{"start":52,"end":63,"tag":"siltuximab"},{"start":68,"end":77,"tag":"medicine"},{"start":82,"end":92,"tag":"Castleman"}]},"id":"479609924876775424","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T13:01:31.000Z","conversation_id":"479609924876775424","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Sylvant (#siltuximab), a #medicine for #Castleman’s disease: http://t.co/pM2BRw9K5O","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/HhUj00eyE7","expanded_url":"http://europa.eu/!XB79Fr","display_url":"europa.eu/!XB79Fr"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":73,"end":83,"username":"EUCouncil","id":"206717989"}],"annotations":{},"hashtags":[{"start":22,"end":25,"tag":"EU"},{"start":48,"end":62,"tag":"patientsafety"}]},"id":"479609496483139584","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T12:59:49.000Z","conversation_id":"479609496483139584","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: How do #EU Member States address #patientsafety following @EUCouncil recommendation in 2009? http://t.co/HhUj00eyE7 http://t…","referenced_tweets":[{"type":"retweeted","id":"479572585093799936"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Vacancy"},{"start":43,"end":56,"tag":"statistician"}]},"id":"479609322096578560","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T12:59:07.000Z","conversation_id":"479609322096578560","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #Vacancy. Are you a dedicated #statistician with proven experience in quantitative data analysis and modelling? Apply http://t…","referenced_tweets":[{"type":"retweeted","id":"479579351798018048"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/HhUj00eyE7","expanded_url":"http://europa.eu/!XB79Fr","display_url":"europa.eu/!XB79Fr"},{"start":106,"end":128,"url":"http://t.co/LGRjSV44Jm","expanded_url":"https://twitter.com/EU_Health/status/479580879736832000/photo/1","display_url":"pic.twitter.com/LGRjSV44Jm"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":53,"end":62,"tag":"patients"},{"start":64,"end":78,"tag":"patientsafety"},{"start":79,"end":82,"tag":"EU"}]},"id":"479609268447215616","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T12:58:54.000Z","conversation_id":"479609268447215616","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: What type of adverse events happen to #patients? #patientsafety #EU http://t.co/HhUj00eyE7 http://t.co/LGRjSV44Jm","referenced_tweets":[{"type":"retweeted","id":"479580879736832000"}],"attachments":{"media_keys":["3_479580878746578944"]}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/lRWyEE5Lwl","expanded_url":"http://bit.ly/Ug2bRm","display_url":"bit.ly/Ug2bRm"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Obesity"}]},"id":"479608908991184896","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T12:57:29.000Z","conversation_id":"479608908991184896","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EPHA_EU: #Obesity: policymaker survey 2014. Perception and policy– multi-country review &amp; survey of policymakers:http://t.co/lRWyEE5Lwl…","referenced_tweets":[{"type":"retweeted","id":"479598394068205569"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/EHvjxRLax8","expanded_url":"http://1.usa.gov/1vXzczs","display_url":"1.usa.gov/1vXzczs"}],"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"annotations":{},"hashtags":[{"start":135,"end":139,"tag":"fda"}]},"id":"479608655856533504","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T12:56:28.000Z","conversation_id":"479608655856533504","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAcdrhIndustry: Draft Guidance -  Internet/Social Media: \nCorrecting Misinformation re Drugs &amp; Devices http://t.co/EHvjxRLax8 #fda #me…","referenced_tweets":[{"type":"retweeted","id":"479606405071396864"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/pF1fZosqJc","expanded_url":"http://bit.ly/1mxa6TU","display_url":"bit.ly/1mxa6TU"}],"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"}]},"id":"479607643246706688","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T12:52:27.000Z","conversation_id":"479607643246706688","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our Management Board meeting in March: http://t.co/pF1fZosqJc","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/oiS8CE07Om","expanded_url":"http://bit.ly/1sqdGFi","display_url":"bit.ly/1sqdGFi"}],"mentions":{},"annotations":{},"hashtags":[{"start":38,"end":53,"tag":"clinicaltrials"},{"start":94,"end":102,"tag":"EudraCT"}]},"id":"479571991616577536","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-19T10:30:47.000Z","conversation_id":"479571991616577536","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":6,"quote_count":0},"lang":"en","text":"From 21 July it will be mandatory for #clinicaltrials sponsors to post summary results in the #EudraCT database: http://t.co/oiS8CE07Om","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":66,"end":74,"tag":"Coxiril"},{"start":94,"end":99,"tag":"feed"},{"start":113,"end":120,"tag":"guinea"}]},"id":"479291328648716288","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T15:55:32.000Z","conversation_id":"479291328648716288","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: Scientific Opinion on the safety and efficacy of #Coxiril® (diclazuril) as a #feed additive for #guinea fowl http://t.co/S…","referenced_tweets":[{"type":"retweeted","id":"479290800028016640"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":66,"end":74,"tag":"Coxiril"},{"start":94,"end":99,"tag":"feed"}]},"id":"479291017347477504","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T15:54:18.000Z","conversation_id":"479291017347477504","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: Scientific Opinion on the safety and efficacy of #Coxiril® (diclazuril) as a #feed additive for turkeys for fattening http…","referenced_tweets":[{"type":"retweeted","id":"479290270283231233"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{}},"id":"479288530116820992","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T15:44:25.000Z","conversation_id":"479288530116820992","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: REMINDER: Join @DrFriedenCDC &amp; @CMSinnovates for #SafeCareChat TODAY, June 18, 2-3PM EDT to discuss #patientsafety &amp; how to #sa…","referenced_tweets":[{"type":"retweeted","id":"479288282615148545"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":72,"end":86,"tag":"antimicrobial"},{"start":104,"end":115,"tag":"healthcare"}]},"id":"479284104052375552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T15:26:49.000Z","conversation_id":"479284104052375552","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Directory w/ online resources: prevention &amp; control of #antimicrobial resistance &amp; #healthcare-associated infections http://t.…","referenced_tweets":[{"type":"retweeted","id":"479282931014565888"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"479279326253551616","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T15:07:50.000Z","conversation_id":"479279326253551616","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Webinar on IMI 2-Call 1 New procedures, rules, guidance &amp; IPR - 14 July 2014, Online: New procedures, rules,... http:/…","referenced_tweets":[{"type":"retweeted","id":"479275115624951808"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":50,"end":55,"tag":"IMI2"},{"start":71,"end":80,"tag":"diabetes"},{"start":87,"end":95,"tag":"retinal"}]},"id":"479279051241455616","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T15:06:45.000Z","conversation_id":"479279051241455616","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: We’re counting down for the launch of #IMI2 with topics on #diabetes &amp; #retinal disease. Learn more at our webinars http://t.co…","referenced_tweets":[{"type":"retweeted","id":"479273040560525312"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"479268837352013825","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T14:26:09.000Z","conversation_id":"479268837352013825","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Webinar on IMI 2-Call 1 New procedures, rules, guidance &amp; IPR - 14 July 2014, Online: New procedures, rules,... http:/…","referenced_tweets":[{"type":"retweeted","id":"479268483792789504"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"479268825264054272","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T14:26:07.000Z","conversation_id":"479268825264054272","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Webinar on IMI 2-Call 1 diabetes topic - 11 July 2014, Online: Translational approaches to disease modifying... http:/…","referenced_tweets":[{"type":"retweeted","id":"479268476008153089"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":{}},"id":"479268813205417984","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T14:26:04.000Z","conversation_id":"479268813205417984","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Webinar on IMI 2-Call 1 retinal diseases - 15 July 2014, Online: Discovery and validation of novel endpoints in... htt…","referenced_tweets":[{"type":"retweeted","id":"479268466671632384"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/l0lsZWNDvB","expanded_url":"http://ht.ly/yaYkS","display_url":"ht.ly/yaYkS"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":{},"hashtags":[{"start":37,"end":41,"tag":"FDA"},{"start":121,"end":130,"tag":"FDAvoice"}]},"id":"479257567802449920","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T13:41:23.000Z","conversation_id":"479257567802449920","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: Blog post on new draft #FDA social media guidance - designed with patients in mind: http://t.co/l0lsZWNDvB #FDAvoice","referenced_tweets":[{"type":"retweeted","id":"479253446689038336"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/n7h9gtYpyr","expanded_url":"http://bit.ly/1njwUp8","display_url":"bit.ly/1njwUp8"},{"start":119,"end":141,"url":"http://t.co/6XWTXGWsW4","expanded_url":"http://bit.ly/ULLBJR","display_url":"bit.ly/ULLBJR"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{},"hashtags":[{"start":49,"end":65,"tag":"plantprotection"},{"start":72,"end":77,"tag":"bees"},{"start":79,"end":92,"tag":"microbiology"}]},"id":"479256581927092225","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T13:37:27.000Z","conversation_id":"479256581927092225","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @agesnews: Jobs at Austrian medicines agency: #plantprotection &amp; #bees, #microbiology... http://t.co/n7h9gtYpyr http://t.co/6XWTXGWsW4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/7o4jZL8oCx","expanded_url":"http://bit.ly/1jysb04","display_url":"bit.ly/1jysb04"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":100,"end":111,"username":"MagdaEfpia","id":"301066342"}],"annotations":{},"hashtags":{}},"id":"479243108136521728","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T12:43:55.000Z","conversation_id":"479243108136521728","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Innovative Medicines Initiative to recruit new Executive Director http://t.co/7o4jZL8oCx @MagdaEfpia","referenced_tweets":[{"type":"retweeted","id":"479242037666271232"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{},"hashtags":{}},"id":"479242863566663680","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T12:42:57.000Z","conversation_id":"479242863566663680","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Class 2 Medicines Recall (action within 48 hours): Clarithromycin 500mg Powder for Solution for Infusion in Ag... http:/…","referenced_tweets":[{"type":"retweeted","id":"479242791680110592"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":87,"end":92,"probability":0.9898,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":122,"end":132,"tag":"EFSApanel"}]},"id":"479239707625545728","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T12:30:24.000Z","conversation_id":"479239707625545728","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Interested in delivering high-quality scientific advice on food &amp; feed to Europe’s decision-makers? Join #EFSApanel. http://t.…","referenced_tweets":[{"type":"retweeted","id":"479239613677338624"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/0fn4ixcJ3z","expanded_url":"http://bit.ly/1r6rvEe","display_url":"bit.ly/1r6rvEe"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":{}},"id":"479231631237320704","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T11:58:19.000Z","conversation_id":"479231631237320704","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI is recruiting a new Executive Director – deadline for applications is 16 July http://t.co/0fn4ixcJ3z","referenced_tweets":[{"type":"retweeted","id":"479231435887607809"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/K3wrDSwkzU","expanded_url":"http://bit.ly/1vQ9DjK","display_url":"bit.ly/1vQ9DjK"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":69,"end":71,"probability":0.5046,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"id":"479213601635708928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T10:46:40.000Z","conversation_id":"479213601635708928","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: First steps of adaptive licensing pilot project, EMA has selected first two medicines http://t.co/K3wrDSwkzU","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":116,"end":119,"probability":0.9766,"type":"Place","normalized_text":"Oslo"}],"hashtags":[{"start":13,"end":35,"tag":"ScientificCooperation"},{"start":43,"end":58,"tag":"RiskAssessment"},{"start":98,"end":112,"tag":"AdvisoryForum"}]},"id":"479204253064761344","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T10:09:31.000Z","conversation_id":"479204253064761344","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #ScientificCooperation and EU #RiskAssessment agenda being discussed today at EFSA’s #AdvisoryForum in Oslo http://t.co/XiMkrO…","referenced_tweets":[{"type":"retweeted","id":"479201016702074881"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/Xk3JQ5IhAb","expanded_url":"http://bit.ly/1l0rGAz","display_url":"bit.ly/1l0rGAz"}],"mentions":{},"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Revinty"},{"start":22,"end":30,"tag":"Ellipta"},{"start":32,"end":44,"tag":"fluticasone"},{"start":55,"end":66,"tag":"vilanterol"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":92,"tag":"asthma"},{"start":97,"end":102,"tag":"COPD"}]},"id":"479187688453857280","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T09:03:42.000Z","conversation_id":"479187688453857280","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The EPAR for #Revinty #Ellipta (#fluticasone furoate / #vilanterol), a #medicine for #asthma and #COPD, is available: http://t.co/Xk3JQ5IhAb","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/rngLegp5JZ","expanded_url":"http://bit.ly/1nM4vse","display_url":"bit.ly/1nM4vse"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":22,"tag":"ESOF2014"},{"start":35,"end":40,"tag":"EFSA"},{"start":68,"end":83,"tag":"RiskAssessment"},{"start":88,"end":92,"tag":"Bee"}]},"id":"479187471788695552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T09:02:50.000Z","conversation_id":"479187471788695552","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #ESOF2014: Don't miss #EFSA’s seminar on environmental #RiskAssessment and #Bee Health on 25 June http://t.co/rngLegp5JZ","referenced_tweets":[{"type":"retweeted","id":"479186763240718336"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/5DHIeJ5Asa","expanded_url":"http://bit.ly/1qomEAO","display_url":"bit.ly/1qomEAO"}],"mentions":{},"annotations":{},"hashtags":[{"start":68,"end":75,"tag":"cancer"},{"start":125,"end":138,"tag":"consultation"}]},"id":"479187235770990592","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T09:01:54.000Z","conversation_id":"479187235770990592","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment now on our reflection paper on patient-reported outcomes in #cancer studies. Deadline 30 Nov: http://t.co/5DHIeJ5Asa #consultation","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/aUJ5YgLoDS","expanded_url":"http://bit.ly/1jy4ncQ","display_url":"bit.ly/1jy4ncQ"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":{}},"id":"479186533573218304","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T08:59:07.000Z","conversation_id":"479186533573218304","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Genetic pathway can slow spread of ovarian cancer http://t.co/aUJ5YgLoDS","referenced_tweets":[{"type":"retweeted","id":"479185709262454784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{}},"id":"479183927547289600","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T08:48:45.000Z","conversation_id":"479183927547289600","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: Our updated guidance on atrial fibrillation says 1000s of people could be saved by offering them the right treatments http:/…","referenced_tweets":[{"type":"retweeted","id":"479179583779270657"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/62rlPVkjjL","expanded_url":"http://bit.ly/1qbRiLu","display_url":"bit.ly/1qbRiLu"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":103,"end":114,"username":"MagdaEfpia","id":"301066342"},{"start":115,"end":122,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":123,"end":128,"tag":"IMI2"},{"start":129,"end":138,"tag":"JTIs2014"}]},"id":"479183878645886976","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T08:48:34.000Z","conversation_id":"479183878645886976","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Three Week to Go until Second Innovative Medicines Initiative Launch http://t.co/62rlPVkjjL @MagdaEfpia @IMI_JU #IMI2 #JTIs2014","referenced_tweets":[{"type":"retweeted","id":"479179355965644801"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/qQsKrv62jM","expanded_url":"http://bit.ly/TTGaru","display_url":"bit.ly/TTGaru"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{},"hashtags":[{"start":92,"end":107,"tag":"immunizeEurope"},{"start":108,"end":121,"tag":"VaccinesWork"}]},"id":"479182803993911296","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-18T08:44:17.000Z","conversation_id":"479182803993911296","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: Applying the anti-vaccine mentality to car seats http://t.co/qQsKrv62jM #immunizeEurope #VaccinesWork","referenced_tweets":[{"type":"retweeted","id":"479168296030601216"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":105,"end":112,"username":"CDCgov","id":"146569971"},{"start":113,"end":120,"username":"cdchep","id":"40271841"}],"annotations":{},"hashtags":[{"start":59,"end":69,"tag":"Hepatitis"}]},"id":"478945380525436929","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T17:00:51.000Z","conversation_id":"478945380525436929","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: 25th Anniversary of the Discovery of the #Hepatitis C Virus: Live webcast starting now @CDCgov @cdchep http://t.co/yOPTtZ…","referenced_tweets":[{"type":"retweeted","id":"478943934857498624"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/onDUF6VetS","expanded_url":"http://shar.es/PRThI","display_url":"shar.es/PRThI"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":132,"end":140,"username":"RAPSorg","id":"111425542"}],"annotations":{},"hashtags":[{"start":20,"end":24,"tag":"FDA"},{"start":43,"end":50,"tag":"Pharma"},{"start":76,"end":84,"tag":"Twitter"}]},"id":"478945046830788608","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T16:59:32.000Z","conversation_id":"478945046830788608","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @nakosbalamotis: #FDA Guidance: How Can #Pharma and Device Companies Use #Twitter? Not Easily. | RAPS http://t.co/onDUF6VetS via @RAPSorg","referenced_tweets":[{"type":"retweeted","id":"478939682072297472"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/cveRkSMW4k","expanded_url":"http://bit.ly/1pcT5k2","display_url":"bit.ly/1pcT5k2"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":17,"end":25,"tag":"Coxiril"}]},"id":"478936944421109760","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T16:27:20.000Z","conversation_id":"478936944421109760","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: #Coxiril® (diclazuril) for chickens for fattening http://t.co/cveRkSMW4k","referenced_tweets":[{"type":"retweeted","id":"478935227633782784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/4TkRhyiOJr","expanded_url":"http://bit.ly/1lxxrRw","display_url":"bit.ly/1lxxrRw"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":17,"end":24,"tag":"Oralin"}]},"id":"478936930772877313","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T16:27:17.000Z","conversation_id":"478936930772877313","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: #Oralin® for several species http://t.co/4TkRhyiOJr","referenced_tweets":[{"type":"retweeted","id":"478935210768482305"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/ClBNIKaH7q","expanded_url":"http://bit.ly/U6t4Hv","display_url":"bit.ly/U6t4Hv"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{},"hashtags":[{"start":17,"end":27,"tag":"Natugrain"}]},"id":"478936918949134336","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T16:27:14.000Z","conversation_id":"478936918949134336","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: #Natugrain® TS for laying hens http://t.co/ClBNIKaH7q","referenced_tweets":[{"type":"retweeted","id":"478935191109795840"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/ehsCz2JDSn","expanded_url":"http://bit.ly/1qoyYRH","display_url":"bit.ly/1qoyYRH"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":[{"start":41,"end":51,"probability":0.5072,"type":"Person","normalized_text":"Escherichia"}],"hashtags":{}},"id":"478936806197829632","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T16:26:47.000Z","conversation_id":"478936806197829632","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: L-Threonine produced by Escherichia coli for all animal species http://t.co/ehsCz2JDSn","referenced_tweets":[{"type":"retweeted","id":"478935174043152384"}],"attachments":{"media_keys":{}}},{"source":"Bitly","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Xk3JQ5IhAb","expanded_url":"http://bit.ly/1l0rGAz","display_url":"bit.ly/1l0rGAz"}],"mentions":{},"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Revinty"},{"start":22,"end":30,"tag":"Ellipta"},{"start":32,"end":44,"tag":"fluticasone"},{"start":55,"end":66,"tag":"vilanterol"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":92,"tag":"asthma"},{"start":97,"end":102,"tag":"COPD"}]},"id":"478930814445826048","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T16:02:58.000Z","conversation_id":"478930814445826048","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Revinty #Ellipta (#fluticasone furoate / #vilanterol), a #medicine for #asthma and #COPD, is now live: http://t.co/Xk3JQ5IhAb","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.8488,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"id":"478921590051467264","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T15:26:19.000Z","conversation_id":"478921590051467264","public_metrics":{"retweet_count":60,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: FDA Issues Draft Guidances for Industry on Social Media and Internet Communications About Medical Products http://t.co/lV3QZYkD…","referenced_tweets":[{"type":"retweeted","id":"478919950527373312"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/DasOClppgt","expanded_url":"http://bit.ly/1jwdeMb","display_url":"bit.ly/1jwdeMb"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":{}},"id":"478921320047316992","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T15:25:15.000Z","conversation_id":"478921320047316992","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Want to have the latest ECDC reports and publications?Subscribe here: http://t.co/DasOClppgt","referenced_tweets":[{"type":"retweeted","id":"478912369813635072"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/EvF4iMO7Nd","expanded_url":"http://go.usa.gov/9xzH","display_url":"go.usa.gov/9xzH"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":[{"start":16,"end":23,"tag":"SocMed"}]},"id":"478921250895835136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-06-17T15:24:58.000Z","conversation_id":"478921250895835136","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: New #SocMed Guidance for Industry on Correcting Misinformation http://t.co/EvF4iMO7Nd and Character Limitations http://t.co/1UU…","referenced_tweets":[{"type":"retweeted","id":"478912328420052992"}],"attachments":{"media_keys":{}}}]
